<ead xmlns="urn:isbn:1-931666-22-9" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:isbn:1-931666-22-9 http://www.loc.gov/ead/ead.xsd">
  <eadheader countryencoding="iso3166-1" dateencoding="iso8601" langencoding="iso639-2b" repositoryencoding="iso15511">
    <eadid>FA1103A.xml</eadid>
    <filedesc>
      <titlestmt>
        <titleproper type="filing">Rockefeller University collection of the Medical Letter publication, 1996-2004</titleproper>
        <titleproper>A Guide to the Rockefeller University collection of the Medical Letter publication, 1996-2004 <num>FA1103A</num></titleproper>
      </titlestmt>
      <publicationstmt>
        <publisher>Rockefeller Archive Center</publisher>
        <address>
          <addressline>15 Dayton Avenue</addressline>
          <addressline>Sleepy Hollow 10591</addressline>
          <addressline>archive@rockarch.org</addressline>
          <addressline>URL: <extptr xlink:href="http://www.rockarch.org" xlink:show="new" xlink:title="http://www.rockarch.org" xlink:type="simple"/></addressline>
        </address>
      </publicationstmt>
    </filedesc>
    <profiledesc>
      <creation>This finding aid was produced using ArchivesSpace on <date>2017-03-02 02:18:56 -0500</date>.</creation>
      <descrules>Describing Archives: A Content Standard</descrules>
    </profiledesc>
  </eadheader>
  <archdesc level="collection">
    <did>
      <langmaterial>
        <language langcode="eng">English</language>
      </langmaterial>
      <repository>
        <corpname>Rockefeller Archive Center</corpname>
      </repository>
      <unittitle>Rockefeller University collection of the Medical Letter publication</unittitle>
      <origination label="creator">
        <corpname role="aut" source="lcnaf">Rockefeller University</corpname>
      </origination>
      <origination label="creator">
        <corpname role="aut" source="lcnaf">Medical Letter, Inc</corpname>
      </origination>
      <unitid>FA1103A</unitid>
      <physdesc altrender="whole">
        <extent altrender="materialtype spaceoccupied">122.5 Cubic Feet</extent>
      </physdesc>
      <unitdate normal="1996/2004" type="inclusive">1996-2004</unitdate>
    </did>
    <processinfo id="4f6518ea8bae3b64eb48a7b6e5a4ac82">
      <head>Processing Information</head>
      <p>Minimal processing</p>
    </processinfo>
    <prefercite id="08d6bd5a3343d88ae174562240e1c48c">
      <head>Preferred Citation</head>
      <p>Information regarding the Rockefeller Archive Center's preferred elements and forms of citation can be found at <extref href="http://www.rockarch.org/research/citations.php">http://www.rockarch.org/research/citations.php</extref></p>
    </prefercite>
    <accessrestrict id="8e22992d16c1acad66ec2350a423e469">
      <head>Conditions Governing Access</head>
      <p>Records more than 25 years old are open for research with select materials restricted as noted. Brittle or damaged items are available at the discretion of RAC.</p>
    </accessrestrict>
    <fileplan id="b18026630ad0911a346cf5ce064ebdd5">
      <head>File Plan</head>
      <p>Former Classification: I 891-U</p>
    </fileplan>
    <otherfindaid id="80d67a066600f6ef1d33e75468f27af6">
      <head>Other Finding Aids</head>
      <p>For additional Medical Letter materials open for research see:</p>
      <p>FA241 Rockefeller University collection of the Medical Lettter publication</p>
    </otherfindaid>
    <scopecontent id="96fc3f4b0ecc38c530137eb411f39ada">
      <head>Scope and Contents</head>
      <p>Contents includes: original manuscripts, reprints, advertising and package inserts, sources check, consultatnts drafts, manufacturers replies, and bibliography.</p>
    </scopecontent>
    <bioghist id="6c159867ba2a2151b8b7399752c3890b">
      <head>Biographical / Historical</head>
      <p>The Medical Letter on Drugs and Therapeutics is an independent, non-profit publication providing unbiased critical evaluation of drugs in terms of their effectiveness, adverse effects and possible alternative medications.</p>
    </bioghist>
    <userestrict id="37e428481bbdbecee9f5c722527c7cfc">
      <head>Conditions Governing Use</head>
      <p>Use agreement is required prior to providing access. See RAC Head of Reference for assistance.</p>
    </userestrict>
    <dsc>
      <c id="722d135ab2e6b9a0415068e6118db069" level="file">
        <did>
          <unittitle>TML, 38-9 - Acarbose for diabetes mellitus</unittitle>
          <unitdate type="inclusive">1996 February 2</unitdate>
          <container id="cdaa36e1f79eb2fffd454637a12c605c" label="mixed materials (A0000000075844)" type="box">1</container>
          <container id="230df5fe0c8202c298a5c888daf7e104" parent="cdaa36e1f79eb2fffd454637a12c605c" type="folder">1-4</container>
        </did>
        <accessrestrict id="6413d819e0f61297a55139d343bc6b2f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="8e0dd5900ff39bfca71872aabc11f428" level="file">
        <did>
          <unittitle>TML, 38-55 - Acetaminophen, NSAIDs and Alcohol</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="eb20cfe7502242b192e3b81205e4b521" label="mixed materials (A0000000075844)" type="box">1</container>
          <container id="6477e84cf969d28a1e17762f19762433" parent="eb20cfe7502242b192e3b81205e4b521" type="folder">5-7</container>
        </did>
        <accessrestrict id="656f8049cade326890b44a882a172390">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="92bb9fbbd017dace4f8bbbdfdcec0a7a" level="file">
        <did>
          <unittitle>TML, 38-43 - Acute reactions to Drugs of Abuse</unittitle>
          <unitdate type="inclusive">1996 May 10</unitdate>
          <container id="df10775334ff804a7d6e3506eb3fa72a" label="mixed materials (A0000000075844)" type="box">1</container>
          <container id="7769ec3988378011e8b0e41767603777" parent="df10775334ff804a7d6e3506eb3fa72a" type="folder">8-12</container>
        </did>
        <accessrestrict id="ca3616172a78ef218806617937be4ae3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="299c68349552c9c16b93a8a4762f739e" level="file">
        <did>
          <unittitle>TML, 38-35 - New drugs for HIV</unittitle>
          <unitdate type="inclusive">1996 April 12</unitdate>
          <container id="620403c4b65be358485a72bd69f411c3" label="mixed materials (A0000000075844)" type="box">1</container>
          <container id="56bca4933969ebb05bda5c1ee584c94f" parent="620403c4b65be358485a72bd69f411c3" type="folder">13-17</container>
        </did>
        <accessrestrict id="86a00cb09aea1b9f00fe35947afa8c0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c5fa85f3bd2884f1a9dfd36830a4fb4d" level="file">
        <did>
          <unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="388a604b772ac459f687598abcbbb22d" label="mixed materials (A0000000075844)" type="box">1</container>
          <container id="b506ee80c01f0360a717054105246558" parent="388a604b772ac459f687598abcbbb22d" type="folder">18</container>
        </did>
        <accessrestrict id="6490910db6cb9773d516babe0e3ba2c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="25c672276d8de231f00bfa483bb42cb2" level="file">
        <did>
          <unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="f3137a9075fe4901f58fc110e1a1c0a9" label="mixed materials (A0000000075845)" type="box">2</container>
          <container id="53035046f80ecb7f953b61190d9517f6" parent="f3137a9075fe4901f58fc110e1a1c0a9" type="folder">1-3</container>
        </did>
        <accessrestrict id="2d841e9b213eca4386b5020a0f960ab2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="520cba0819f4d1a661ffbae9d84a72d2" level="file">
        <did>
          <unittitle>TML, 38-61 - Anatrozle for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="26b7cccdc0c030bbe4a5de0caecc4839" label="mixed materials (A0000000075845)" type="box">2</container>
          <container id="bb282f6faa2d4258d0154bd09a290606" parent="26b7cccdc0c030bbe4a5de0caecc4839" type="folder">4-6</container>
        </did>
        <accessrestrict id="391e7265783eb309c372f58724caf420">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="b466c2ae20545eb902a029aabfadd4a2" level="file">
        <did>
          <unittitle>TML, 38-25 - Choice of Antimicrobial Drugs</unittitle>
          <unitdate type="inclusive">1996 March 29</unitdate>
          <container id="45578806a402f7e03cd62535852dca1c" label="mixed materials (A0000000075845)" type="box">2</container>
          <container id="7e6d111bb0241f6df39237ea7427855a" parent="45578806a402f7e03cd62535852dca1c" type="folder">7-9</container>
        </did>
        <accessrestrict id="abc8cefbfb0e5ceded73db45b93e2776">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="ef71891079fc8afb056a13746e052f75" level="file">
        <did>
          <unittitle>TML, 38-52 - Drugs for Cardiac Arrythmias</unittitle>
          <unitdate type="inclusive">1996 August 30</unitdate>
          <container id="45acf04a8bfa7d0639196cf9a3dddbdb" label="mixed materials (A0000000075845)" type="box">2</container>
          <container id="9e6b622c6ac0469d07a451fc3a4412fb" parent="45acf04a8bfa7d0639196cf9a3dddbdb" type="folder">10-16</container>
        </did>
        <accessrestrict id="e9ba90f8f6e01a82041a2cb46e749402">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="630284f8fa9310d4604f35f82942ec99" level="file">
        <did>
          <unittitle>TML, 38-52 - Azelaic acid a new topical drug for acne</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="6fb6f0cda4bd2602bf1107ccd9b5b607" label="mixed materials (A0000000075845)" type="box">2</container>
          <container id="7b7d0e40730b8256fa48812c916c1763" parent="6fb6f0cda4bd2602bf1107ccd9b5b607" type="folder">17-18</container>
        </did>
        <accessrestrict id="7d350d2c114c77a5007cc5bd6bef48d0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="4b06c4e94eeae1bbd7e893099db3bb23" level="file">
        <did>
          <unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="87843555b3d15c5cf9fb43066e6d11b6" label="mixed materials (A0000000075845)" type="box">2</container>
          <container id="17d2856ba20753b20ca460b58b5d9208" parent="87843555b3d15c5cf9fb43066e6d11b6" type="folder">19-20</container>
        </did>
        <accessrestrict id="c9d5e1a415d2921805aa74b729504b02">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="cdf8cc07b4cfdaccc7c2d14cfe460d41" level="file">
        <did>
          <unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="270624c8abb5187e91f9b7851ec65a85" label="mixed materials (A0000000075846)" type="box">3</container>
          <container id="de682954fcefdf477cfcc4f8a050938e" parent="270624c8abb5187e91f9b7851ec65a85" type="folder">1</container>
        </did>
        <accessrestrict id="bc8ec69f68ddfbb05692b444a9d33f73">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="8e8440ccfa5de303b70df4a8556b7da1" level="file">
        <did>
          <unittitle>TML, 38-103 - Bone Density Testing</unittitle>
          <unitdate type="inclusive">1996 November 26</unitdate>
          <container id="992302cea427031e8ef789f49e3b694e" label="mixed materials (A0000000075846)" type="box">3</container>
          <container id="7047d6cda2561766288d3075d589e975" parent="992302cea427031e8ef789f49e3b694e" type="folder">2-3</container>
        </did>
        <accessrestrict id="9371d9820f979006c113e8341494696d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="2bc3e056d1f8fa2492e7303d95310131" level="file">
        <did>
          <unittitle>TML, 37-109 - Dirithromycin</unittitle>
          <unitdate type="inclusive">1995 November 24</unitdate>
          <container id="573df347afebbe2ecffd0c71f2872da2" label="mixed materials (A0000000075846)" type="box">3</container>
          <container id="be1be561d1dda933246f7498417d6fb5" parent="573df347afebbe2ecffd0c71f2872da2" type="folder">4-7</container>
        </did>
        <accessrestrict id="70e63df474c05d465a52ed6834a63c2e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="404e68490aeea4bc03276bd2e1972297" level="file">
        <did>
          <unittitle>TML, 38-108 - Calcium Supplements</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="124280580d08032f6d92d0f76e46619e" label="mixed materials (A0000000075846)" type="box">3</container>
          <container id="d582ae60d7c00abfb548af82834abde3" parent="124280580d08032f6d92d0f76e46619e" type="folder">8-12</container>
        </did>
        <accessrestrict id="6397bcfd119b8dee01530ad0c01d2fe0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="787f855d64193a39aa5fa640c29b09f9" level="file">
        <did>
          <unittitle>TML, 38-40 - Radiofrequency cather abilation for treatment of cardiac arrhythmias</unittitle>
          <unitdate type="inclusive">1996 April 26</unitdate>
          <container id="3c837abc0747c1f4e0b4f0c053fc54a6" label="mixed materials (A0000000075846)" type="box">3</container>
          <container id="50a5c2452d8d3b3cd85bfc7d6487f040" parent="3c837abc0747c1f4e0b4f0c053fc54a6" type="folder">13-16</container>
        </did>
        <accessrestrict id="9407b24c4bbb8b9a8280fd95b434f402">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="6ee9fed32bd765fba31910157fc457da" level="file">
        <did>
          <unittitle>TML, 38-23 - Cetibuten - a new oral cephalosporin</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="0148174eaa684f3ddda2fbacbbde0a1e" label="mixed materials (A0000000075846)" type="box">3</container>
          <container id="631570ce50483ecae5c9ae60d39874ab" parent="0148174eaa684f3ddda2fbacbbde0a1e" type="folder">17-19</container>
        </did>
        <accessrestrict id="fe428baa314a27bf86569a7a685bf75c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="cf9669d33a59dba3ffbe8f50f22fca78" level="file">
        <did>
          <unittitle>TML, 38-84 - Cefepime (Maxime) - a new parenteral cephalosporin</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="f5791422c0004bda5fe97f247169a37f" label="mixed materials (A0000000075847)" type="box">4</container>
          <container id="03a7490e7acacdcacbd5f54a92406f90" parent="f5791422c0004bda5fe97f247169a37f" type="folder">1-4</container>
        </did>
        <accessrestrict id="cd47248ae2cfc55d2fb4424654263054">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="7dd0747a03e955ecdd43cb4fc77cc296" level="file">
        <did>
          <unittitle>TML, 38-46 - Chlorzoxazone hepatotoxsicity</unittitle>
          <unitdate type="inclusive">1996 May 10</unitdate>
          <container id="630a9e1d9f6fa0575a3a305986b014d2" label="mixed materials (A0000000075847)" type="box">4</container>
          <container id="520236eaa48dbe3662f8cf7388a88067" parent="630a9e1d9f6fa0575a3a305986b014d2" type="folder">5</container>
        </did>
        <accessrestrict id="2fb3ed462271aeec0fb14801053de435">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9050bc8c28970ad791e377582e9c079c" level="file">
        <did>
          <unittitle>TML, 38-67 - Choice of Lipid-Lowering drugs</unittitle>
          <unitdate type="inclusive">1996 August 2</unitdate>
          <container id="5817d1cad994a52e8e627c12364fd947" label="mixed materials (A0000000075847)" type="box">4</container>
          <container id="7f7a37696bd8bbfb6cc38bf45c114875" parent="5817d1cad994a52e8e627c12364fd947" type="folder">6-13</container>
        </did>
        <accessrestrict id="88da501863cd117b47bcae321e4b3b00">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="5c5e7299af1de05e46453f0fea0e1720" level="file">
        <did>
          <unittitle>TML, 38-21 - Cetirizine - a new antihistamine</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="770b11e5fe3ae4dc88ab124f39d4d066" label="mixed materials (A0000000075847)" type="box">4</container>
          <container id="0520ec4e966c08187f800c80edf00bf4" parent="770b11e5fe3ae4dc88ab124f39d4d066" type="folder">14-18</container>
        </did>
        <accessrestrict id="0f7c6d142759503d2196573bb0b89f9a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="0f91362447d7a3cdff68d7ebac520b38" level="file">
        <did>
          <unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="886916bb0d213141f518dafe6d6bf354" label="mixed materials (A0000000075847)" type="box">4</container>
          <container id="c3675a08b849109ac2734a2fe412ea2b" parent="886916bb0d213141f518dafe6d6bf354" type="folder">19-20</container>
        </did>
        <accessrestrict id="4e5c9545497b1cea799d01d6d8e16965">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c714362a04b8f852b521155e586e0af2" level="file">
        <did>
          <unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="4567c81a4964d58aec23e4b30029f9cc" label="mixed materials (A0000000075848)" type="box">5</container>
          <container id="5e8c7896c77944f5ad15e31b06c160ec" parent="4567c81a4964d58aec23e4b30029f9cc" type="folder">1</container>
        </did>
        <accessrestrict id="a545b57ddc41b86449988949e310c707">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="484f5bda82347b92c1fd763adae1bf8a" level="file">
        <did>
          <unittitle>TML, 38-64 - Dexfenfluramine for obesity</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="8a2b5d2e91a664474b5efe195e306002" label="mixed materials (A0000000075848)" type="box">5</container>
          <container id="2d1877fa967595b43313a5906e318144" parent="8a2b5d2e91a664474b5efe195e306002" type="folder">2-5</container>
        </did>
        <accessrestrict id="0ae4223f8a683f538d4cd77c366f1250">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="8d0423127d33593f9f53a6262dc9f97c" level="file">
        <did>
          <unittitle>TML, 38-87 - Docetaxel (Taxotere) for advanced breast cancer</unittitle>
          <unitdate type="inclusive">1996 September 27</unitdate>
          <container id="09ede2cdee3063652070b49881268644" label="mixed materials (A0000000075848)" type="box">5</container>
          <container id="859b83f28d939fed500dabd1a9feb34b" parent="09ede2cdee3063652070b49881268644" type="folder">6-8</container>
        </did>
        <accessrestrict id="ed7cc80f5cac6080418667469e63fcc5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="a348057f4e83121c70f8e63e18862273" level="file">
        <did>
          <unittitle>TML, 38-14 - Epoprostenol for primary pulmonary hypertension</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="68de4ca620b7ec033576cfea6aec10a8" label="mixed materials (A0000000075848)" type="box">5</container>
          <container id="6901d62e78c5148625a84fcccb559e45" parent="68de4ca620b7ec033576cfea6aec10a8" type="folder">9-10</container>
        </did>
        <accessrestrict id="9060f4c1941e62cde507283711c42123">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="4fb37dc500fa2658eede9f802e9df8f8" level="file">
        <did>
          <unittitle>TML, 38-95 - Fexofenadine</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="a8ca7d7649055ac131b18d29a4c1fd86" label="mixed materials (A0000000075848)" type="box">5</container>
          <container id="4e9e5dcf4cb6e165202d58c4f855c5c9" parent="a8ca7d7649055ac131b18d29a4c1fd86" type="folder">11-12</container>
        </did>
        <accessrestrict id="a8ff5bd8f8c9a8beb936876d0ab13404">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="64be8e3eb6b9a7f019087998bc44abd8" level="file">
        <did>
          <unittitle>TML, 37-13 - Fluvoxamine for obsessive compulsive disorder</unittitle>
          <unitdate type="inclusive">1995 February 17</unitdate>
          <container id="5707f49d1c22d0f08c580c6945cf5f23" label="mixed materials (A0000000075848)" type="box">5</container>
          <container id="e763fd23fb3d9bf40ae4d50f6922d75a" parent="5707f49d1c22d0f08c580c6945cf5f23" type="folder">13-16</container>
        </did>
        <accessrestrict id="695bcbd1bf632b907b932d7960966f9f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="892b6eca462f2e15ad9ec8aa8eca30aa" level="file">
        <did>
          <unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="7418487c4b9a8f55f7440d80cf029642" label="mixed materials (A0000000075848)" type="box">5</container>
          <container id="db8c6b0a008baeb7991995292e607aeb" parent="7418487c4b9a8f55f7440d80cf029642" type="folder">17-21</container>
        </did>
        <accessrestrict id="beb3673044e9a99bc1e5e6f80a600a9c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="35c106caf84841f600db741ede502382" level="file">
        <did>
          <unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="ba31a820039d519ef1f007ed49bb68b2" label="mixed materials (A0000000075849)" type="box">6</container>
          <container id="64f29780b0905df314aac86350df434f" parent="ba31a820039d519ef1f007ed49bb68b2" type="folder">1</container>
        </did>
        <accessrestrict id="f54d8351e9c7683733c760ddc9c6386f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9c02c90545e46d220940cf2a507e0a28" level="file">
        <did>
          <unittitle>TML, 38-10 - Systematic antifungal drugs</unittitle>
          <unitdate type="inclusive">1996 February 2</unitdate>
          <container id="54236efa8f47027b33682d878cf77f58" label="mixed materials (A0000000075849)" type="box">6</container>
          <container id="0d882b4d0252bedcde4c50d8c50ebd1a" parent="54236efa8f47027b33682d878cf77f58" type="folder">2-3</container>
        </did>
        <accessrestrict id="24650d75f7a4fe5ddaf748532b77d1c8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="af3d9dfc1b1412c493e47fcf1216a75b" level="file">
        <did>
          <unittitle>TML, 38-102 - Gemcitabine for treatment of pancreatic cancer</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="9807bb1db32b0f05b078fb453cea5058" label="mixed materials (A0000000075849)" type="box">6</container>
          <container id="c2b466db325453e16c290cd2ef0ab0ce" parent="9807bb1db32b0f05b078fb453cea5058" type="folder">4-6</container>
        </did>
        <accessrestrict id="7105d2dd194378e7c1b806e1786142c0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="237f462175824d3b36e04281c83344ac" level="file">
        <did>
          <unittitle>TML, 38-47 - Glimepiride for NIDDM</unittitle>
          <unitdate type="inclusive">1996 May 24</unitdate>
          <container id="5f0db6c80f36b2b4d0260f0cf2f06542" label="mixed materials (A0000000075849)" type="box">6</container>
          <container id="a491242e139bd61defbd05389b8d1972" parent="5f0db6c80f36b2b4d0260f0cf2f06542" type="folder">7-8</container>
        </did>
        <accessrestrict id="d0c68415f609b87b8e322217b54f482b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="f5f43d18d02fa3b8ac7f25b5d2f4bf4e" level="file">
        <did>
          <unittitle>TML, 38-92 - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">1996 October 11</unitdate>
          <container id="b6c358cf73533e3e0001a0550a3df526" label="mixed materials (A0000000075849)" type="box">6</container>
          <container id="e3368a58ff22c858a3a0db478330afbf" parent="b6c358cf73533e3e0001a0550a3df526" type="folder">9-13</container>
        </did>
        <accessrestrict id="a3631f3ddc4c9deaa183f2128f324ec8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="df185de80953b9ba72734fc53563026f" level="file">
        <did>
          <unittitle>TML, 37-73 - Grapefruit juice interactions with drugs</unittitle>
          <unitdate type="inclusive">1995 August 18</unitdate>
          <container id="aa8fdc845b8e5f2758f56b55d617d49c" label="mixed materials (A0000000075849)" type="box">6</container>
          <container id="31c8df1b21e7420f26830a2ec5a38c8d" parent="aa8fdc845b8e5f2758f56b55d617d49c" type="folder">14-16</container>
        </did>
        <accessrestrict id="ee2185b1e98265927be53db9e0fa2dda">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9ea393808d7941a34a9237ff7d3e21d0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="5fa44516bcebd2148d3a59f6a6d0aafd" label="mixed materials (A0000000075849)" type="box">6</container>
          <container id="9a9e33dcb53090a6c39add7be811318b" parent="5fa44516bcebd2148d3a59f6a6d0aafd" type="folder">17-20</container>
        </did>
        <accessrestrict id="052ebcc34a91845237e97c0df53775e3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="b5728f730c61991eb3d049832355c05c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="5a792bbee16b21a1489afd380e2f915c" label="mixed materials (A0000000075850)" type="box">7</container>
          <container id="0ace3b5b9f584092a292ad64eb8826c7" parent="5a792bbee16b21a1489afd380e2f915c" type="folder">1-2</container>
        </did>
        <accessrestrict id="8725ceb0317248c73c37ce2386f5e01b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="34fded3e81407289cef7298c43db888c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Pain</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="790927cc16f96aed73fa17f7eee6a9f8" label="mixed materials (A0000000075850)" type="box">7</container>
          <container id="fdadf3fef8f221d2bbf8870bba40c0c9" parent="790927cc16f96aed73fa17f7eee6a9f8" type="folder">3-7</container>
        </did>
        <accessrestrict id="fd6c1b22c3706f5ee95e16758bf6f9f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="73f114dc6e630afb990634a443031d95" level="file">
        <did>
          <unittitle>TML, 37-95 - OTC H2 Blockers for heartburn</unittitle>
          <unitdate type="inclusive">1995 October 27</unitdate>
          <container id="fe2ad466db31612e54a8ea16eb10dc00" label="mixed materials (A0000000075850)" type="box">7</container>
          <container id="c5e40bca52431ac6b0d8ac294d24fd68" parent="fe2ad466db31612e54a8ea16eb10dc00" type="folder">8-10</container>
        </did>
        <accessrestrict id="6f9d54ac52d448a971ae1e70ff68a5a9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e3ff759a8063b390ff0175205e40649d" level="file">
        <did>
          <unittitle>TML, 38-6 - Rho (D) IV Immune Globulin</unittitle>
          <unitdate type="inclusive">1996 January 19</unitdate>
          <container id="4cd995350ffd4f73f08639efeba56786" label="mixed materials (A0000000075850)" type="box">7</container>
          <container id="c9ac29617344a0135756ff1f7582ef5b" parent="4cd995350ffd4f73f08639efeba56786" type="folder">11-13</container>
        </did>
        <accessrestrict id="ce939d07fa2fe96e5b623cff81c37a02">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="343b5e9d7ba1058f32a08341d9be9f4a" level="file">
        <did>
          <unittitle>TML, 38-17 - Advice for Travelers</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="a4050bcf7f66fc85782ab43be5ee77a2" label="mixed materials (A0000000075850)" type="box">7</container>
          <container id="b4ee72036d42dbfbe19f446567054cee" parent="a4050bcf7f66fc85782ab43be5ee77a2" type="folder">14-16</container>
        </did>
        <accessrestrict id="c3bea7a676bd5b9981068ccf42242297">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="314ebfe0a12d0bad31002df2bbabf782" level="file">
        <did>
          <unittitle>TML, 37-98 - Influenza Vaccine, 1995-1996</unittitle>
          <unitdate type="inclusive">1995 September 1</unitdate>
          <container id="e7f0c6c00887d6db00a9550d4f62b800" label="mixed materials (A0000000075850)" type="box">7</container>
          <container id="69713c4d46d4a835acf81b39678ae247" parent="e7f0c6c00887d6db00a9550d4f62b800" type="folder">17</container>
        </did>
        <accessrestrict id="aaa5f55ecc1b4da36b3c2d152b9841b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="fa30b8e25d30bd60ee7b9207731748dd" level="file">
        <did>
          <unittitle>TML, 38-86 - Influenza Vaccine, 1996-1997</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="99ad23fbe8807430d05f3e9948cde4c5" label="mixed materials (A0000000075850)" type="box">7</container>
          <container id="0ea805e57d19229e51e60b5e2840a2f3" parent="99ad23fbe8807430d05f3e9948cde4c5" type="folder">18</container>
        </did>
        <accessrestrict id="5726a4d76a933c3152d68d2618f96f58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="76dcb6a56a7b5f83636afb906304e3de" level="file">
        <did>
          <unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="08851bd3d9e499ac9c76188a3a100f3b" label="mixed materials (A0000000075850)" type="box">7</container>
          <container id="931dd8b5307cdc51fd2a7469fe65ace0" parent="08851bd3d9e499ac9c76188a3a100f3b" type="folder">19</container>
        </did>
        <accessrestrict id="c85f0b8357c82829d2a4eb5e651846cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="bcfc06fa9fa8a02872f2c29e1146f46b" level="file">
        <did>
          <unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="8610791626c2b02f6572b35c723ad6cb" label="mixed materials (A0000000075851)" type="box">8</container>
          <container id="20be0048614f230c88a61c080e3b0bd9" parent="8610791626c2b02f6572b35c723ad6cb" type="folder">1-4</container>
        </did>
        <accessrestrict id="5afb2bc4dd74607653137719b41bcbd1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="ca2a00af5d69b29922032ebf4abb0fa9" level="file">
        <did>
          <unittitle>TML, 38-63 - Interferon beta IA for relapsing multiple sclerosis</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="3a952f87c1bfc8eecd8ad35c86e19709" label="mixed materials (A0000000075851)" type="box">8</container>
          <container id="8a8405eef757cccd3b5603be033fc2a9" parent="3a952f87c1bfc8eecd8ad35c86e19709" type="folder">5-6</container>
        </did>
        <accessrestrict id="03343319e99b7f0ef24a7fc83ce57bad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c90350a57c09afa4b1edf8990faf82c4" level="file">
        <did>
          <unittitle>TML, 38-5 - Intraconazole for onychomycosis</unittitle>
          <unitdate type="inclusive">1996 January 19</unitdate>
          <container id="59b40e47c56badc1c28f5cc933a28547" label="mixed materials (A0000000075851)" type="box">8</container>
          <container id="636a035c3535b26c957fea7c67bfc840" parent="59b40e47c56badc1c28f5cc933a28547" type="folder">7-10</container>
        </did>
        <accessrestrict id="a3ae42f0dfac2f6884835c0dd4cbe74b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="838bd206e5b57f1350c9a04ae42f2583" level="file">
        <did>
          <unittitle>TML, 38-100 - Latanoprost - A topical prostaglandin for glaucoma</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="04db29b0d4cf5379755ebf743cf9ffbe" label="mixed materials (A0000000075851)" type="box">8</container>
          <container id="bd7382fe5f43eec4f556a88583974631" parent="04db29b0d4cf5379755ebf743cf9ffbe" type="folder">11-14</container>
        </did>
        <accessrestrict id="2e48e9ac6a735700c373ee378f599caa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="45a205e5a189cb71c6708535b75c4937" level="file">
        <did>
          <unittitle>TML, 38-97 - Lispro - A rapid onset insulin</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="d08cf441388475208f549a6b3f396099" label="mixed materials (A0000000075851)" type="box">8</container>
          <container id="216ea396e28ba9207355ef8f181c335d" parent="d08cf441388475208f549a6b3f396099" type="folder">15-16</container>
        </did>
        <accessrestrict id="0c7d5401af543b0c0983defbe212a6e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="2cbe2967f283fa20d7d713e0125238d8" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="a769bc5a25f8547526b4e4635c8ff37b" label="mixed materials (A0000000075851)" type="box">8</container>
          <container id="364ee98947d7bc23b91c0d9e12fbc04b" parent="a769bc5a25f8547526b4e4635c8ff37b" type="folder">17-18</container>
        </did>
        <accessrestrict id="25976cdf1f32d7fc8a1e78cb2f48d34d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="f7093bc2141bbd10998f3dc5ff41875b" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="38029bbf165b143dc48695610080badb" label="mixed materials (A0000000075852)" type="box">9</container>
          <container id="3bdfc481fb8f3b39df36db08b2c02190" parent="38029bbf165b143dc48695610080badb" type="folder">1-3</container>
        </did>
        <accessrestrict id="5de98fca91cbe16591ff580840223c8c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e7f67d0b2048a576bdc2a8c6ef1f5674" level="file">
        <did>
          <unittitle>TML, 38-13 - Nisoldipine - a new calcium-channel blocker for hypertension</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="a732ec5e42f0dffbcf97ed78e23e3d6d" label="mixed materials (A0000000075852)" type="box">9</container>
          <container id="6a8b4a23de63ad78ba44c470867c4ede" parent="a732ec5e42f0dffbcf97ed78e23e3d6d" type="folder">4-7</container>
        </did>
        <accessrestrict id="310f0f0a8b17bda4d5be0d11e8e3909a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="0ab086d0742f0a6f31a054d358cbefcf" level="file">
        <did>
          <unittitle>TML, 35-62 - Nedocromil for asthma</unittitle>
          <unitdate type="inclusive">1993 July 9</unitdate>
          <container id="04392f3657fe618c3ad27e80ba8e7219" label="mixed materials (A0000000075852)" type="box">9</container>
          <container id="7b9c4c5e40b0f1387520cab51b43de89" parent="04392f3657fe618c3ad27e80ba8e7219" type="folder">8-12</container>
        </did>
        <accessrestrict id="d876b6e0e035d2d97ee9711f878a831c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9f3042b173404cf6a3ccd9df900d20c0" level="file">
        <did>
          <unittitle>TML, 38-1 - New drugs for osteoporosis</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="8c1eca9dcad48be47edb63a812078131" label="mixed materials (A0000000075852)" type="box">9</container>
          <container id="0a7855364c853abe4f8201323bf1092b" parent="8c1eca9dcad48be47edb63a812078131" type="folder">13-18</container>
        </did>
        <accessrestrict id="059f4c0e348f3f79f9eac8942a1b7673">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e20404fc9c2c5857d90b819cb9c70cc0" level="file">
        <did>
          <unittitle>TML, 38-53 - Prostatron</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="a03fed578ebc8b831a29cd2dd0a60e80" label="mixed materials (A0000000075852)" type="box">9</container>
          <container id="26903da1413b5081889b6b3c8aacd4d5" parent="a03fed578ebc8b831a29cd2dd0a60e80" type="folder">19-20</container>
        </did>
        <accessrestrict id="fa8555c81ed0ff184e52c7e939db327c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="cbfa8d04b93b4e3d89a843bbf9e3d7f8" level="file">
        <did>
          <unittitle>TML, 38-107 - Pallidotomy for Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="303529ea500858c0bb66322f7d3fca76" label="mixed materials (A0000000075853)" type="box">10</container>
          <container id="f3bd1e83f3431f05fd4b236b58734f60" parent="303529ea500858c0bb66322f7d3fca76" type="folder">1-3</container>
        </did>
        <accessrestrict id="6ec525e7fd9b38dcd1bce23ad46d101c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c1416d4fc58c7899cbc27ca73d15c172" level="file">
        <did>
          <unittitle>TML, 38-57 - Simethicone for gastrointestinal gas</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="f0897b7212dee40e7242b1622a610a71" label="mixed materials (A0000000075853)" type="box">10</container>
          <container id="731c819493f18c307f8a4325c6504e1e" parent="f0897b7212dee40e7242b1622a610a71" type="folder">4-5</container>
        </did>
        <accessrestrict id="76d78aedee8d1ddf219a07affe27bb10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="26af25957e59124a08f91eba499fc700" level="file">
        <did>
          <unittitle>TML, 38-106 - Sodium Phenylbutyrate for urea cycle enzyme deficiencies</unittitle>
          <unitdate type="inclusive">1996 November 22</unitdate>
          <container id="e39b18f5f324a7010d3e921cb87c505f" label="mixed materials (A0000000075853)" type="box">10</container>
          <container id="c2ccfbbb996ebaf7aa6f7fc0709d7993" parent="e39b18f5f324a7010d3e921cb87c505f" type="folder">6-7</container>
        </did>
        <accessrestrict id="8f55e867e223cf7fc8c205180e5bb1b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="4273a72d699f99aeabfcab12d5bde513" level="file">
        <did>
          <unittitle>TML, 38-72 - Terabinafine for onychomycosis</unittitle>
          <unitdate type="inclusive">1996 August 16</unitdate>
          <container id="ba2f47372e3edc32f5c7c79935536542" label="mixed materials (A0000000075853)" type="box">10</container>
          <container id="ffdb08d1bbe64938f212ad8f5a36c776" parent="ba2f47372e3edc32f5c7c79935536542" type="folder">8-11</container>
        </did>
        <accessrestrict id="f99d89a3af0b743be45c7d543c9a47b3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="afa8fcead3849c57e46148fac07fdf16" level="file">
        <did>
          <unittitle>TML, 38-49 - Androderm (Testosterone patches)</unittitle>
          <unitdate type="inclusive">1996 May 24</unitdate>
          <container id="44d84cc7901df7a2af1339e0652dbf05" label="mixed materials (A0000000075853)" type="box">10</container>
          <container id="27455b98db85a92810cef558a55a1488" parent="44d84cc7901df7a2af1339e0652dbf05" type="folder">12-15</container>
        </did>
        <accessrestrict id="6c9daad633f6ca6f23f9cb9675ec5725">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e83fc33c009862fb85873ce44225451e" level="file">
        <did>
          <unittitle>TML, 38-96 - Toptecan hydrochloride for metastic ovarian cancer</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="56948ff2e8269ef05f60fd2e0978cb78" label="mixed materials (A0000000075853)" type="box">10</container>
          <container id="3844c6f553ff5b819818e8bd5b73cbf2" parent="56948ff2e8269ef05f60fd2e0978cb78" type="folder">16-18</container>
        </did>
        <accessrestrict id="f4f4ca0b76dee28258679841660c3e53">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="1d1e2499f47a2c5a2498c508251c060e" level="file">
        <did>
          <unittitle>TML, 38-3 - Valacyclovir</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="cff2c6d18afaaf3e4dcd96af9d59b134" label="mixed materials (A0000000075853)" type="box">10</container>
          <container id="cc6bce3475da7cd9ef993d355096b8d3" parent="cff2c6d18afaaf3e4dcd96af9d59b134" type="folder">19</container>
        </did>
        <accessrestrict id="5e026f0f926c42121383574e48a743ca">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e3cd99c272218799e02c72a5e28f33c9" level="file">
        <did>
          <unittitle>TML, 38-3 - Valacyclovir</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="6891fd1afdf18ca48f6ebe2eaedb7ecc" label="mixed materials (A0000000075946)" type="box">11</container>
          <container id="74fe1e1f34d3132d8df5c7e03f048f6a" parent="6891fd1afdf18ca48f6ebe2eaedb7ecc" type="folder">1-2</container>
        </did>
        <accessrestrict id="ed67782a99870c0e712a42cf95c5cfc7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="2146f075bfb01adf0c99fddbe6268b26" level="file">
        <did>
          <unittitle>TML, 38-104 - Trandolapril - An ACE inhibitor for treatment of hypertension</unittitle>
          <unitdate type="inclusive">1996 November 22</unitdate>
          <container id="5d94ff3e16419678cf0995a487c30f9a" label="mixed materials (A0000000075946)" type="box">11</container>
          <container id="4e5ec573232c88b4f08eccb84575eb18" parent="5d94ff3e16419678cf0995a487c30f9a" type="folder">3-5</container>
        </did>
        <accessrestrict id="a1dd4aa7256167e609397b035b7478d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="7a2f268994b16b4876604d64167ade0b" level="file">
        <did>
          <unittitle>TML, 38-71 - Umbilical cord blood for bone marrow transplantation</unittitle>
          <unitdate type="inclusive">1996 August 16</unitdate>
          <container id="6db453f6be40a5a88ab7e921ef94a016" label="mixed materials (A0000000075946)" type="box">11</container>
          <container id="bb71dd5ea88ed5e0242f2111c8bc634b" parent="6db453f6be40a5a88ab7e921ef94a016" type="folder">6-8</container>
        </did>
        <accessrestrict id="c284795ebfbae6dd142f49e2c3d64449">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c7fa6ad1765f84becedf7fbe8dae1981" level="file">
        <did>
          <unittitle>TML, 38-51 - Clarithromycine and omeprazole of helliobacter pylori</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="194bb69e658cbdac21e6d1e5aca81fc9" label="mixed materials (A0000000075946)" type="box">11</container>
          <container id="6981a4b7f598a058a4a876b44bf618e0" parent="194bb69e658cbdac21e6d1e5aca81fc9" type="folder">9-11</container>
        </did>
        <accessrestrict id="d93e4e485f03621de43519409ecd0ebb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="d2847f832cf8b7dfa8bae10d4079561b" level="file">
        <did>
          <unittitle>TML, 38-15 - New Uses of Thalidomide</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="b8405d81f660f86e240ef2175f0c3946" label="mixed materials (A0000000075946)" type="box">11</container>
          <container id="0fa5dcacd4cef62865691b01aef233e3" parent="b8405d81f660f86e240ef2175f0c3946" type="folder">12-14</container>
        </did>
        <accessrestrict id="5a934c0b2b5e5cf25f836a73de95c999">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="07f911d357717fedb196ba2a95b08c6f" level="file">
        <did>
          <unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="788f434610892cbb944fed868476fcbf" label="mixed materials (A0000000075946)" type="box">11</container>
          <container id="a097853cd6087a2d8dcb28eac76febf3" parent="788f434610892cbb944fed868476fcbf" type="folder">15-19</container>
        </did>
        <accessrestrict id="7ad69902cf7b5b84adb8b1470b88ef97">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c0d2ae8c9a59eb2afc81bad688a8e0d9" level="file">
        <did>
          <unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="55d8281e8c3d42d9c33e8437e62bfbe6" label="mixed materials (A0000000075854)" type="box">12</container>
          <container id="bb42649cac5ee9f2627ad36b33a32560" parent="55d8281e8c3d42d9c33e8437e62bfbe6" type="folder">1-2</container>
        </did>
        <accessrestrict id="42570c5418d18c7d11e5ecb6d56fc38d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="0d91fc0adca0e054072c6a3fff1ac1f6" level="file">
        <did>
          <unittitle>TML, 38-65 - Drugs past their expiration date</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="c79cee94faefc27f8abc56165d139747" label="mixed materials (A0000000075854)" type="box">12</container>
          <container id="1639daf108aeefebdbb1d5d13eb0c4d1" parent="c79cee94faefc27f8abc56165d139747" type="folder">3-4</container>
        </did>
        <accessrestrict id="861175c1c60e1d08ff94909fca12e380">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="b6e8488842fc6d3ed56539b8c5e7c344" level="file">
        <did>
          <unittitle>TML, 38-38 - Ibutilide</unittitle>
          <unitdate type="inclusive">1996 April 12</unitdate>
          <container id="aea9730c3f063b26b8526801a7bed12e" label="mixed materials (A0000000075854)" type="box">12</container>
          <container id="a65526c93ca4a037513acf197052d92b" parent="aea9730c3f063b26b8526801a7bed12e" type="folder">5-6</container>
        </did>
        <accessrestrict id="d854aa1bc446941f011a8970567a2b37">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="93c5ceb8486269a6440d4a1164bd8a19" level="file">
        <did>
          <unittitle>TML, 38-91 - DHEA</unittitle>
          <unitdate type="inclusive">1996 October 11</unitdate>
          <container id="89daa81aed94b3316de405e1f03be393" label="mixed materials (A0000000075854)" type="box">12</container>
          <container id="1d36c692e8140694264e76032fea3194" parent="89daa81aed94b3316de405e1f03be393" type="folder">7-9</container>
        </did>
        <accessrestrict id="0b753cb331038a0a1193ae254361f43e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="489aaa51c24f7c3822366d6381860b83" level="file">
        <did>
          <unittitle>TML, 38-88 - Meropenem - A new parenteral broad-spectrum antibiotic</unittitle>
          <unitdate type="inclusive">1996 September 27</unitdate>
          <container id="c90eb8cf9c662863f6c482c5d9c42ada" label="mixed materials (A0000000075854)" type="box">12</container>
          <container id="826fb519ad465c8ab8f480a0a26a6360" parent="c90eb8cf9c662863f6c482c5d9c42ada" type="folder">10-14</container>
        </did>
        <accessrestrict id="06a4c2f05bc64d8b4ee6a3b07e593fe9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="3a54f51aec4a83bee985f1670be2aff6" level="file">
        <did>
          <unittitle>TML, 38-39 - Methotrexate and Misoprostol for abortion</unittitle>
          <unitdate type="inclusive">1996 April 26</unitdate>
          <container id="3bd087055bb14b7efc335d99cc9a6360" label="mixed materials (A0000000075854)" type="box">12</container>
          <container id="45c67632a4b2614da851716ba104eb51" parent="3bd087055bb14b7efc335d99cc9a6360" type="folder">15</container>
        </did>
        <accessrestrict id="6b3edef9531f4a2fde2d3628c5d7cdd0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="43193a32312eb0204d12fd64fa6b6993" level="file">
        <did>
          <unittitle>TML, 38-111 - Zafirlukast for asthma</unittitle>
          <unitdate type="inclusive">1996 December 20</unitdate>
          <container id="8963318b9ed05cc749f6545c24862906" label="mixed materials (A0000000075854)" type="box">12</container>
          <container id="e6b501e9c90307ae826ecc670f8c48bc" parent="8963318b9ed05cc749f6545c24862906" type="folder">16-18</container>
        </did>
        <accessrestrict id="13e892949bbc4a48ce8c4285b3b1007e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="49b7007dcadc3c636c88f299dc526e0d" level="file">
        <did>
          <unittitle>TML, 31-83 - Samarium 153 lexidronam for painful bone metastases</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="710ef00b18b549a1753f9a131fd1e60b" label="mixed materials (A0000000075855)" type="box">13</container>
          <container id="6a140c9763222bd058725c69af868d50" parent="710ef00b18b549a1753f9a131fd1e60b" type="folder">1-3</container>
        </did>
        <accessrestrict id="592e1bece31e2f3f6b5ae1b6e1a8011e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="61b0c640e3f013a34c64133724020fa2" level="file">
        <did>
          <unittitle>TML, 38-69 - Drugs for non-HIV viral infections</unittitle>
          <unitdate type="inclusive">1997 August 1</unitdate>
          <container id="f6a5c0414782bb9c46a6c10036d38e18" label="mixed materials (A0000000075855)" type="box">13</container>
          <container id="c02ab0a5a01b29be09d94141ebd638b1" parent="f6a5c0414782bb9c46a6c10036d38e18" type="folder">4-12</container>
        </did>
        <accessrestrict id="84c4988675afd57f7b095139aa7bfdfe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="133977107f40fa3272c401b7abcc89de" level="file">
        <did>
          <unittitle>TML, 39-18 - Zileuton for asthma</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="31e8ab451d2074d80aad86a60d75dcd3" label="mixed materials (A0000000075855)" type="box">13</container>
          <container id="955db1d438fbf51054b8b8743b777002" parent="31e8ab451d2074d80aad86a60d75dcd3" type="folder">13-14</container>
        </did>
        <accessrestrict id="4717fa288dd120e806e05499350ddf6f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="be46a606b805462c6cc03b6ec8b2c39e" level="file">
        <did>
          <unittitle>TML, 39-9 - Zinc for the common cold</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="06c06a278d825b6d80b6bda8c66a3376" label="mixed materials (A0000000075855)" type="box">13</container>
          <container id="7242c09f2665c9a1c016cb97ef509153" parent="06c06a278d825b6d80b6bda8c66a3376" type="folder">15-17</container>
        </did>
        <accessrestrict id="ad1088be46d6652eb0405e32258a0bf9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="1a7499e6fbd604c0b75b6d778dc5c0f9" level="file">
        <did>
          <unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="abfda4ec3aa13e0264bb3ebb4088bf45" label="mixed materials (A0000000075855)" type="box">13</container>
          <container id="6fff445d5d21224ec2f64d009052e653" parent="abfda4ec3aa13e0264bb3ebb4088bf45" type="folder">18-20</container>
        </did>
        <accessrestrict id="ebe0ac100a42ac94570bd02c0e0ccdbb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="c3fee2e8cf6e2d58695098807e086dab" level="file">
        <did>
          <unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="567ebf24ec2003110d429effbb8dd91c" label="mixed materials (A0000000075856)" type="box">14</container>
          <container id="7160b90a58cdfc457d45dbded857d024" parent="567ebf24ec2003110d429effbb8dd91c" type="folder">1</container>
        </did>
        <accessrestrict id="898d939f278bc6e6c335eb092f07c5a8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="393de6e6b75d4f4817695af30349dd68" level="file">
        <did>
          <unittitle>TML, 39-80 - Ropivocaine - a new local anesthetic</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="bd5667fdbb429c7631cd618283ef947a" label="mixed materials (A0000000075856)" type="box">14</container>
          <container id="f4c1b8d34d8c255dc4511c0acf4dde68" parent="bd5667fdbb429c7631cd618283ef947a" type="folder">2-4</container>
        </did>
        <accessrestrict id="7af0a96e2cfe06eaffa6999f5bfd2c77">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="4be741eb1bacb7f18527f5b2df647302" level="file">
        <did>
          <unittitle>TML, 39-41 - Levofloxacin and sparfloxacin</unittitle>
          <unitdate type="inclusive">1997 April 25</unitdate>
          <container id="1e8b0ad50920090bdf04c1266b6878cf" label="mixed materials (A0000000075856)" type="box">14</container>
          <container id="77021a0da31876ce35e7a0ce70a119c3" parent="1e8b0ad50920090bdf04c1266b6878cf" type="folder">5-10</container>
        </did>
        <accessrestrict id="7550d2d00d3b056285daa384c568544b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b81fc7aadd5fecc407e846095655da0e" level="file">
        <did>
          <unittitle>TML, 39-10 - Lasers in dermatologic surgery</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="2ef09a410c6612bdc1a8fc252b9facb1" label="mixed materials (A0000000075856)" type="box">14</container>
          <container id="30bd0a582d617fd40b8b4c9401c712fd" parent="2ef09a410c6612bdc1a8fc252b9facb1" type="folder">11-15</container>
        </did>
        <accessrestrict id="0f1f31dc544a7820b6b3740572840e2c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="d6a872b6263ad2beca76d2809d741c78" level="file">
        <did>
          <unittitle>TML, 39-84 - Skin surgery with lasers - an additional note</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="cc2df1d55047016c2b050da6f0f39002" label="mixed materials (A0000000075856)" type="box">14</container>
          <container id="e0dd52b866498bdec0d7fbd53c82cad8" parent="cc2df1d55047016c2b050da6f0f39002" type="folder">16</container>
        </did>
        <accessrestrict id="37b13c54d0d04ba5299304f96256cfc0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="62572ae54e7b47c32783a5b7f9f92261" level="file">
        <did>
          <unittitle>TML, 39-51 - Topiramate for epilepsy</unittitle>
          <unitdate type="inclusive">1997 May 23</unitdate>
          <container id="5acd43f00a71304bbf9a9641a2288861" label="mixed materials (A0000000075856)" type="box">14</container>
          <container id="18169718eac06110f62adf7927927d2d" parent="5acd43f00a71304bbf9a9641a2288861" type="folder">17-19</container>
        </did>
        <accessrestrict id="1f453b72cb65c772c8bbcb8b965fc251">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="bbfc9de7adb6df0701f6173947f38bd2" level="file">
        <did>
          <unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="9d395adc9c87e46b0a0b8b2d1259eee4" label="mixed materials (A0000000075856)" type="box">14</container>
          <container id="643319493b908913f0069cb1200fcdc4" parent="9d395adc9c87e46b0a0b8b2d1259eee4" type="folder">20</container>
        </did>
        <accessrestrict id="63c006cdd8a94fd253916b0a5c2fcbfc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6b378b12b2f16c81d85d36343d81a41b" level="file">
        <did>
          <unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="5c8967c3dfdb9870f2f4346a9270295d" label="mixed materials (A0000000075857)" type="box">15</container>
          <container id="38dbd8fce9ac06e872a69c6f7dc206d4" parent="5c8967c3dfdb9870f2f4346a9270295d" type="folder">1-2</container>
        </did>
        <accessrestrict id="62290c3388efd25a1b03329c60a4c2c5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="bf256a51de793456a4c7d083f141288c" level="file">
        <did>
          <unittitle>TML, 39-65 - Tiludronate for Paget's disease of bone</unittitle>
          <unitdate type="inclusive">1997 July 18</unitdate>
          <container id="51719e927bb428629f0d4624fa36a097" label="mixed materials (A0000000075857)" type="box">15</container>
          <container id="4a896fe1007133560fc68b39a908e33f" parent="51719e927bb428629f0d4624fa36a097" type="folder">3-5</container>
        </did>
        <accessrestrict id="a0af36cf2f0f39c3b6bf43a2f3d1a8f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="e50c791d98c44790d8141d27cd4cfcab" level="file">
        <did>
          <unittitle>TML, 39-62 - Tizanidine for spasticity</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="9d3d090bc452d4b5e2bab4910de9971a" label="mixed materials (A0000000075857)" type="box">15</container>
          <container id="b939995040e97e4f6ada4a2eac4e365b" parent="9d3d090bc452d4b5e2bab4910de9971a" type="folder">6-8</container>
        </did>
        <accessrestrict id="264d6479c0b4544b7007e8c452a7cee5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="12444cf584e83734f66bfc290040544a" level="file">
        <did>
          <unittitle>TML, 39-49 - Troglitazone for non-insulin-dependent diabetes mellitus</unittitle>
          <unitdate type="inclusive">1997 May 23</unitdate>
          <container id="65aceae7d3ab3485d61cf0b3d01e4a83" label="mixed materials (A0000000075857)" type="box">15</container>
          <container id="e5440fd898333807355663730c74fa2c" parent="65aceae7d3ab3485d61cf0b3d01e4a83" type="folder">9-11</container>
        </did>
        <accessrestrict id="c2dbaf70c1400524b9601ade32d9aa09">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="64f0edfa5bd3b5159911a74e751d912b" level="file">
        <did>
          <unittitle>TML, 39-43 - Valsartan for hypertension</unittitle>
          <unitdate type="inclusive">1997 April 25</unitdate>
          <container id="f001f2175b70deb5296e1b077d6051d0" label="mixed materials (A0000000075857)" type="box">15</container>
          <container id="a08227302779c8b007d854ddd516c190" parent="f001f2175b70deb5296e1b077d6051d0" type="folder">12-14</container>
        </did>
        <accessrestrict id="d5a76faf4ca30d9de5137cfcad807f6e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="eb014687998353d0fb60326357526127" level="file">
        <did>
          <unittitle>TML, 39-1 - Drugs for treatment of peptic ulcers</unittitle>
          <unitdate type="inclusive">1997 January 3</unitdate>
          <container id="061c8ba43d043de959bd352aa201970a" label="mixed materials (A0000000075857)" type="box">15</container>
          <container id="55a31ec7fe0ff786a69875e514e4203f" parent="061c8ba43d043de959bd352aa201970a" type="folder">15-20</container>
        </did>
        <accessrestrict id="1fcec8ea591c0f4b6123d11e89e69ddb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="3436a17eac9c6f31692eb5d354b51a44" level="file">
        <did>
          <unittitle>TML, 39-109 - Pramipexole and Ropinirole for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="693dcc79b44d0440f1da6cafa51bb8c7" label="mixed materials (A0000000075858)" type="box">16</container>
          <container id="c259c4d9593910c26bf9c448cfdb315d" parent="693dcc79b44d0440f1da6cafa51bb8c7" type="folder">1-4</container>
        </did>
        <accessrestrict id="9f23fe9c137d23133c2b5049c5b64530">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="ea94f0229ffb76d4e8a48dbf172eec36" level="file">
        <did>
          <unittitle>TML, 39-105 - New drugs for psoriasis</unittitle>
          <unitdate type="inclusive">1997 November 7</unitdate>
          <container id="41460805b4bee40d8587568b813152e6" label="mixed materials (A0000000075858)" type="box">16</container>
          <container id="90428fd3e2f8276eeef2d17bcfcc1ee3" parent="41460805b4bee40d8587568b813152e6" type="folder">5-8</container>
        </did>
        <accessrestrict id="d1471d567708b0ca9a5c6d93f5f254f0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="12f50952f7ba8eb3afd7e492d332b4a1" level="file">
        <did>
          <unittitle>TML, 39-33 - New drugs for psychiatric disorders</unittitle>
          <unitdate type="inclusive">1997 April 11</unitdate>
          <container id="797ab9804beb1ab47422570aa7fc94f6" label="mixed materials (A0000000075858)" type="box">16</container>
          <container id="cf4d700a6db65af5df6e75f6800f6532" parent="797ab9804beb1ab47422570aa7fc94f6" type="folder">9-15</container>
        </did>
        <accessrestrict id="dbaf4673299ed575f189876448054a58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="123a71748e8ade20af228276bab2d8b6" level="file">
        <did>
          <unittitle>TML, 39-117 - Quetiapine for schizophrenia</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="5d527a1393077d03b07ca0f7899bc859" label="mixed materials (A0000000075858)" type="box">16</container>
          <container id="5fa846b29e90b7fa0be192b261aee78b" parent="5d527a1393077d03b07ca0f7899bc859" type="folder">16-18</container>
        </did>
        <accessrestrict id="8bbc739b2ed931419befe4ab8eb4eb63">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="498df0f2d9dce92679b2aa347629be3f" level="file">
        <did>
          <unittitle>TML, 39-17 - Reteplase (Retavase)</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="32849b66048ab642ac5d4cedb0b5d47a" label="mixed materials (A0000000075859)" type="box">17</container>
          <container id="5615188f71ffb191f51ff49d4a4cf28b" parent="32849b66048ab642ac5d4cedb0b5d47a" type="folder">1-2</container>
        </did>
        <accessrestrict id="b2dca34162d6868414a816046edfdff2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6ba7d8b0dcb752d130b074f42b440dd7" level="file">
        <did>
          <unittitle>TML, 39-53 - Donepezil (Aricept) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="3f27e165fea6323135b93d8a90b7b3b4" label="mixed materials (A0000000075859)" type="box">17</container>
          <container id="0546a89d1f33ea860cc1822053c1bbce" parent="3f27e165fea6323135b93d8a90b7b3b4" type="folder">3-5</container>
        </did>
        <accessrestrict id="6532d645696e8a65297e0563e103f695">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="7c2e04e9e7b332289a442e6977a1f7d9" level="file">
        <did>
          <unittitle>TML, 39-81 - Diagnostic tests for HIV</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="27d60224a3e89bcaa8c7acd9a295f25d" label="mixed materials (A0000000075859)" type="box">17</container>
          <container id="af23edb31d8c4098fc966f537d0fffbe" parent="27d60224a3e89bcaa8c7acd9a295f25d" type="folder">6-10</container>
        </did>
        <accessrestrict id="9570ef3f38bf3a851322c3c3fb7d17cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fdd2b028e08760f46ba2467c4b638924" level="file">
        <did>
          <unittitle>TML, 39-21 - Drugs of Choice - Cancer Chemotherapy</unittitle>
          <unitdate type="inclusive">1997 March 14</unitdate>
          <container id="471f814c9b0f3e17112c2dfbfe0c5f62" label="mixed materials (A0000000075859)" type="box">17</container>
          <container id="4a9614d85ce8728bfa8aa02c2621d8c6" parent="471f814c9b0f3e17112c2dfbfe0c5f62" type="folder">11-16</container>
        </did>
        <accessrestrict id="28f03f207bd6c378f505103883232f68">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="42935bf2b5b11b084838a1252d3b3db8" level="file">
        <did>
          <unittitle>TML, 39-77 - Bupropion for smoking cessation</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="3938b31ed44d1f7166f7a67e5e59e49d" label="mixed materials (A0000000075859)" type="box">17</container>
          <container id="0a694f0e12e4e132098f7a3fc5075c13" parent="3938b31ed44d1f7166f7a67e5e59e49d" type="folder">17</container>
        </did>
        <accessrestrict id="6c0f62c3539d7b57d8122eb2501ba830">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="be3b6c8f67d8d9c4ef7e3226b17983fb" level="file">
        <did>
          <unittitle>TML, 39-63 - Topical butenafine for tinea pedis</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="e58d8dadc6a6fc85be491183ba64c3c2" label="mixed materials (A0000000075860)" type="box">18</container>
          <container id="49c2f96580db07a60a91200796c5e397" parent="e58d8dadc6a6fc85be491183ba64c3c2" type="folder">1-2</container>
        </did>
        <accessrestrict id="5cc6b055d5b6e621ab0c71131fdd66e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="856acb144bbba7a94b1cb63f73185f43" level="file">
        <did>
          <unittitle>TML, 39-56 - Pentosan</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="125e25ca977e9c1df3a11b861753effe" label="mixed materials (A0000000075860)" type="box">18</container>
          <container id="f5cf34b24a2cc69bdc103df26dfe9cc8" parent="125e25ca977e9c1df3a11b861753effe" type="folder">3-4</container>
        </did>
        <accessrestrict id="9279dfdd8fa0fb9cdb6e31006d0ff6a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="afd34d20934d1be77bfc49f4d1241183" level="file">
        <did>
          <unittitle>TML, 39-103 - Mibefradil - a new calcium-channel blocker</unittitle>
          <unitdate type="inclusive">1997 November 7</unitdate>
          <container id="78706c6401c6835ca3c48739842066c2" label="mixed materials (A0000000075860)" type="box">18</container>
          <container id="a3294d05a91e5782e275c03164b9981c" parent="78706c6401c6835ca3c48739842066c2" type="folder">5-8</container>
        </did>
        <accessrestrict id="bc77a13d4a14fc45f23bfb7a5bb57c5d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="de42e2f43ebae331da9c0b8180abb87c" level="file">
        <did>
          <unittitle>TML, 39-59 - Midodrine for orthostatic hypotension</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="e7dc81346b32bf0aac8f0c15b376f3b4" label="mixed materials (A0000000075860)" type="box">18</container>
          <container id="8bd121e878796a1406d4eb35db00d1b3" parent="e7dc81346b32bf0aac8f0c15b376f3b4" type="folder">9-11</container>
        </did>
        <accessrestrict id="01d73c68e8dd39b1c0b73b6d7700c7a0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="96ceef3812b648bc28698beed66c5d75" level="file">
        <did>
          <unittitle>TML, 39-47 - Treatment of Lyme disease</unittitle>
          <unitdate type="inclusive">1997 May 9</unitdate>
          <container id="c1c9424d4e559f4679049bc060e6e844" label="mixed materials (A0000000075860)" type="box">18</container>
          <container id="c939ae3c2fdfba505e0881efb2483a40" parent="c1c9424d4e559f4679049bc060e6e844" type="folder">12-14</container>
        </did>
        <accessrestrict id="1456685e80bfcccf0ad9c93511c65c4d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="eaedccce6a322747a43e566f8dfc2b7d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="22cd8b96f9867cc1d16fbbd074ea1294" label="mixed materials (A0000000075860)" type="box">18</container>
          <container id="f99c20ada92c7aee3cca4748453d3d4e" parent="22cd8b96f9867cc1d16fbbd074ea1294" type="folder">15-17</container>
        </did>
        <accessrestrict id="640807ffbd5e5ea720da4f60f781a4b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="95b6682482a9d062317fcf262cc7f718" level="file">
        <did>
          <unittitle>TML, 39-85 - Influenza vaccine</unittitle>
          <unitdate type="inclusive">1997 September 12</unitdate>
          <container id="078b4adaca6862c4ab7cc52940de4afc" label="mixed materials (A0000000075860)" type="box">18</container>
          <container id="187aeea890c3b14293fde55f7cfb0992" parent="078b4adaca6862c4ab7cc52940de4afc" type="folder">18</container>
        </did>
        <accessrestrict id="bae55e07ca01b84992a5b395e88b6ccc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="9c5534af6d0a227ae1ad47876c813383" level="file">
        <did>
          <unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="bedc0f68008984b92c1f48c2721aa765" label="mixed materials (A0000000075860)" type="box">18</container>
          <container id="0c12179894d7cd7f44260d75c3626ab9" parent="bedc0f68008984b92c1f48c2721aa765" type="folder">19</container>
        </did>
        <accessrestrict id="071f86249d57b3a639f1f0ac1e82c1db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="8d02c5507ec798ca4d7bb6188acc62a5" level="file">
        <did>
          <unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="01b6b589306709c3cfd87adfd46c0eb1" label="mixed materials (A0000000075861)" type="box">19</container>
          <container id="12f8ae3eb365d34dbc0cb26ea9b426ff" parent="01b6b589306709c3cfd87adfd46c0eb1" type="folder">1</container>
        </did>
        <accessrestrict id="36454ffdeab70b1b39646403fa3b2960">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="0cdb2a091afd3228142c89eb37d2380a" level="file">
        <did>
          <unittitle>TML, 39-118 - Imiquimod for genital warts</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="59ce96501069517c405e36120e80f8e3" label="mixed materials (A0000000075861)" type="box">19</container>
          <container id="cc3fdd8b030d404026dd781fc71fd9fd" parent="59ce96501069517c405e36120e80f8e3" type="folder">2-3</container>
        </did>
        <accessrestrict id="d975c63ad23263fd275260f9460dcf1e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="f4d2ffb826a588ff6c493adbd06a92be" level="file">
        <did>
          <unittitle>TML, 39-64 - Drugs for epilepsy</unittitle>
          <unitdate type="inclusive">1997 February 6</unitdate>
          <container id="d81b9aedf872c16ee83ba42d9e056b2b" label="mixed materials (A0000000075861)" type="box">19</container>
          <container id="aebac109b5b2d46d434743c6e1b9b2c0" parent="d81b9aedf872c16ee83ba42d9e056b2b" type="folder">4-6</container>
        </did>
        <accessrestrict id="c20b70cbd97aa855e62537fb259a09f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="028b89ba84e332c879eab9899c191875" level="file">
        <did>
          <unittitle>TML, 39-66 - Fosfomycin for urinary tract infections</unittitle>
          <unitdate type="inclusive">1997 July 18</unitdate>
          <container id="5221ae50c9fd26df0e611a8e67546e25" label="mixed materials (A0000000075861)" type="box">19</container>
          <container id="88b59dfae2c9e6987f52d7d70401a9c2" parent="5221ae50c9fd26df0e611a8e67546e25" type="folder">7-9</container>
        </did>
        <accessrestrict id="e0aa9d9341298313dcd22b6a4157d3bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="73ee7f93d0af26d64d0c1fc7ba0c7201" level="file">
        <did>
          <unittitle>TML, 39-86 - Systemic antifungal drugs</unittitle>
          <unitdate type="inclusive">1997 September 12</unitdate>
          <container id="3e51116bc6d7c9bf879c2fcde844e223" label="mixed materials (A0000000075861)" type="box">19</container>
          <container id="531d1838fb4d74d69e5d52e377a23322" parent="3e51116bc6d7c9bf879c2fcde844e223" type="folder">10-13</container>
        </did>
        <accessrestrict id="226ecab6ab43654c9c5dd63a5e3e2b52">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6bf77dfe11efd36cf8146b826560cb4c" level="file">
        <did>
          <unittitle>TML, 39-61 - Glatiramer acetate for relapsing mutiple sclerosis</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="47f64e7666c314901e5e58a2120d3540" label="mixed materials (A0000000075861)" type="box">19</container>
          <container id="a25bdee91586592394c02af75bd50512" parent="47f64e7666c314901e5e58a2120d3540" type="folder">14-16</container>
        </did>
        <accessrestrict id="58267fbb42c582dd03ac8830411c1803">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="f36ff800dacbd73013d42dab42cf5f5b" level="file">
        <did>
          <unittitle>TML, 38-6 - Drugs for head lice</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="71039b4d20fb2303a5fd2cfad4a9df73" label="mixed materials (A0000000075861)" type="box">19</container>
          <container id="6e8f53a6bb9361ab22456afa1131da67" parent="71039b4d20fb2303a5fd2cfad4a9df73" type="folder">17-18</container>
        </did>
        <accessrestrict id="92296119b0cbe67e59973a003090f421">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="e13f3fa0ec576057f7033815a81111e1" level="file">
        <did>
          <unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="b3acfbcf9872de1758544e695e7f3c6d" label="mixed materials (A0000000075861)" type="box">19</container>
          <container id="3cc8340f9aae3e222784d74ef0541db5" parent="b3acfbcf9872de1758544e695e7f3c6d" type="folder">19-20</container>
        </did>
        <accessrestrict id="e7cb03a6203eb58d2833529692c66d60">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="dfc2de9cdb5bf3a8437e564fa717ffbd" level="file">
        <did>
          <unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="da9ca5e2233fdf577f91b1c89cc39b12" label="mixed materials (A0000000075862)" type="box">20</container>
          <container id="d6395a9665d57bf9cfa3473cdc2e3b94" parent="da9ca5e2233fdf577f91b1c89cc39b12" type="folder">1-2</container>
        </did>
        <accessrestrict id="d913972842d3a79acf9b906df7f951e7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="95d8be151e4ef26242db019df375f791" level="file">
        <did>
          <unittitle>TML, 39-94 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">1997 November 1</unitdate>
          <container id="e02d4fcb140b2609af2b834d3108a7cb" label="mixed materials (A0000000075862)" type="box">20</container>
          <container id="6f34256fe55d1dbf8482437552f5f134" parent="e02d4fcb140b2609af2b834d3108a7cb" type="folder">3-5</container>
        </did>
        <accessrestrict id="2db96bdb2ad3f2367bdf1559b5ea1133">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="f8696aa81da52173ff18b97bd7eb4067" level="file">
        <did>
          <unittitle>TML, 39-19 - Adapalene for acne</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="fa34ba376943b2a38bf72d6ff343a04f" label="mixed materials (A0000000075862)" type="box">20</container>
          <container id="cf518ae365095bbee1266857dece5098" parent="fa34ba376943b2a38bf72d6ff343a04f" type="folder">6-7</container>
        </did>
        <accessrestrict id="cefd2ab82f2cd38f2cef5b4253fea1fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="d3c8f38c2b75ab98def9cb12e7933ba3" level="file">
        <did>
          <unittitle>TML, 39-29 - Atorvastatin - a new lipid-lowering drug</unittitle>
          <unitdate type="inclusive">1997 March 28</unitdate>
          <container id="23d9419068d7aa9a4038c26de373cf96" label="mixed materials (A0000000075862)" type="box">20</container>
          <container id="c2e2a53c1a0bcc5abffbdc498d879597" parent="23d9419068d7aa9a4038c26de373cf96" type="folder">8-9</container>
        </did>
        <accessrestrict id="f50e6cdc96d78aa80586f8c46bb4b44f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b2a72d06fe2be2cec8bad5a6a0fda27b" level="file">
        <did>
          <unittitle>TML, 39-45 - Azelastine nasal spray for allergic rhinitis</unittitle>
          <unitdate type="inclusive">1997 May 9</unitdate>
          <container id="2dd05573c882a678381aea743485e53f" label="mixed materials (A0000000075862)" type="box">20</container>
          <container id="0296f27d3338e8d35b4bc550d489f62c" parent="2dd05573c882a678381aea743485e53f" type="folder">10-13</container>
        </did>
        <accessrestrict id="2c8bdc164c637c083bf92b35d52554fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="36e76c3b20aacff333ba5d98cfca27de" level="file">
        <did>
          <unittitle>TML, 39-12 - Betaine for homocystinuria</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="05f7354ca5765b6e04e92b9b54836f77" label="mixed materials (A0000000075862)" type="box">20</container>
          <container id="cccb6c58db827b961cf599957d95e293" parent="05f7354ca5765b6e04e92b9b54836f77" type="folder">14-15</container>
        </did>
        <accessrestrict id="55bd4c86ccf4811f99aac2673693e945">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="e4ca902373c4579a78db0d3b8d513633" level="file">
        <did>
          <unittitle>TML, 39-93 - Bromfenac for analgesia</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="d91cff6ff6f8b55f7501f8797857005a" label="mixed materials (A0000000075862)" type="box">20</container>
          <container id="75ddeb6adcd59b93e2b97e20222a708a" parent="d91cff6ff6f8b55f7501f8797857005a" type="folder">16-17</container>
        </did>
        <accessrestrict id="18bd5ce580d159e1acce03ad34266cc9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="1a9cef87a6b1f62bf27f90e19d47c4e1" level="file">
        <did>
          <unittitle>TML, 39-54 - Brimonidine - an alpha2-agonist for glaucoma</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="abbcc76b9cdca2bcbdb5ee77cbaa8544" label="mixed materials (A0000000075862)" type="box">20</container>
          <container id="0ec2cb3099fea9e2c977d125201e334b" parent="abbcc76b9cdca2bcbdb5ee77cbaa8544" type="folder">18-19</container>
        </did>
        <accessrestrict id="c12a956b010223394c6ca9d2025942d6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="56fc5093674d1372e80ed218ae8bd368" level="file">
        <did>
          <unittitle>TML, 39-13 - Safety of channel blockers</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="3e88683ab0ed5cc04c8fa88d04e7ae31" label="mixed materials (A0000000075862)" type="box">20</container>
          <container id="ad83840d6907b84f93a5fdc81233616a" parent="3e88683ab0ed5cc04c8fa88d04e7ae31" type="folder">20</container>
        </did>
        <accessrestrict id="12b089183fda270bbeecc135b190b589">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="1f85013ec13e639596b728f22f1aafc4" level="file">
        <did>
          <unittitle>TML, 39-13 - Safety of channel blockers</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="b75884e82e3ac730a9141ad0785b20cb" label="mixed materials (A0000000075863)" type="box">21</container>
          <container id="65c5b821f6e5937cb38aca309dddad99" parent="b75884e82e3ac730a9141ad0785b20cb" type="folder">1-2</container>
        </did>
        <accessrestrict id="8a33d90a046f00da2d8b9b030020c09e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b4a11be555144c67db801913b3a95361" level="file">
        <did>
          <unittitle>TML, 39-58 - Cabergoline for hyperprolactinemia</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="eb97209630fe4e82e38b23945ebdc3bf" label="mixed materials (A0000000075863)" type="box">21</container>
          <container id="d8c7acf8306f8977da10977812e69972" parent="eb97209630fe4e82e38b23945ebdc3bf" type="folder">3-6</container>
        </did>
        <accessrestrict id="300ca74e312c726f3bc6c5c2409ffa88">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="8fa954deb6dc2ce7385244a3d8abc5a9" level="file">
        <did>
          <unittitle>TML - Dovonex</unittitle>
          <unitdate type="inclusive">1993</unitdate>
          <container id="fe3da8863bbbb2a50ba7dddae30fe7e2" label="mixed materials (A0000000075863)" type="box">21</container>
          <container id="9be9da210d6b2d120b3732881be05552" parent="fe3da8863bbbb2a50ba7dddae30fe7e2" type="folder">7</container>
        </did>
        <accessrestrict id="7ed0890a439df753466be5a70bc31770">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="c70f3345ad4c90f6af9d560ffb1f3777" level="file">
        <did>
          <unittitle>TML, 39-108 - Olopatadine for allergic conjunctivitis</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="ab99889d3fe66fc63e19eeaa85d34f97" label="mixed materials (A0000000075863)" type="box">21</container>
          <container id="9ea16df9d46c952b77321fef2184dc4e" parent="ab99889d3fe66fc63e19eeaa85d34f97" type="folder">8-9</container>
        </did>
        <accessrestrict id="7e05d25159387c3bcb0a7a1a1a57fbe9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="0f25168045c3874b852fc2566864c22b" level="file">
        <did>
          <unittitle>TML, 37-1 - Drugs for asthma</unittitle>
          <unitdate type="inclusive">1996 January 6</unitdate>
          <container id="9e844ce473e2bc9f190d461b5a2eba5d" label="mixed materials (A0000000075863)" type="box">21</container>
          <container id="bce821785018c8b7e49018f05aaee359" parent="9e844ce473e2bc9f190d461b5a2eba5d" type="folder">10-14</container>
        </did>
        <accessrestrict id="5124cbd46d2a439f4f59c00468b6016b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="dbe0049fdc51d967d42b54af228c58ae" level="file">
        <did>
          <unittitle>TML, 39-32 - Intra-transurethral Alprostadil for impotence</unittitle>
          <unitdate type="inclusive">1997 March 28</unitdate>
          <container id="b407d5e9431d4464009d9fa6b7bff46d" label="mixed materials (A0000000075863)" type="box">21</container>
          <container id="a3bcef7e8c60db5e4cd9e0335a074c37" parent="b407d5e9431d4464009d9fa6b7bff46d" type="folder">15-16</container>
        </did>
        <accessrestrict id="108454fd852ec91b5893f1a78b4694b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="3fff697896297fb5b3e546b99c7bb615" level="file">
        <did>
          <unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="560137a053a24707a95377a5b75788c6" label="mixed materials (A0000000075863)" type="box">21</container>
          <container id="17504e59317821f98e4bfb3e0f6fcb49" parent="560137a053a24707a95377a5b75788c6" type="folder">17-21</container>
        </did>
        <accessrestrict id="6e01c10d6e482faec33ca1e6f744b4e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="ac009d8a6eba90db98f499f6852dd496" level="file">
        <did>
          <unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="2a7302e7146ac368d81c968369e85ce8" label="mixed materials (A0000000075864)" type="box">22</container>
          <container id="48d506b4a0b8d47221730b0dd5371578" parent="2a7302e7146ac368d81c968369e85ce8" type="folder">1-3</container>
        </did>
        <accessrestrict id="1cdb7a1ff11f6e216e339e64f20c58a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="364c7d8d424593144cdef790c4e94d75" level="file">
        <did>
          <unittitle>TML, 39-111 - AIDS - Drugs for HIV infection</unittitle>
          <unitdate type="inclusive">1997 December 12</unitdate>
          <container id="d0d236cf34694579fade8ce3155352ce" label="mixed materials (A0000000075864)" type="box">22</container>
          <container id="73f0f756c7ec8ef01df2e3668110fd7f" parent="d0d236cf34694579fade8ce3155352ce" type="folder">4-9</container>
        </did>
        <accessrestrict id="a96e0ada70322de7df279993ca3ff3a5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fe5bfd483d4da9cb09abcd8d8e9114e4" level="file">
        <did>
          <unittitle>TML, 39-97 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1997 October 24</unitdate>
          <container id="ba7d9bbcae2b49967d4c476983676e79" label="mixed materials (A0000000075864)" type="box">22</container>
          <container id="c9cb06c60d48be5c9d5e884cbe3a8996" parent="ba7d9bbcae2b49967d4c476983676e79" type="folder">10-15</container>
        </did>
        <accessrestrict id="ce3e85fc72e05bedc7f21da6973965b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6568c1026445dec6f8e364671c21bd39" level="file">
        <did>
          <unittitle>TML, 39-120 - Anagrelide for essential thrombocythemia</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="f2c293f998045ee66d2e59108ecf255b" label="mixed materials (A0000000075864)" type="box">22</container>
          <container id="8085674c6b3513a628d556289d0642fc" parent="f2c293f998045ee66d2e59108ecf255b" type="folder">16-18</container>
        </did>
        <accessrestrict id="8df589a9af326009da84ebecd5cf8932">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b0b4f71d2ecf84b337ced4a504f89306" level="file">
        <did>
          <unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="5d7a4fa7f1c39660b209cf343b0b7ad2" label="mixed materials (A0000000075864)" type="box">22</container>
          <container id="aaf88988d1d0d872a40acae21336cd04" parent="5d7a4fa7f1c39660b209cf343b0b7ad2" type="folder">19</container>
        </did>
        <accessrestrict id="8df622f363be5b50961c92589e209dc4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b1ac2f651904161cd98b8d42f99e3aa1" level="file">
        <did>
          <unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="6a1c89c058642981bac83894141c49a7" label="mixed materials (A0000000075865)" type="box">23</container>
          <container id="5eae00a189d0c6c7dd2169da4a46801e" parent="6a1c89c058642981bac83894141c49a7" type="folder">1-4</container>
        </did>
        <accessrestrict id="181d3a4b218653d1790e4861871f62dd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="edca2ebba2d38b14ec07a5b9c16a0276" level="file">
        <did>
          <unittitle>TML, 39-89 - Carvedilol for heart failure</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="64864f87bdadaa05a8cf23590a65d0c7" label="mixed materials (A0000000075865)" type="box">23</container>
          <container id="b4a66b29d9c8c12a769e7f1b1f9487eb" parent="64864f87bdadaa05a8cf23590a65d0c7" type="folder">5-9</container>
        </did>
        <accessrestrict id="f5705dc19e306f206ec780b8d160e15c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="3f1ba5c10401cadfc440c87da71224cb" level="file">
        <did>
          <unittitle>TML, 39-57 - Topical penciclovir for herpes labialis</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="7c409f942cd85378572dc3bd3fea06f3" label="mixed materials (A0000000075865)" type="box">23</container>
          <container id="f037b551f1d8038897e2f95469f2bc51" parent="7c409f942cd85378572dc3bd3fea06f3" type="folder">10-11</container>
        </did>
        <accessrestrict id="053d8eeeb8327c9a50460b4a07f88f4f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6311bd1ab3c17838b525980881eb7804" level="file">
        <did>
          <unittitle>TML, 38-17 - Drugs for migraine</unittitle>
          <unitdate type="inclusive">1995 March 3</unitdate>
          <container id="1a991b75f0ae04a44c1c5d1b9a3b4a7c" label="mixed materials (A0000000075865)" type="box">23</container>
          <container id="a8880daa0de6d09bc5f7da31212a89a7" parent="1a991b75f0ae04a44c1c5d1b9a3b4a7c" type="folder">12-16</container>
        </did>
        <accessrestrict id="3d255045a576ae1c355c7f2fcc48b4a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="d46efc5621917384073357b190321659" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="e7b3f517c397a0f14702846cdeb2f845" label="mixed materials (A0000000075865)" type="box">23</container>
          <container id="810ea1f787b038e1e057694ee56b0798" parent="e7b3f517c397a0f14702846cdeb2f845" type="folder">17-21</container>
        </did>
        <accessrestrict id="663777121320adda427992b307d1db2f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fa4a7928ccfffaadb72cf4771e4d8edc" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="50cc44f2101e52ee8ec1ae9de437b35b" label="mixed materials (A0000000075866)" type="box">24</container>
          <container id="dee5059d2a4fddd70d9e3c60bd0b50db" parent="50cc44f2101e52ee8ec1ae9de437b35b" type="folder">1</container>
        </did>
        <accessrestrict id="702b01fd73a7deda0a72869d6f566a47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="318ae2efe1275c93a47e9ae522f706ea" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="49378edf3603eeb93fba15acc8393294" label="mixed materials (A0000000075866)" type="box">24</container>
          <container id="0ae8068a2f3df5725049f14c73f752fe" parent="49378edf3603eeb93fba15acc8393294" type="folder">2-3</container>
        </did>
        <accessrestrict id="f2ea2b6f0f794d84b25ea1befb0a8255">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b4b3b22e307f4ce6c5d2eb8f6d664d9c" level="file">
        <did>
          <unittitle>TML, 38-5 - Olanzapine for schizophrenia</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="355ad0444aa7e665e4041aba6166a1fb" label="mixed materials (A0000000075866)" type="box">24</container>
          <container id="15d35c5a0ffc2c1f744156c526320f1e" parent="355ad0444aa7e665e4041aba6166a1fb" type="folder">4-6</container>
        </did>
        <accessrestrict id="54d3d516459a5d0fc04e78b00339b8f9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b5cf0dfe90fdcc6067f140e30b6809d1" level="file">
        <did>
          <unittitle>TML, 38-113 - Mirtazapine - a new anti-depressant</unittitle>
          <unitdate type="inclusive">1996 December 20</unitdate>
          <container id="223a93353a8e8446774e2e4acc3ebc05" label="mixed materials (A0000000075866)" type="box">24</container>
          <container id="aa5acbc6614bdf07e07645bce674ecc6" parent="223a93353a8e8446774e2e4acc3ebc05" type="folder">7-9</container>
        </did>
        <accessrestrict id="6a61863bdf42f359838de02eb3140260">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="c2e1fc197d7490d826da206b516a38a5" level="file">
        <did>
          <unittitle>TML, 40-5 - Drugs of Choice - Rheumatoid Arthritis</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="17a92310c93488ae83685a16a90a2c42" label="mixed materials (A0000000075866)" type="box">24</container>
          <container id="90d4f7802a897fcf5f040f3d563d79ad" parent="17a92310c93488ae83685a16a90a2c42" type="folder">10-16</container>
        </did>
        <accessrestrict id="5d151812a70ad7aab1e31b15864a8198">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fc12244326436c163ce3062f2ee5441e" level="file">
        <did>
          <unittitle>TML, 40-59 - Clopidogrel for reduction of artherosclerotic events</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="c0c0a66cd8c7e93483db77cb621944fd" label="mixed materials (A0000000075867)" type="box">25</container>
          <container id="425328c47b8d260702b6315f87ea1512" parent="c0c0a66cd8c7e93483db77cb621944fd" type="folder">1-3</container>
        </did>
        <accessrestrict id="010c90cf26351f4881154a4f6ad41ad3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b00d90227ff22e5ebe7df4b968c6ec73" level="file">
        <did>
          <unittitle>TML, 40-113 - Citalopram for depression</unittitle>
          <unitdate type="inclusive">1998 December 4</unitdate>
          <container id="f6e37ce28b29617b70781b7d4089d706" label="mixed materials (A0000000075867)" type="box">25</container>
          <container id="eea3da766e3540c8fdc2c3d296d7f54d" parent="f6e37ce28b29617b70781b7d4089d706" type="folder">4-8</container>
        </did>
        <accessrestrict id="e132e378e63282bf8014cd21bd84bf26">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="85788caeb20c27238d916bb497645405" level="file">
        <did>
          <unittitle>TML, 40-52 - Anthrax vaccine</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="6d249efbee62f598f2ff1cf7df3420c4" label="mixed materials (A0000000075867)" type="box">25</container>
          <container id="f60b6381bad3873bcfa3580621e96681" parent="6d249efbee62f598f2ff1cf7df3420c4" type="folder">9-10</container>
        </did>
        <accessrestrict id="0a33ad6cdce119b325c656b5c6f11151">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="7481cf56a926bcaa665f596bebcba058" level="file">
        <did>
          <unittitle>TML, 40-63 - Ginkgo Biloba for dementia</unittitle>
          <unitdate type="inclusive">1998 June 19</unitdate>
          <container id="db33822d8e25f7c262fe95dc8b21037e" label="mixed materials (A0000000075867)" type="box">25</container>
          <container id="f812817cb998ec16cde90ca298ab50ed" parent="db33822d8e25f7c262fe95dc8b21037e" type="folder">11-13</container>
        </did>
        <accessrestrict id="16e326bcc4bc4a1b019667382b3e42a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="276f7a6dda26470f835e467b2e300373" level="file">
        <did>
          <unittitle>TML, Sildenafil - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="d50bf9164518f1fbfe68b36cb21ecfdd" label="mixed materials (A0000000075867)" type="box">25</container>
          <container id="41d4add35feb284fa6c6c16bc9f9f185" parent="d50bf9164518f1fbfe68b36cb21ecfdd" type="folder">14-16</container>
        </did>
        <accessrestrict id="c072f69e2c5f4579df7b9a32a2d6638a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="8d9d5a14ea3c38a9bcf53eea15278788" level="file">
        <did>
          <unittitle>TML, 40-69 - Hyaluronan injections for osteoarthritis of the knee</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="53c9822719d22ec7ff6dae64b30310cc" label="mixed materials (A0000000075867)" type="box">25</container>
          <container id="a7b75e424137f4b0ae426e9b1a26c8eb" parent="53c9822719d22ec7ff6dae64b30310cc" type="folder">17-19</container>
        </did>
        <accessrestrict id="548bd13d1ee4dd091a7071fb17973086">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e605d151c50d15b7436fa8b95fabcc04" level="file">
        <did>
          <unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="5633111e212c0baf2bfee6603dc80c58" label="mixed materials (A0000000075867)" type="box">25</container>
          <container id="5883dd41c8bb673628fb799a85d73bed" parent="5633111e212c0baf2bfee6603dc80c58" type="folder">20-21</container>
        </did>
        <accessrestrict id="72272d08b8d2095400f484d84b5c8623">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a2c45fce823914fd5f240eb8ce64a6d3" level="file">
        <did>
          <unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="d04f68a777e8b04219ecc1e1feb63a86" label="mixed materials (A0000000075868)" type="box">26</container>
          <container id="0f603717168bfa8674a73c24f17a4166" parent="d04f68a777e8b04219ecc1e1feb63a86" type="folder">1</container>
        </did>
        <accessrestrict id="e61fbc122231a69d11de05471824b4f7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="58fc0933c16d75f16f20c226741f40fc" level="file">
        <did>
          <unittitle>TML, 40-21 - Drugs that cause psychiatric symptoms</unittitle>
          <unitdate type="inclusive">1998 February 13</unitdate>
          <container id="3a6d080d116c1780686f95d8a1316ab7" label="mixed materials (A0000000075868)" type="box">26</container>
          <container id="b7f17cb3149b64bd402c2e111208c0d8" parent="3a6d080d116c1780686f95d8a1316ab7" type="folder">2-5</container>
        </did>
        <accessrestrict id="cd18c294101a7fb036bca53986751b48">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f466040faafb3cd515b6f7e5924186a3" level="file">
        <did>
          <unittitle>TML, 40-47 - Advice for Travelers</unittitle>
          <unitdate type="inclusive">1998 April 24</unitdate>
          <container id="d43935eb53719d584aaf76031aa2f472" label="mixed materials (A0000000075868)" type="box">26</container>
          <container id="0f5d79d88246b62ffd5cdd24249fe212" parent="d43935eb53719d584aaf76031aa2f472" type="folder">6-9</container>
        </did>
        <accessrestrict id="d3ea0598c816f490bd7b26c48572450a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="d9d7051c247d055cb3a4caa57119bc34" level="file">
        <did>
          <unittitle>TML, 40-68 - Fenofibrate</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="c9fed97d6b8cf834989d463d26917035" label="mixed materials (A0000000075868)" type="box">26</container>
          <container id="300759a09a254393833c0ee34e8783b8" parent="c9fed97d6b8cf834989d463d26917035" type="folder">10-13</container>
        </did>
        <accessrestrict id="a905e6ecf288f2137eb025ea245ec0aa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="0902f98f4048374d057a60de2d1b7855" level="file">
        <did>
          <unittitle>TML, 40-30 - Trovafloxacin</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="2b0ddf7a371fac36dbdd04b46c4ebea4" label="mixed materials (A0000000075868)" type="box">26</container>
          <container id="d73c2c7556d4400a2ea7720cdb57f7db" parent="2b0ddf7a371fac36dbdd04b46c4ebea4" type="folder">14-16</container>
        </did>
        <accessrestrict id="d64cfc2f0c18fe44c79492b16479dde8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="40a127b41aba4ab1210aebb60355f7eb" level="file">
        <did>
          <unittitle>TML - Tuberculosis - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="c637eed3b8713702a17bc0772ca68073" label="mixed materials (A0000000075868)" type="box">26</container>
          <container id="ad38560db75333831319e05021ebd122" parent="c637eed3b8713702a17bc0772ca68073" type="folder">17-18</container>
        </did>
        <accessrestrict id="aa2e94224c5f71c8078141e7e709d476">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="2821241f88ab33b4108c2fb8ef546a03" level="file">
        <did>
          <unittitle>TML - Tuberculosis - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="8c19b6be6b81675953f549cd50e186f1" label="mixed materials (A0000000075869)" type="box">27</container>
          <container id="c06600c21ea58167a4e94b49f592383c" parent="8c19b6be6b81675953f549cd50e186f1" type="folder">1-2</container>
        </did>
        <accessrestrict id="0fedc35030a79ffd7934a9d9c5acbe14">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a5e3fba9d86330d4c75e3f31b4844108" level="file">
        <did>
          <unittitle>TML, 40-51 - Sildenafil - An oral drug for impotence</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="f6344988f7b2b0dcce3537eae9fc75e3" label="mixed materials (A0000000075869)" type="box">27</container>
          <container id="14d3b0045455e9c7916b375ddfab32af" parent="f6344988f7b2b0dcce3537eae9fc75e3" type="folder">3-4</container>
        </did>
        <accessrestrict id="c2a74a29c84ba08cf5bbb6cb60889b41">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="41484f1614916c304d00c6a0e2776c25" level="file">
        <did>
          <unittitle>TML, 40-67 - Sucralose - a new artificial sweetner</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="3a6c29d473b237e7aac85676aef5912b" label="mixed materials (A0000000075869)" type="box">27</container>
          <container id="3d2d44c33f941e0c3d5b6e638b2c6a64" parent="3a6c29d473b237e7aac85676aef5912b" type="folder">5-7</container>
        </did>
        <accessrestrict id="9e54423aecee12c7635588555d8c357f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="18a33071dfc9246e7c9a4f9970fc624f" level="file">
        <did>
          <unittitle>TML, 40-17 - Grepafloxacin - a new fluoroquinolone</unittitle>
          <unitdate type="inclusive">1998 January 30</unitdate>
          <container id="e6489fb16a33a58f56a5cea0121a4b52" label="mixed materials (A0000000075869)" type="box">27</container>
          <container id="c4958351875b3166f24b7555b81fdae4" parent="e6489fb16a33a58f56a5cea0121a4b52" type="folder">8-9</container>
        </did>
        <accessrestrict id="bc7dcf48bb1a978d5d8891678f65f0b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="95bd003fd739d4b3a6ffdfb96fae1bc6" level="file">
        <did>
          <unittitle>TML, 40-55 - Repaglinide for type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="c33f9b35a98feb6b764387296681dc84" label="mixed materials (A0000000075869)" type="box">27</container>
          <container id="76bf3dbc260b12d7b7d92296568353c5" parent="c33f9b35a98feb6b764387296681dc84" type="folder">10-12</container>
        </did>
        <accessrestrict id="ea7f89c9aaeab7997ab0ab65a3fbabdf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="c689105113c5b23ebb896f340bf02ea0" level="file">
        <did>
          <unittitle>TML, 40-62 - Crystal Ear hearing aid</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="f21700b55439f9be2621ff166718f814" label="mixed materials (A0000000075869)" type="box">27</container>
          <container id="8613e7219591f4991861cfffac07d63d" parent="f21700b55439f9be2621ff166718f814" type="folder">13</container>
        </did>
        <accessrestrict id="dc4b7b184944400de9cfe92635a05ead">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="705d7bf07e8ff402ef32c0df389a3828" level="file">
        <did>
          <unittitle>TML, 40-89 - Antiplatelet</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="9d30026a68b65b4453fe569099c968e7" label="mixed materials (A0000000075869)" type="box">27</container>
          <container id="9c0f0af51250060965470c2cee56d97d" parent="9d30026a68b65b4453fe569099c968e7" type="folder">14-16</container>
        </did>
        <accessrestrict id="ae0c798c535816e3564f3b350306c0eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="cc4045365330c91030e2afc2941ff362" level="file">
        <did>
          <unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="f2dd09ef8df581efe64178ef526e366e" label="mixed materials (A0000000075869)" type="box">27</container>
          <container id="aa0617309d9137f0cfbe043ce75514ee" parent="f2dd09ef8df581efe64178ef526e366e" type="folder">17-19</container>
        </did>
        <accessrestrict id="d3830363a0deac040fb1a2187fcc43a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="74cd9f3df4304220a489f3cd523e97f4" level="file">
        <did>
          <unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="b8e7b61c6662d0dd6fd8e77c57e080b5" label="mixed materials (A0000000075870)" type="box">28</container>
          <container id="4a115ded0fccfe25fb629b349454b7a7" parent="b8e7b61c6662d0dd6fd8e77c57e080b5" type="folder">1</container>
        </did>
        <accessrestrict id="78f65a64160f8c684e6ad4a73eb82afd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="8f7886d013678b0f444c0e7ce3af676b" level="file">
        <did>
          <unittitle>TML, 40-65 - Rituximab for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">1998 June 19</unitdate>
          <container id="017be8115cef2719403ba8f7db2609ce" label="mixed materials (A0000000075870)" type="box">28</container>
          <container id="49aebb0fbf1bf9ab043145f9f41d7778" parent="017be8115cef2719403ba8f7db2609ce" type="folder">2</container>
        </did>
        <accessrestrict id="8e2b80b72a52938a5c321da498c8b722">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="236c02b396ea229adb1f079d93029f01" level="file">
        <did>
          <unittitle>TML, 40-32 - Sibutramine for obesity</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="98d23c753f0cff6f58c22f49d933d2ee" label="mixed materials (A0000000075870)" type="box">28</container>
          <container id="800c6998b4c949899cf3fbd882abfbc1" parent="98d23c753f0cff6f58c22f49d933d2ee" type="folder">3-5</container>
        </did>
        <accessrestrict id="83216716b614ac8cc38fcaa01b43355e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="34d5d1374a9121f748a24968ebe6c128" level="file">
        <did>
          <unittitle>TML, 40-27 - Zolmitriptan for migraine</unittitle>
          <unitdate type="inclusive">1998 February 27</unitdate>
          <container id="65f2b3142e540f332e859d84d77e399d" label="mixed materials (A0000000075870)" type="box">28</container>
          <container id="77f377feb9bc56036d212b6bba6eb38b" parent="65f2b3142e540f332e859d84d77e399d" type="folder">6-8</container>
        </did>
        <accessrestrict id="9f78fcde35549e85ae6f6ddddad23091">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f1f292c6e674c3d7e6f2610c2dbf9aec" level="file">
        <did>
          <unittitle>TML, 40-73 - Becaplermin - Platelet-derived growth factor for diabetic ulcers</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="d0f6f23b1585431510e5940c8e233dd7" label="mixed materials (A0000000075870)" type="box">28</container>
          <container id="ac1ec9997d5907e2b355b82f368212cd" parent="d0f6f23b1585431510e5940c8e233dd7" type="folder">9</container>
        </did>
        <accessrestrict id="a90cd7de6fbf79e2a9a41d8e6d5f1884">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="fae1826f224dc5554dd9d77d43d63320" level="file">
        <did>
          <unittitle>TML, 40-19 - Arbutamine for stress testing</unittitle>
          <unitdate type="inclusive">1998 January 2</unitdate>
          <container id="d2c4c8c1919b8b6eb8bfb8f2cc5911a3" label="mixed materials (A0000000075870)" type="box">28</container>
          <container id="0f62042486805a53b1e063ffd73c1de7" parent="d2c4c8c1919b8b6eb8bfb8f2cc5911a3" type="folder">10-11</container>
        </did>
        <accessrestrict id="3cf800c016782dc93e3a36b622f7b36c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b4e4ab750a7b095f09a475bb6f5bb4c1" level="file">
        <did>
          <unittitle>TML, 40-75 - Vitamin supplements</unittitle>
          <unitdate type="inclusive">1998 July 31</unitdate>
          <container id="b87fe1fdfe60a495106d06df2fecbced" label="mixed materials (A0000000075870)" type="box">28</container>
          <container id="fed2ae82e8732ca85efa1ee37099daad" parent="b87fe1fdfe60a495106d06df2fecbced" type="folder">12-16</container>
        </did>
        <accessrestrict id="59259d5d91da3a2acb6cb86529f69bd9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="06914f95afdacb00ca224c63b35cc3e5" level="file">
        <did>
          <unittitle>TML, 40-92 - Gliadel wafers for treatment of brain tumors</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="5ed847e54de302b1cea29ad9d21af436" label="mixed materials (A0000000075870)" type="box">28</container>
          <container id="709a08f13f2ff5b22e34e9807650d8a2" parent="5ed847e54de302b1cea29ad9d21af436" type="folder">17-18</container>
        </did>
        <accessrestrict id="e29a7c4b92a2feed9fd0b7e0a0bb8f72">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f35a3fcbf2b099a50baf329b7d2a8f36" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="9a68115ddc44c7e01a189083719d31b1" label="mixed materials (A0000000075870)" type="box">28</container>
          <container id="3efde083100bb010b93398d1fd6c7e6d" parent="9a68115ddc44c7e01a189083719d31b1" type="folder">19</container>
        </did>
        <accessrestrict id="0093f9f9cae39c07366f1e9c0c119fa4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="bc19dc00f1b6834157cb02e6fcfef4a4" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="2706d66b000bcaae0613cc0441a73509" label="mixed materials (A0000000075871)" type="box">29</container>
          <container id="30bb7d69dc9f404ce288c8d39e873f5f" parent="2706d66b000bcaae0613cc0441a73509" type="folder">1-5</container>
        </did>
        <accessrestrict id="530223b01deda9e053da32d105382b18">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="559cb584a41d6690a7e856498ab89795" level="file">
        <did>
          <unittitle>TML, 40-106 - Trastuzumab for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1998 November 6</unitdate>
          <container id="df693bcef9c666d1083a1bac2a743773" label="mixed materials (A0000000075871)" type="box">29</container>
          <container id="4edb915bf83898e961e9c192237e4b86" parent="df693bcef9c666d1083a1bac2a743773" type="folder">6-7</container>
        </did>
        <accessrestrict id="cf7ce77fd85e6bc2a2e126d922cb2364">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="ece2250f2916521ae284b1830da4848e" level="file">
        <did>
          <unittitle>TML, 40-114 - Three new drugs for HIV infection</unittitle>
          <unitdate type="inclusive">1998 December 4</unitdate>
          <container id="86cf00196b6aa63af21f71c1de036cab" label="mixed materials (A0000000075871)" type="box">29</container>
          <container id="1c8069013ffc19b54c299f1af7ab52fa" parent="86cf00196b6aa63af21f71c1de036cab" type="folder">8-11</container>
        </did>
        <accessrestrict id="4e7f5d2236f53f8ccc2b28a5bf8873c1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="7dd5458e0da29270a7d0b887632c23ac" level="file">
        <did>
          <unittitle>TML, Sexually Trasmitted Diseases - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="3b652652ef7ae2a5c4091bf2f7c2c55d" label="mixed materials (A0000000075871)" type="box">29</container>
          <container id="1477643496304f6a5f24b2fb806a45fe" parent="3b652652ef7ae2a5c4091bf2f7c2c55d" type="folder">12-14</container>
        </did>
        <accessrestrict id="0b261ea329af56d20325ac31bcf03cbe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6e5b03bb37f1b1e46c63603fddb7f5a0" level="file">
        <did>
          <unittitle>TML, 40-53 - Dolasetron</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="f5081c811fde0ffdc6c3b55da8481872" label="mixed materials (A0000000075871)" type="box">29</container>
          <container id="377418d21d827bf604f75c1b4295c8b0" parent="f5081c811fde0ffdc6c3b55da8481872" type="folder">15-18</container>
        </did>
        <accessrestrict id="2f191b313a6f595b28c9d77fec25b021">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b33fb65d9a2e71bddfa4f269d47aeef6" level="file">
        <did>
          <unittitle>TML, 40-18 - Irbesartan for hypertension</unittitle>
          <unitdate type="inclusive">1998 January 30</unitdate>
          <container id="b85e1466beaf739b5bd351ef822d16d2" label="mixed materials (A0000000075872)" type="box">30</container>
          <container id="3f5456092645b986eaf5f1de29c86029" parent="b85e1466beaf739b5bd351ef822d16d2" type="folder">1-4</container>
        </did>
        <accessrestrict id="5fe32f0354336c745f49eaad8ec99c60">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6332598d843148b2b6fcca7483c23ff2" level="file">
        <did>
          <unittitle>TML, 40-33 - The Choice of Antibacterial Drugs</unittitle>
          <unitdate type="inclusive">1998 March 27</unitdate>
          <container id="a32dbb287d48ba7c3868899503a0d4c1" label="mixed materials (A0000000075872)" type="box">30</container>
          <container id="a34d2a92c54595475de934ff80b49644" parent="a32dbb287d48ba7c3868899503a0d4c1" type="folder">5-8</container>
        </did>
        <accessrestrict id="4de55d18dd59d1c77f9f4fdd38e7a4d2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6062e376e8011b03bf27092730e8219d" level="file">
        <did>
          <unittitle>TML, 40-93 - New monoclonal antibodies to prevent transplant rejection</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="fd18128858bb4910ca34281f2f16f834" label="mixed materials (A0000000075872)" type="box">30</container>
          <container id="e5d4a74f0274aca109a7d3f19c6d540f" parent="fd18128858bb4910ca34281f2f16f834" type="folder">9-12</container>
        </did>
        <accessrestrict id="a10e4c82bc99d39cee6a7ddd1ca31b10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="de828b3fc932777396bebd27f5fab7dd" level="file">
        <did>
          <unittitle>TML, 40-117 - Choice of lipid-lowering drugs</unittitle>
          <unitdate type="inclusive">1998 December 18</unitdate>
          <container id="6d8ab406c5b76936b53d00f899678582" label="mixed materials (A0000000075872)" type="box">30</container>
          <container id="3ab795ffa933f6d682c52f31d6741adc" parent="6d8ab406c5b76936b53d00f899678582" type="folder">13-16</container>
        </did>
        <accessrestrict id="ec87238d62e4af8195602bcb6756e8f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="0bba41a40cc25a8da0e7a635fb7e3df8" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="62f61869d796894be9eecd3a5fe3877c" label="mixed materials (A0000000075872)" type="box">30</container>
          <container id="0733de531854aa5f4bc46a201b520ca1" parent="62f61869d796894be9eecd3a5fe3877c" type="folder">17-19</container>
        </did>
        <accessrestrict id="e69b8784cca126a51aa694fe76fa93ef">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="13029629c9a2c8c4645ba910bddc0ec5" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="31b289290bff1febe621a1f4313425a8" label="mixed materials (A0000000075873)" type="box">31</container>
          <container id="db542f9ef99475c204a663a0fee4f161" parent="31b289290bff1febe621a1f4313425a8" type="folder">1-3</container>
        </did>
        <accessrestrict id="efd535a28d84b26cb3f39bdbca07f951">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="c768307fb6b27100b14034cebd5227a9" level="file">
        <did>
          <unittitle>TML, 40-43 - Toremifene and Letrozole for advance breast cancer</unittitle>
          <unitdate type="inclusive">1998 April 10</unitdate>
          <container id="6cbecb844005d90c8b2f294d0a4f553a" label="mixed materials (A0000000075873)" type="box">31</container>
          <container id="415c5c3deeb1ca8c7074ee319ef775db" parent="6cbecb844005d90c8b2f294d0a4f553a" type="folder">4-8</container>
        </did>
        <accessrestrict id="4fead382cbe8272480e24c54bdac4aa5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="edbc39d29ce93f5d2d89c1070b90a888" level="file">
        <did>
          <unittitle>TML, 40-95 - Brinzolamide for glaucoma</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="9f5c185e1309263cb9e89838c9caa6e1" label="mixed materials (A0000000075873)" type="box">31</container>
          <container id="eeb09fd083747f7888581fa3a6a350e2" parent="9f5c185e1309263cb9e89838c9caa6e1" type="folder">9-10</container>
        </did>
        <accessrestrict id="4761d1070aff6ae3d4f74655713baaa7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6d7c66707bdf53045a7ff953d6e108d3" level="file">
        <did>
          <unittitle>TML, 40-45 - Tigabine for epilepsy</unittitle>
          <unitdate type="inclusive">1998 April 10</unitdate>
          <container id="159807f03c6c6d38e4ece771fa68044f" label="mixed materials (A0000000075873)" type="box">31</container>
          <container id="7c4e2e07b7c71dd2443b407a79ee2dc7" parent="159807f03c6c6d38e4ece771fa68044f" type="folder">11-13</container>
        </did>
        <accessrestrict id="94fdedf900cf20f12d378b25deedc2ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a07a54028f90ac0076d2802b57942911" level="file">
        <did>
          <unittitle>TML, 40-64 - A new rabies vaccine</unittitle>
          <unitdate type="inclusive">1998 June 14</unitdate>
          <container id="62134d3f08049ae0571ec43930dadf81" label="mixed materials (A0000000075873)" type="box">31</container>
          <container id="173e14a82472464c3b7517dde3ed1e4f" parent="62134d3f08049ae0571ec43930dadf81" type="folder">14-15</container>
        </did>
        <accessrestrict id="47ed997eea8759fcee2c1c993e8bbb47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3bd95f95656aa72b9a953a7b60fc1ff8" level="file">
        <did>
          <unittitle>TML, 40-29 - Raloxifene for postmenopausal osteoporosis</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="e055a72d708bd8d19f2e22e76f43d3e9" label="mixed materials (A0000000075873)" type="box">31</container>
          <container id="9d25e1178da05ba5289446c4727e4823" parent="e055a72d708bd8d19f2e22e76f43d3e9" type="folder">16-18</container>
        </did>
        <accessrestrict id="072da8fc19d0e0c642d2808e0b9452ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="fa4c88d1fa307e4c1c36721c687359e5" level="file">
        <did>
          <unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="477ca97d31720725114101c7b635a74a" label="mixed materials (A0000000075873)" type="box">31</container>
          <container id="c5e1501bc3eb2d041225a29de6b2f973" parent="477ca97d31720725114101c7b635a74a" type="folder">19</container>
        </did>
        <accessrestrict id="4326873ad2b2259141a757cbab189cb2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b31307f7682d799e34699487a403a926" level="file">
        <did>
          <unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="7f4739d09aae9b18d116b9d3c4ecab18" label="mixed materials (A0000000075874)" type="box">32</container>
          <container id="9d0572be2e82cbb7bc6fd16b533658ff" parent="7f4739d09aae9b18d116b9d3c4ecab18" type="folder">1-2</container>
        </did>
        <accessrestrict id="2802926a9875868eb77bbf4162293dea">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="c0f605353f7f9186d9e181b0e5a7b35c" level="file">
        <did>
          <unittitle>TML, 40-15 - Budesonide turbuhaler for asthma</unittitle>
          <unitdate type="inclusive">1998 January 16</unitdate>
          <container id="3d162875b0320eb160105e77d8bb85d8" label="mixed materials (A0000000075874)" type="box">32</container>
          <container id="7f6081d68dade7d36daa0db6899b91af" parent="3d162875b0320eb160105e77d8bb85d8" type="folder">3-8</container>
        </did>
        <accessrestrict id="63c818b79b8463447ba0a35c3ed08e0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="fc1c9413add7682bf34765d07e37871c" level="file">
        <did>
          <unittitle>TML - Cholesterol-Lowering - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="b42a89b2b1359e377b80a9af8e24f029" label="mixed materials (A0000000075874)" type="box">32</container>
          <container id="0656b8a29843bb8c94775882eceb09fe" parent="b42a89b2b1359e377b80a9af8e24f029" type="folder">9-10</container>
        </did>
        <accessrestrict id="263b366a38ae16d96e1447c8e1c8953b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="9212aaed4209e15330e340d1c8675d23" level="file">
        <did>
          <unittitle>TML - Parasitic Infections - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="e31513605f6048147a2c50768b00001c" label="mixed materials (A0000000075874)" type="box">32</container>
          <container id="deab0bea0ca95548f957394adea39481" parent="e31513605f6048147a2c50768b00001c" type="folder">11-14</container>
        </did>
        <accessrestrict id="5db4f9b0242f10ed336d20896e08899c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="367ee47d6747fc683d4571ad991fcb28" level="file">
        <did>
          <unittitle>TML - Malaria - Drugs for parastic infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="578d0399b7a7ac6ac1dae7eb03dd7c89" label="mixed materials (A0000000075874)" type="box">32</container>
          <container id="2d185dff1c68ccc8723e1aedd1a5f523" parent="578d0399b7a7ac6ac1dae7eb03dd7c89" type="folder">15-16</container>
        </did>
        <accessrestrict id="e3f66807c02c01517706efbf9eeaff5f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="d64c5c233f60d11993a1dd5cef9c5ec4" level="file">
        <did>
          <unittitle>TML - Antimicrobial drugs - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="bd63f45ae318704047cfab1b03454d4e" label="mixed materials (A0000000075874)" type="box">32</container>
          <container id="c501ce4d3456d862d5c605d63a9c45a5" parent="bd63f45ae318704047cfab1b03454d4e" type="folder">17</container>
        </did>
        <accessrestrict id="f6a6fff3786ff1d521cdf342567849ee">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3d41d005cf4c13e14913cd67a32a5047" level="file">
        <did>
          <unittitle>TML - Antimicrobial drugs - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="afadf9a205fdc018c16c29ccad8b5e1c" label="mixed materials (A0000000075875)" type="box">33</container>
          <container id="3aed15754bd92d551e566b6f54f212a1" parent="afadf9a205fdc018c16c29ccad8b5e1c" type="folder">1-2</container>
        </did>
        <accessrestrict id="8075ff059f0d4d931fa3535cefb097fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a70dd9355ee98a30aebc26b8daacffc8" level="file">
        <did>
          <unittitle>TML - Psychiatric Symptoms - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="fafec1c6bcdaabec3ddbecb5469b61b5" label="mixed materials (A0000000075875)" type="box">33</container>
          <container id="66f24d70f9c18d57e5f5e0a2e7eb6bc6" parent="fafec1c6bcdaabec3ddbecb5469b61b5" type="folder">3</container>
        </did>
        <accessrestrict id="9dfab18fed33b99b2f9c6ca42c51a487">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="878b0cb8e4fc058b68a1ed9db09469eb" level="file">
        <did>
          <unittitle>TML, 40-109 - Candesartan</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="624baae51ed4533644b30fad23890b3a" label="mixed materials (A0000000075875)" type="box">33</container>
          <container id="a303413722c11066f5562b071bba2633" parent="624baae51ed4533644b30fad23890b3a" type="folder">4-6</container>
        </did>
        <accessrestrict id="ba7cc6a8281cf2cb771c412c8f89cd3f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e61911867cf616602aa72255f38dc9ba" level="file">
        <did>
          <unittitle>TML, 40-77 - Interleukin-11</unittitle>
          <unitdate type="inclusive">1998 July 31</unitdate>
          <container id="f31deb84ea36f59625707f6f3d615033" label="mixed materials (A0000000075875)" type="box">33</container>
          <container id="6c3b2d12820eec3246ba704472030f44" parent="f31deb84ea36f59625707f6f3d615033" type="folder">7-9</container>
        </did>
        <accessrestrict id="4f66d0ee0cc0c75d98d5ce57dfee6a86">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="4f7233bf7c77fcfc22d806ea70169968" level="file">
        <did>
          <unittitle>TML, 40-85 - Cefdinir</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="1c98a9d3516813fda85470de6eeaf8c1" label="mixed materials (A0000000075875)" type="box">33</container>
          <container id="ca74dcdbc3367125fdd99e7162081a06" parent="1c98a9d3516813fda85470de6eeaf8c1" type="folder">10-12</container>
        </did>
        <accessrestrict id="028c35e32d1addf3672d48cb03ad70d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="910ff3d576f61dcba1783abe6210dff1" level="file">
        <did>
          <unittitle>TML, 40-79 - Drugs for pain</unittitle>
          <unitdate type="inclusive">1998 August 14</unitdate>
          <container id="ec742c1118b961029945b6bd5a0a9cbf" label="mixed materials (A0000000075875)" type="box">33</container>
          <container id="8533dae622c555633f8042a69eb2ed82" parent="ec742c1118b961029945b6bd5a0a9cbf" type="folder">13-17</container>
        </did>
        <accessrestrict id="72993e3876c2683037ab6df23f908193">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="960c1722fd9da508635b32ac38c60f80" level="file">
        <did>
          <unittitle>TML, 40-87 - Risedronate</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="3c404296b064a4ac87c74eaafed449f3" label="mixed materials (A0000000075875)" type="box">33</container>
          <container id="35414bb9582f311040ebb63961090bfe" parent="3c404296b064a4ac87c74eaafed449f3" type="folder">18-19</container>
        </did>
        <accessrestrict id="c3d8c6875a01ba6968c3fea93fe65185">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="8e8879c55ee8242081f7f64851b4db08" level="file">
        <did>
          <unittitle>TML, 40-87 - Risedronate</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="ef44a3f568d00a37cfa3ca0c9cb66611" label="mixed materials (A0000000075876)" type="box">34</container>
          <container id="4497f3bcb2f8068ebe07104e680a0c2e" parent="ef44a3f568d00a37cfa3ca0c9cb66611" type="folder">1-2</container>
        </did>
        <accessrestrict id="54d5c0c828c3316a8382b3f15461804c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="5d664f33dcd2cabbe962a4227379c390" level="file">
        <did>
          <unittitle>TML, 40-94 - Lepirudin for heparin-induced thrombocytopenia</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="3c5d0a4124504955d40dd4057a4abe8a" label="mixed materials (A0000000075876)" type="box">34</container>
          <container id="ba3acabd2fc87e842f045bf87b732323" parent="3c5d0a4124504955d40dd4057a4abe8a" type="folder">3-4</container>
        </did>
        <accessrestrict id="df311ee9e0d78fb33b148774389da7c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3d76a36572332e4c480702f762cc9918" level="file">
        <did>
          <unittitle>TML, 40-25 - Propecia and Rogaine Extra Stength for Alopecia</unittitle>
          <unitdate type="inclusive">1998 February 27</unitdate>
          <container id="1cbfd2a9e6b23e1844eb700c3187e6c2" label="mixed materials (A0000000075876)" type="box">34</container>
          <container id="5083829e9a2949df89cbbc74ad83a93c" parent="1cbfd2a9e6b23e1844eb700c3187e6c2" type="folder">5-8</container>
        </did>
        <accessrestrict id="c3ab3185c9cf9153482322e821491aa5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="affe7599f3c787d823e95823bfc0cbfc" level="file">
        <did>
          <unittitle>TML, 40-106 - Capecitabine for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1998 November</unitdate>
          <container id="99325467df8b875a23788726fc68cca9" label="mixed materials (A0000000075876)" type="box">34</container>
          <container id="240f51a2cc4d54e40e7f5aaa3702a9c8" parent="99325467df8b875a23788726fc68cca9" type="folder">9-10</container>
        </did>
        <accessrestrict id="544789c77c743995f3e1041b8e18aab6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="2e2e66929019d8531954a7ad095700fb" level="file">
        <did>
          <unittitle>TML, 40-13 - Cerivastatin for hypercholesterolemia</unittitle>
          <unitdate type="inclusive">1998 January 16</unitdate>
          <container id="35c7eb9ad91a49d8789b88ac8bbe5294" label="mixed materials (A0000000075876)" type="box">34</container>
          <container id="f5cda176e091448dca55e83d7b7a7095" parent="35c7eb9ad91a49d8789b88ac8bbe5294" type="folder">11-13</container>
        </did>
        <accessrestrict id="c00a8622a08054369fa43b3f435559cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="4043d39a1cb0cf7a9edea397c7574337" level="file">
        <did>
          <unittitle>TML, 40-101 - Tolterodine for overactive bladder</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="224d95cefa23ad5eba48318bbe47e0e9" label="mixed materials (A0000000075876)" type="box">34</container>
          <container id="20443a49842f6238b6af4ddb86550d8b" parent="224d95cefa23ad5eba48318bbe47e0e9" type="folder">14-16</container>
        </did>
        <accessrestrict id="5ed653620eb193653bb7be17c3823301">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e5341af61e6a0539c242e29242b615c6" level="file">
        <did>
          <unittitle>TML, 40-102 - An Emergency Contraceptive Kit</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="35b0dbc00071b2fa2b911d01d81fc540" label="mixed materials (A0000000075876)" type="box">34</container>
          <container id="685967d09f09980794b9696b18ff3d69" parent="35b0dbc00071b2fa2b911d01d81fc540" type="folder">17-18</container>
        </did>
        <accessrestrict id="5f3dbedbdfcd288cd297f8d578fd4ced">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3f39fb343e118836671bfce7c8c9e0be" level="file">
        <did>
          <unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="962ac526205ad0687db5cae8816e8e84" label="mixed materials (A0000000075876)" type="box">34</container>
          <container id="a3d4f26a41b96a612dca74522730bc3f" parent="962ac526205ad0687db5cae8816e8e84" type="folder">19</container>
        </did>
        <accessrestrict id="a3bdebd3c863cd5e8915acd5b9e97a95">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e43a7710b28863a0de4803cfd4c0b542" level="file">
        <did>
          <unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="d6c8f06f8c49806f99f0f3d90665ec56" label="mixed materials (A0000000075877)" type="box">35</container>
          <container id="7096c735ce52258993ad96af698d5c1e" parent="d6c8f06f8c49806f99f0f3d90665ec56" type="folder">1-2</container>
        </did>
        <accessrestrict id="4b8fa308ff1db3b9b6869466f7f0fe98">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f487b7ea1e7909af55b4d7eeee8db68c" level="file">
        <did>
          <unittitle>TML, 40-103 - Thalidomide</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="722a93aa0519340a1429980f475ae7dc" label="mixed materials (A0000000075877)" type="box">35</container>
          <container id="bf5ac20450f9df6d9420004389bd78c6" parent="722a93aa0519340a1429980f475ae7dc" type="folder">3-6</container>
        </did>
        <accessrestrict id="afd021cfb4388a63de5e218998fd47c7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="31cfa0b79a02b7866aa0dc7e48743280" level="file">
        <did>
          <unittitle>TML, 40-97 - New Triptans and other drugs for migraine</unittitle>
          <unitdate type="inclusive">1998 October 9</unitdate>
          <container id="e8ddd8a14d3369da48f5e353e23d199e" label="mixed materials (A0000000075877)" type="box">35</container>
          <container id="9c8d976852f2d07a80dca15a9442255b" parent="e8ddd8a14d3369da48f5e353e23d199e" type="folder">7-12</container>
        </did>
        <accessrestrict id="43083e8c7ccdb0aa74b842657cd508ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f35138cee47bea646beb32b2995d4598" level="file">
        <did>
          <unittitle>TML, 40-91 - Influenza vaccine, 1998-1999</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="fcffc6ba0368a56932f5f5f061e609b1" label="mixed materials (A0000000075877)" type="box">35</container>
          <container id="24ea84dc2cd9dbef0b4831cca3c61efe" parent="fcffc6ba0368a56932f5f5f061e609b1" type="folder">13</container>
        </did>
        <accessrestrict id="a29dd57181aa1c5e6c3a1e5d3b488af7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="7c2b7e050833f74d66d0b600d186eae5" level="file">
        <did>
          <unittitle>TML, 40-105 - Creatine and Androstenedione - two "dietary supplements"</unittitle>
          <unitdate type="inclusive">1998 November 6</unitdate>
          <container id="956762b1f31fa2b26ebd49518a0ef80c" label="mixed materials (A0000000075877)" type="box">35</container>
          <container id="a3d8b51fc1ca85823b433b8bbe57cff5" parent="956762b1f31fa2b26ebd49518a0ef80c" type="folder">14-16</container>
        </did>
        <accessrestrict id="bcbeeba99d41f442379b4633e1dc7778">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a4342729d9ef2567742167972402009f" level="file">
        <did>
          <unittitle>TML, 39-107 - St. John's Wort</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="d0ef510055efc7ad3d63ea845b5a3131" label="mixed materials (A0000000075877)" type="box">35</container>
          <container id="1375601bd5f6613cc23eb1c8e3b0f999" parent="d0ef510055efc7ad3d63ea845b5a3131" type="folder">17-18</container>
        </did>
        <accessrestrict id="f27838dbfd9cecfa9e71bf77f07fe682">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="ddfb397d4b944785854d8ea719c202bd" level="file">
        <did>
          <unittitle>TML, 41-73 - Malathion for treatment of head lice</unittitle>
          <unitdate type="inclusive">1999 August 13</unitdate>
          <container id="864813036bc53eb57b4204eb47ebf02c" label="mixed materials (A0000000075878)" type="box">36</container>
          <container id="94e6f02ba7cd0ce5f175c8b04ec177d6" parent="864813036bc53eb57b4204eb47ebf02c" type="folder">1-2</container>
        </did>
        <accessrestrict id="854b0f58396665c4e2d4a0465f949fd7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="35b97709b422b46ecdc94c987c5952ec" level="file">
        <did>
          <unittitle>TML, 41-39 - Advice for travelers</unittitle>
          <unitdate type="inclusive">1999 April 23</unitdate>
          <container id="7937d29691a16edbc026d534ee6ddf74" label="mixed materials (A0000000075878)" type="box">36</container>
          <container id="73f7098155be648747c2373222d77d7c" parent="7937d29691a16edbc026d534ee6ddf74" type="folder">3-4</container>
        </did>
        <accessrestrict id="04ad6f830bf72709637049c7b301499d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="f916a9e5c338ff7fc1707311815267f1" level="file">
        <did>
          <unittitle>TML, 41-30 - Modafinil for narcolepsy</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="0af8831a77503b4567f35d70f3e59f2c" label="mixed materials (A0000000075878)" type="box">36</container>
          <container id="ceded89e182afb59dd51becd3d3a5909" parent="0af8831a77503b4567f35d70f3e59f2c" type="folder">5-7</container>
        </did>
        <accessrestrict id="113f676d893d247079b5e4ff614aec1e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="2fc16ae414cf9dd501de68ee706014d5" level="file">
        <did>
          <unittitle>TML, 41-51 - Levalbuterol for asthma</unittitle>
          <unitdate type="inclusive">1999 June 4</unitdate>
          <container id="ff087cbe5818986fa683dc79232672cd" label="mixed materials (A0000000075878)" type="box">36</container>
          <container id="31d079fbce903f5f26b43a5ff79e8efb" parent="ff087cbe5818986fa683dc79232672cd" type="folder">8-10</container>
        </did>
        <accessrestrict id="17d7935132e18e8bac890aeefcb5960f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="3922b9c381c0b19cb3d63cbe803305a6" level="file">
        <did>
          <unittitle>TML, 41-16 - Mometasone furoate nasal spray for allergic rhinitis</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="b2a8de94878539fb68de1dfb47fbe8c7" label="mixed materials (A0000000075878)" type="box">36</container>
          <container id="33951ad1345444a50f1c95d19fea1be6" parent="b2a8de94878539fb68de1dfb47fbe8c7" type="folder">11-12</container>
        </did>
        <accessrestrict id="481e161096febedcc11b1ed837e0109b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="4d4ebb415f82a62d6c6b5091a9afeb7a" level="file">
        <did>
          <unittitle>TML, 41-50 - Vaccine for rotavirus</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="bf484372199274b1b91cdaa6833a19f5" label="mixed materials (A0000000075878)" type="box">36</container>
          <container id="0bc1fe8ac4691809da9d4612582abee2" parent="bf484372199274b1b91cdaa6833a19f5" type="folder">13-14</container>
        </did>
        <accessrestrict id="b72eb586cf031b15f2ce8b6037f013b2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="65d972dc57e884b250ec76744f2d84f9" level="file">
        <did>
          <unittitle>TML, 41-91 - Two neuraminidase inhibitors for treatment of influenza</unittitle>
          <unitdate type="inclusive">1999 October 8</unitdate>
          <container id="05a73144633c6d78e8673f83f4bb001e" label="mixed materials (A0000000075878)" type="box">36</container>
          <container id="41578fae0072f06076087ee0c0d8155d" parent="05a73144633c6d78e8673f83f4bb001e" type="folder">15-17</container>
        </did>
        <accessrestrict id="6e3fe48fdf68db20082fc8bad62e904f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="26fd68ebafc0d8085fe92d2eb77fcbf6" level="file">
        <did>
          <unittitle>TML, 41-93 - Zaleplon for insomnia</unittitle>
          <unitdate type="inclusive">1999 October 8</unitdate>
          <container id="026f7b18bc99d19112dbf17fce230b80" label="mixed materials (A0000000075879)" type="box">37</container>
          <container id="3262b736a7f246e21b1b6284a7442798" parent="026f7b18bc99d19112dbf17fce230b80" type="folder">1-4</container>
        </did>
        <accessrestrict id="b25acf713bbbe8621cf294856e16ba28">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="ec877eb8397cacf7d82d77f65b127412" level="file">
        <did>
          <unittitle>TML, 41-1 - Tamoxife for the prevention of breast cancer</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="15ace823ed6a1bb088b5de693a354d7c" label="mixed materials (A0000000075879)" type="box">37</container>
          <container id="db46164628e141c63ae14c7021ab3ec0" parent="15ace823ed6a1bb088b5de693a354d7c" type="folder">5-6</container>
        </did>
        <accessrestrict id="5090105f2f60079c4d3f971adf860516">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="94ff8cec3e58b5c4d7bd8582a705f051" level="file">
        <did>
          <unittitle>TML, 41-123 - Temozolomide</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="1f4504db0529977ccded84a4e00d713e" label="mixed materials (A0000000075879)" type="box">37</container>
          <container id="fbfb42380049d96caff6a20a589e8ef7" parent="1f4504db0529977ccded84a4e00d713e" type="folder">7-8</container>
        </did>
        <accessrestrict id="7a64776358d5df180bb0a5ddbff0bef7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a4b43b9f4b92e02c161ee56d03e178c9" level="file">
        <did>
          <unittitle>TML, 41-53 - Interferon plus ribavirin for chronic hepatitis C</unittitle>
          <unitdate type="inclusive">1999 June 4</unitdate>
          <container id="0f66b1e395149a933452ffb2e12667cb" label="mixed materials (A0000000075879)" type="box">37</container>
          <container id="112ffca643c4cae2a5d832bbc4df22e4" parent="0f66b1e395149a933452ffb2e12667cb" type="folder">9-11</container>
        </did>
        <accessrestrict id="af177345fcae67c9d255185c0a10e870">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="024012e8b7f7de531d716961ead029ce" level="file">
        <did>
          <unittitle>TML, 41-49 - Miglitol for Type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="663b62ce3c44b90c634a418d5023b4ef" label="mixed materials (A0000000075879)" type="box">37</container>
          <container id="466fcd1d99985da6ae86fd7f6bd71cbf" parent="663b62ce3c44b90c634a418d5023b4ef" type="folder">12-13</container>
        </did>
        <accessrestrict id="d6f81a58c2dc3eaf1f79b5dc23f9a66b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a9621527ed50246d7a862b61f10afb79" level="file">
        <did>
          <unittitle>TML, 41-110 - Rabeprazole</unittitle>
          <unitdate type="inclusive">1999 November 9</unitdate>
          <container id="11cd6aef60400268cb504b2d9a604e9e" label="mixed materials (A0000000075879)" type="box">37</container>
          <container id="a124669206350d30f3735f0fe4a5af16" parent="11cd6aef60400268cb504b2d9a604e9e" type="folder">14-15</container>
        </did>
        <accessrestrict id="fa2239be1fca64f3de4ed0688d43b5a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="fcec222c26512f8ebe8b672bf459fbe9" level="file">
        <did>
          <unittitle>TML, 41-21 - Rifapentine for tuberculosis</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="50cdfa6bc2e2b939cff2ae9626c94e3c" label="mixed materials (A0000000075879)" type="box">37</container>
          <container id="b36942ea60bf6ab91aca9214000a2d43" parent="50cdfa6bc2e2b939cff2ae9626c94e3c" type="folder">16-17</container>
        </did>
        <accessrestrict id="5eabb94693fe31a0f053df4c9645327d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="c2530250616ca691ba7d71e8d92ca5e1" level="file">
        <did>
          <unittitle>TML, 41-109 - Quinupristin (Dalfopristin)</unittitle>
          <unitdate type="inclusive">1999 November 19</unitdate>
          <container id="00776c347acc9eb8987e8bfd07565f90" label="mixed materials (A0000000075879)" type="box">37</container>
          <container id="111f9cb16e65a62e818e71414c7da525" parent="00776c347acc9eb8987e8bfd07565f90" type="folder">18-19</container>
        </did>
        <accessrestrict id="96db099c24d150d666b7ebe07b50d611">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e80acff708763c79ba27fdf7b90311e5" level="file">
        <did>
          <unittitle>TML, 41-71 - Rosiglitazone for Type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1999 August 13</unitdate>
          <container id="51196aa8adda65ef44f451a99c193b3a" label="mixed materials (A0000000075880)" type="box">38</container>
          <container id="909b3a615987cde623d6f566e26acf9d" parent="51196aa8adda65ef44f451a99c193b3a" type="folder">1-3</container>
        </did>
        <accessrestrict id="165ec4ab5ea0c075fdbea5fe2e192f3d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="703b499487840917db1eeb7a3bbf97c3" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Rheumatoid Arthritis</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="7e078f61721e2c408f8db5cd79598e65" label="mixed materials (A0000000075880)" type="box">38</container>
          <container id="5bff2fa9168710f02e86e89710573063" parent="7e078f61721e2c408f8db5cd79598e65" type="folder">4-7</container>
        </did>
        <accessrestrict id="15f525d3017c59fe2b80a8ae96ac839d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="d1121bbf04acf6873bc6f6be66e80e1c" level="file">
        <did>
          <unittitle>TML, 41-59 - Rofecoxib for osteoarthritis and pain</unittitle>
          <unitdate type="inclusive">1999 July 2</unitdate>
          <container id="25195ee1e34200c6be91d9350e96f8d2" label="mixed materials (A0000000075880)" type="box">38</container>
          <container id="16feb5082b4343ab0b2635fcfc7186b3" parent="25195ee1e34200c6be91d9350e96f8d2" type="folder">8-10</container>
        </did>
        <accessrestrict id="11221f9e1bc9230aebbe4b8afe4c8c85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="755deaec93a3a8f46413cdb9d38a9847" level="file">
        <did>
          <unittitle>TML, 41-84 - Pneumococcal vaccine</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="ad874afd3a203f1975b6f993f054e33e" label="mixed materials (A0000000075880)" type="box">38</container>
          <container id="f6f4b5f0557172e83d6591a8833b6abc" parent="ad874afd3a203f1975b6f993f054e33e" type="folder">11-13</container>
        </did>
        <accessrestrict id="ad40d9598ad03e97e0de7ff5b12324c2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="0ee2e8ec8ef4a025a102da4125d330c6" level="file">
        <did>
          <unittitle>TML, 41-20 - Homeopathic products</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="b31b7ee34ebdc3e0a12b4785895b0777" label="mixed materials (A0000000075880)" type="box">38</container>
          <container id="efa59f359cb4d1e9fdf764e9bb52e7ec" parent="b31b7ee34ebdc3e0a12b4785895b0777" type="folder">14-16</container>
        </did>
        <accessrestrict id="1d27c989e3d0f4c9ca2d59fcac0ed578">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="0f8ace5b9ab967ce17459254fb17ca75" level="file">
        <did>
          <unittitle>TML, 41-55 - Orlistat for obesity</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="bcae25be003387c6932efcc7d03adb34" label="mixed materials (A0000000075880)" type="box">38</container>
          <container id="c0ed607f9149c0bf22c65c57c3dc9757" parent="bcae25be003387c6932efcc7d03adb34" type="folder">17</container>
        </did>
        <accessrestrict id="3afad4f5d733d9716d22ba16c44983fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="b2928e0b146edbf6a03684604b2f6230" level="file">
        <did>
          <unittitle>TML, 41-69 - Prosorba column for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="849d8538c8438b837888a5510553bb69" label="mixed materials (A0000000075880)" type="box">38</container>
          <container id="e1b2de33e76407e8d2fb862023d91035" parent="849d8538c8438b837888a5510553bb69" type="folder">18</container>
        </did>
        <accessrestrict id="f89d8a299f3aa1cb78fdeda3584f26e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e394fdb910a180949b33fcfe30e8b17c" level="file">
        <did>
          <unittitle>TML, 41-23 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">1999 March 12</unitdate>
          <container id="f02893b1acd180c6f032a7c970710812" label="mixed materials (A0000000075881)" type="box">39</container>
          <container id="1b7f7632710fd5c68a51a346b115507a" parent="f02893b1acd180c6f032a7c970710812" type="folder">1-6</container>
        </did>
        <accessrestrict id="a85ce10fe729a0b9b0f29f163788bcd8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="1a3e95e6f5eb2cbf5b0cdb530d4df8b2" level="file">
        <did>
          <unittitle>TML, 41-113 - Drugs for non-HIV viral infection</unittitle>
          <unitdate type="inclusive">1999 December 3</unitdate>
          <container id="b5cd83370c060ea86f4056015b59418e" label="mixed materials (A0000000075881)" type="box">39</container>
          <container id="b42129e32a4955158d4d14f10ad52a8a" parent="b5cd83370c060ea86f4056015b59418e" type="folder">7-10</container>
        </did>
        <accessrestrict id="ddc058cf574899e5d0347e37efa9598e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e42d2f63edb58feb20931053061b1339" level="file">
        <did>
          <unittitle>TML, 41-112 - Pioglitazone (Actos)</unittitle>
          <unitdate type="inclusive">1999 November 19</unitdate>
          <container id="d6a29213f3958f8f7e1bad930fb2f9f7" label="mixed materials (A0000000075881)" type="box">39</container>
          <container id="a157b6582fed5d7f0423d35ccf0ec97e" parent="d6a29213f3958f8f7e1bad930fb2f9f7" type="folder">11</container>
        </did>
        <accessrestrict id="2bf75590065032d73df0e0fa13732a7d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="28427104a307e9895b1500110c4ba78c" level="file">
        <did>
          <unittitle>TML, 41-43 - Suncreens - Are they safe and effective</unittitle>
          <unitdate type="inclusive">1999 May 7</unitdate>
          <container id="e7a7e5c8ad13ee9d7800d1df2069edd2" label="mixed materials (A0000000075881)" type="box">39</container>
          <container id="ae771d608dc3a7f8825839d19b0de62f" parent="e7a7e5c8ad13ee9d7800d1df2069edd2" type="folder">12-16</container>
        </did>
        <accessrestrict id="d50144a362c7ab5f8c046503c10ecf2a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a4c7b991a97b85bed8305af27776e491" level="file">
        <did>
          <unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="a1f93fc3f6c39ba2183884759f54ffe9" label="mixed materials (A0000000075881)" type="box">39</container>
          <container id="53af48db980356b0e4298dee0d7347a4" parent="a1f93fc3f6c39ba2183884759f54ffe9" type="folder">17-18</container>
        </did>
        <accessrestrict id="9b77ea87c2f2795c19e71f426864b471">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="efd202ef6564adfebc4106108c9561f2" level="file">
        <did>
          <unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="8745c75ae282bce2a85e3713c15cd017" label="mixed materials (A0000000075882)" type="box">40</container>
          <container id="ceff24a70469e4b7467dcd304498a721" parent="8745c75ae282bce2a85e3713c15cd017" type="folder">1-2</container>
        </did>
        <accessrestrict id="6304e26af10a0e94e7ef043fee53ad70">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="5422bbde47d91ace2df22b5b7527a0e6" level="file">
        <did>
          <unittitle>TML, 41-105 - A new ACE inhibitorand two new angiotensin receptor blockers for hypertension</unittitle>
          <unitdate type="inclusive">1999 November 5</unitdate>
          <container id="aaea235a613cc925d3c0eba8aa011b46" label="mixed materials (A0000000075882)" type="box">40</container>
          <container id="5fbce9cc1f86b776dcab18e501ba8c27" parent="aaea235a613cc925d3c0eba8aa011b46" type="folder">3-6</container>
        </did>
        <accessrestrict id="e16a540da639162df21cb6fa8cf623e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="087aeda452bdc8c1f70b599b752d152a" level="file">
        <did>
          <unittitle>TML, 41-67 - A new conjugated estrogen</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="33c0b9fd8baf926a5cc3b1a4f4bd47bf" label="mixed materials (A0000000075882)" type="box">40</container>
          <container id="8090ea7dd4d977b8bbf5a9489af78e94" parent="33c0b9fd8baf926a5cc3b1a4f4bd47bf" type="folder">7-8</container>
        </did>
        <accessrestrict id="3dd21eec3f06c65a80aa71eae6b88575">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e1ba3784eccce1db97752b63119a9737" level="file">
        <did>
          <unittitle>TML, 41-15 - Drugs and vaccines against biological warfare</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="0c28b32fa47dd04d2598fcdeb25fff53" label="mixed materials (A0000000075882)" type="box">40</container>
          <container id="942331cc1c0da5da4836beb758926493" parent="0c28b32fa47dd04d2598fcdeb25fff53" type="folder">9</container>
        </did>
        <accessrestrict id="a078c6c919634b8920e26478d73bef6a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="ee9f72d21997962aa5e1d76e60f28954" level="file">
        <did>
          <unittitle>TML, 41-68 - Laser hair removal</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="8d3043690dd70f22562f8a72a3b1ef1d" label="mixed materials (A0000000075882)" type="box">40</container>
          <container id="52b6a68d0516b71adef73d99fdc75658" parent="8d3043690dd70f22562f8a72a3b1ef1d" type="folder">10-11</container>
        </did>
        <accessrestrict id="0797b526bde059f59517ea165bdcb518">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="0f4d6a53975d9232738144f364667da0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="2bcb5b1e9c65a318aa12225d05a6832a" label="mixed materials (A0000000075882)" type="box">40</container>
          <container id="9cc943cda53a78ce910133509a5bfedf" parent="2bcb5b1e9c65a318aa12225d05a6832a" type="folder">12-16</container>
        </did>
        <accessrestrict id="ca7184a59b6ddfe5ef00a19434c19c48">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="5db523527161519d86f176dd07137b4b" level="file">
        <did>
          <unittitle>TML, 41-5 - Drugs for Asthma</unittitle>
          <unitdate type="inclusive">1999 January 15</unitdate>
          <container id="21322efbd885631e334ccd53ebeff9ca" label="mixed materials (A0000000075883)" type="box">41</container>
          <container id="412d2290f7d77d3a57daf710a5455b84" parent="21322efbd885631e334ccd53ebeff9ca" type="folder">1-5</container>
        </did>
        <accessrestrict id="24b467056399b27bd316ca395f5c8a5e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="3c1f55d592280bce047dbd773f816697" level="file">
        <did>
          <unittitle>TML, 41-12 - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">1999 January 29</unitdate>
          <container id="9d7a4f757cb59ce7ead7597d6791d5df" label="mixed materials (A0000000075883)" type="box">41</container>
          <container id="1fe007bbeac1b5216b8cc1e276724f2a" parent="9d7a4f757cb59ce7ead7597d6791d5df" type="folder">6-8</container>
        </did>
        <accessrestrict id="a82b9541fad7707df8ff8e0ecec045a1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a5ef95fdd53a4ad00be13d575b720a90" level="file">
        <did>
          <unittitle>TML, 41-32 - Valrubicin for bladder cancer</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="c17206bd0c73c094231c3695e6ba4280" label="mixed materials (A0000000075883)" type="box">41</container>
          <container id="0f0c0b9100ae0e1ea17d84a05af7f7f2" parent="c17206bd0c73c094231c3695e6ba4280" type="folder">9</container>
        </did>
        <accessrestrict id="1246d47b99a5b28275ca7ac909e04e17">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="c9b5394af1307b91512bebaa47987a03" level="file">
        <did>
          <unittitle>TML, 41-19 - Infliximab (Remicade) for Crohn's disease</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="77f6ec345fd32c1ed8cd3f84935903f7" label="mixed materials (A0000000075883)" type="box">41</container>
          <container id="03ae4b01dbf95d19e0923961574238ae" parent="77f6ec345fd32c1ed8cd3f84935903f7" type="folder">10-11</container>
        </did>
        <accessrestrict id="bceed6a85bb227d8a5c9b54693104fa7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="9431f5004a39b8a0d9a05be98633933b" level="file">
        <did>
          <unittitle>TML, 41-82 - Influenza vaccine, 1999-2000</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="cecb1ac0c3d23eec63f98a128df08377" label="mixed materials (A0000000075883)" type="box">41</container>
          <container id="a001e8ec6ee763dce75a7f64fecedeb2" parent="cecb1ac0c3d23eec63f98a128df08377" type="folder">12-13</container>
        </did>
        <accessrestrict id="cab250b6e8f335e1e9356ce49870aa0f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aa75d744d2b7b8eae4e0c83305434171" level="file">
        <did>
          <unittitle>TML, 41-81 - Spironolactone for heart failure</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="af0495e452b7a03929f6154e456cc68a" label="mixed materials (A0000000075883)" type="box">41</container>
          <container id="dc10f2e844bf9c32b1e5f9c98afda13b" parent="af0495e452b7a03929f6154e456cc68a" type="folder">14-15</container>
        </did>
        <accessrestrict id="4baffc7980c89aadb8cef585c345f731">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="12a411c26719cadf670414ea9db35b3a" level="file">
        <did>
          <unittitle>TML, 41-2 - Growth-hormone-releasing factor for growth hormone deficiency</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="18dd4c8a09cd6c1e1de1e6352d32ccb5" label="mixed materials (A0000000075883)" type="box">41</container>
          <container id="fe9b6d737228b0a5e76d4194ba9b605b" parent="18dd4c8a09cd6c1e1de1e6352d32ccb5" type="folder">16-18</container>
        </did>
        <accessrestrict id="f46608e112550ebc9f422dd17a55e3b3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="50fdbec047db8cdec50f09ae8f09ce33" level="file">
        <did>
          <unittitle>TML, 41-18 - Saw Palmetto for benign prostatic hyperplasia</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="ebc8b3ea599cb88618815e056802e8ec" label="mixed materials (A0000000075884)" type="box">42</container>
          <container id="14292bb8d730afa08f0effa5c629df3f" parent="ebc8b3ea599cb88618815e056802e8ec" type="folder">1-3</container>
        </did>
        <accessrestrict id="ebda9b553416d292abf3337874edf243">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="12974761e15d5b5a631f8a1708a1d0e6" level="file">
        <did>
          <unittitle>TML, 41-107 - SAMe for depression</unittitle>
          <unitdate type="inclusive">1999 November 5</unitdate>
          <container id="659d443af9419fbce69520ceff5bc617" label="mixed materials (A0000000075884)" type="box">42</container>
          <container id="67f41635d93dd449e60c600fbe3ae1da" parent="659d443af9419fbce69520ceff5bc617" type="folder">4-7</container>
        </did>
        <accessrestrict id="9f6ccc892b5225ac4e542904aba616bf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="2891c6463578c91c35a01dfbc0867c34" level="file">
        <did>
          <unittitle>TML, 41-3 - Palivizumab (Synagis) for prevention of RSV infection</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="2caea8cf91e4ce99e0b4fc0f1ee95e29" label="mixed materials (A0000000075884)" type="box">42</container>
          <container id="0b51c15c04bc37448e22e02c5b6f8e0c" parent="2caea8cf91e4ce99e0b4fc0f1ee95e29" type="folder">8-9</container>
        </did>
        <accessrestrict id="b084224a8b4665a510e8da9d5962cae8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aa2d0e7ffb5da88f1ad0bda04c4f91da" level="file">
        <did>
          <unittitle>TML, 41:47 - Generic Drugs</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="fb28b16e633c5b0cc62becd1fa7471dd" label="mixed materials (A0000000075884)" type="box">42</container>
          <container id="f772700d18af1f5e700b87063fe2e3c3" parent="fb28b16e633c5b0cc62becd1fa7471dd" type="folder">10-15</container>
        </did>
        <accessrestrict id="d25ac57dbed224f7c437f5c406d80bfb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="d463206ca7312a03520c55b4035d6d7c" level="file">
        <did>
          <unittitle>TML, 41-64 - Amprenavir - a new HIV protease inhibitor</unittitle>
          <unitdate type="inclusive">1999 July 16</unitdate>
          <container id="769f6bbe66c63d1c058a350c4e219b70" label="mixed materials (A0000000075884)" type="box">42</container>
          <container id="f710d4055f4ffce57f670dc203065897" parent="769f6bbe66c63d1c058a350c4e219b70" type="folder">16-17</container>
        </did>
        <accessrestrict id="bebb6703e7e1148e21f6bff4883b5f0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="dacba7e70abbc68ca64fcd4963a6f95a" level="file">
        <did>
          <unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1999 August 27</unitdate>
          <container id="f962b1ba185d34e9cf359670095ca1d4" label="mixed materials (A0000000075884)" type="box">42</container>
          <container id="ef835c6b32bef2ecd3c0cc765aa50945" parent="f962b1ba185d34e9cf359670095ca1d4" type="folder">18</container>
        </did>
        <accessrestrict id="a555f10f258ebdc237376c5bf299600d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="813dc879c0e4261b5ae728f45f81e536" level="file">
        <did>
          <unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1999 August 27</unitdate>
          <container id="1591c7079b85a8ec50d2703168ea6c85" label="mixed materials (A0000000075885)" type="box">43</container>
          <container id="1a48521acce7f7fbeb42e31e5a410a3f" parent="1591c7079b85a8ec50d2703168ea6c85" type="folder">1-3</container>
        </did>
        <accessrestrict id="64327b946a10f94bc40f30737c8f1cd2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="bdc50b4955f16ee4564f9a2f1ecc15ee" level="file">
        <did>
          <unittitle>TML, 41-95 - The Choice of antibacterial drugs</unittitle>
          <unitdate type="inclusive">1999 October 22</unitdate>
          <container id="e8f09a95124c2a4b1820382f0011be88" label="mixed materials (A0000000075885)" type="box">43</container>
          <container id="837711317cc338e4ba20c7bdcce3cb2f" parent="e8f09a95124c2a4b1820382f0011be88" type="folder">4-8</container>
        </did>
        <accessrestrict id="6b1bb72d82bf5bc8c23cfe7d730b6597">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="9edd35ab1f22644cf6c65fedb0f5fd9d" level="file">
        <did>
          <unittitle>TML, 41-63 - Cosmetic use of botulinum toxin</unittitle>
          <unitdate type="inclusive">1999 July 16</unitdate>
          <container id="a8828a176a347bdfca34dbe686698c40" label="mixed materials (A0000000075885)" type="box">43</container>
          <container id="998357677d826c84c294f716b8a096a1" parent="a8828a176a347bdfca34dbe686698c40" type="folder">9-12</container>
        </did>
        <accessrestrict id="dfa20e59cc18902aef49d7b5c22d5eb5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="cadd4aba2aafedf04d2457bcd20ecb68" level="file">
        <did>
          <unittitle>TML, 41-29 - Lyme disease vaccine</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="53734146fd4f1b5221a8c1e4830933a4" label="mixed materials (A0000000075885)" type="box">43</container>
          <container id="5511a798fed3162ad4ff82a9c0b6a9c8" parent="53734146fd4f1b5221a8c1e4830933a4" type="folder">13-16</container>
        </did>
        <accessrestrict id="ebb5315c0e462b0e2629b5dcb90203c8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="bb27af27ca7507bfd777f78da0d17147" level="file">
        <did>
          <unittitle>TML, 41-121 - Rapid diagnostic tests for influenza</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="32a1eecf4f90a86cbaaad49f539b9be9" label="mixed materials (A0000000075885)" type="box">43</container>
          <container id="70091882a3ef371bf4100ebbe24c45c1" parent="32a1eecf4f90a86cbaaad49f539b9be9" type="folder">17-18</container>
        </did>
        <accessrestrict id="86662934e660af89d7aeaa4e4d013446">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="cf44b51a4bbfd2f5063743b63c4a93e3" level="file">
        <did>
          <unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">1999 September 24</unitdate>
          <container id="8bd71f3b79a7360a4cf90b624efda4de" label="mixed materials (A0000000075885)" type="box">43</container>
          <container id="f8f6269e01dc3ad53f0e080fbc78ccc5" parent="8bd71f3b79a7360a4cf90b624efda4de" type="folder">19</container>
        </did>
        <accessrestrict id="53ace92e24d776a3c07d0e679ac418eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="98fd7e915d5c04bccf9bfee05be98149" level="file">
        <did>
          <unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">1999 September 24</unitdate>
          <container id="24fb5d9d9bae68926c0d82f81e234c84" label="mixed materials (A0000000075886)" type="box">44</container>
          <container id="4a61d61f2be3eb0acba71e8e646d0263" parent="24fb5d9d9bae68926c0d82f81e234c84" type="folder">1-3</container>
        </did>
        <accessrestrict id="4fa538c8b0c22de3e0eea7db981ae287">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="47b865bf089a172b75b4d43ce7a1e447" level="file">
        <did>
          <unittitle>TML, 41-33 - Depression and anxiety</unittitle>
          <unitdate type="inclusive">1999 April 9</unitdate>
          <container id="72ae257cdadc2cdab71b19857ace6f1a" label="mixed materials (A0000000075886)" type="box">44</container>
          <container id="69b20a61c1fa1d2b46c34b332e5933e1" parent="72ae257cdadc2cdab71b19857ace6f1a" type="folder">4-13</container>
        </did>
        <accessrestrict id="b0f422d658f31862e120da53fa05b6f9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="71225c0666898a85e784b2cb281888c6" level="file">
        <did>
          <unittitle>TML, 41-122 - Corneal surgery for correction of refractive errors</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="449ab038cc99afc60afabee352be777d" label="mixed materials (A0000000075886)" type="box">44</container>
          <container id="eb3f945cc893e72287efff3e0c177993" parent="449ab038cc99afc60afabee352be777d" type="folder">14-16</container>
        </did>
        <accessrestrict id="383c5c203f77ebf4dd9e3dfe67c24cf7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="45f2b2be0a5f877794d8dab41d1e2c89" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="cc233da6bc80500ce37cef4a33ba61dc" label="mixed materials (A0000000075886)" type="box">44</container>
          <container id="959e1c1714c31e27a3c1e5953607bf3d" parent="cc233da6bc80500ce37cef4a33ba61dc" type="folder">17-18</container>
        </did>
        <accessrestrict id="149a9e74e2c2eb4d35105c1043e77fd1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="59f39d33e558df2c7a53b2df2d17a4ae" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="8137af58fe8510647f4ae31005d7f76f" label="mixed materials (A0000000075887)" type="box">45</container>
          <container id="b8cc1fb13294f333b0397dd04a4b75e7" parent="8137af58fe8510647f4ae31005d7f76f" type="folder">1-3</container>
        </did>
        <accessrestrict id="6cab2eae0fd66d97ea7c349b2f4718db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="8d82b612550e56f5febd997b649248f6" level="file">
        <did>
          <unittitle>TML - Drugs for Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="87ad20b967eb557a7df4a47c46bd7f49" label="mixed materials (A0000000075887)" type="box">45</container>
          <container id="3cb353deb09ce8d6bce91b4ba006ae8a" parent="87ad20b967eb557a7df4a47c46bd7f49" type="folder">4-9</container>
        </did>
        <accessrestrict id="9ea5dcafb096eb9d1dba6ab8571932c7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="729c9bb0e1660ceb032fe6da8350333c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice for cancer chemotherapy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="4f755a5f0d3f9c95131a410d970826ce" label="mixed materials (A0000000075887)" type="box">45</container>
          <container id="d9f98619fb612d69759f4aa3afe70b51" parent="4f755a5f0d3f9c95131a410d970826ce" type="folder">10-16</container>
        </did>
        <accessrestrict id="5ad67e35d3361f03756bfe78c6e60019">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="737148b055ba101acbd8ee7df7c07e4c" level="file">
        <did>
          <unittitle>TML, 41-44 - Cilostazol for intermittent claudication</unittitle>
          <unitdate type="inclusive">1999 May 7</unitdate>
          <container id="dc488682fa91747fa56689e0aa8bb124" label="mixed materials (A0000000075887)" type="box">45</container>
          <container id="0513407a276ef942855ed0883304397b" parent="dc488682fa91747fa56689e0aa8bb124" type="folder">17-20</container>
        </did>
        <accessrestrict id="91985532c77a98b2be6619b3829a2c87">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="6e0f28a2b5a8cac84be32ec338816dac" level="file">
        <did>
          <unittitle>TML, 41-11 - Celecoxib for arthritis</unittitle>
          <unitdate type="inclusive">1999 January 29</unitdate>
          <container id="a174eefcc1f7b8792c3d324b092faaeb" label="mixed materials (A0000000075888)" type="box">46</container>
          <container id="8cc64dd109f339de45350a3d1b7baac3" parent="a174eefcc1f7b8792c3d324b092faaeb" type="folder">1-4</container>
        </did>
        <accessrestrict id="5220646ffa341e43aaef650d57ef5cbb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="47ee2aa0e1414311aab659a0b7791d48" level="file">
        <did>
          <unittitle>TML, 41-61 - Drug interactions</unittitle>
          <unitdate type="inclusive">1999 July 2</unitdate>
          <container id="00d05e05450e4c6853a67ccfe750edad" label="mixed materials (A0000000075945)" type="box">103</container>
          <container id="d9391cb22101a175828cfe1b267b5292" parent="00d05e05450e4c6853a67ccfe750edad" type="folder">1-4</container>
        </did>
        <accessrestrict id="2310dca3aaada449df04e476753e097f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="ca7a582ccc3762635c6b2b1ab49c2e38" level="file">
        <did>
          <unittitle>TML, 42-51 - Ciclopirox (Penlac) nail lacquer for onychomysis</unittitle>
          <unitdate type="inclusive">2000 June 12</unitdate>
          <container id="7e0256fdaf66b2aad202eafb2889c5f0" label="mixed materials (A0000000075889)" type="box">47</container>
          <container id="aa12def60c5036b76a617df46ebeccfc" parent="7e0256fdaf66b2aad202eafb2889c5f0" type="folder">1-2</container>
        </did>
        <accessrestrict id="9580c594e1986354a883d0b4d0b71bc3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="4b13f0ecb976a0758dff29129231c5ab" level="file">
        <did>
          <unittitle>TML, 42-70 - Cevimeline (Evoxac) for dry mouth</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="6914510b276aedb17528f1e655b1cc73" label="mixed materials (A0000000075889)" type="box">47</container>
          <container id="89d57447b3479e8a38ff70c82247d89f" parent="6914510b276aedb17528f1e655b1cc73" type="folder">3</container>
        </did>
        <accessrestrict id="ab5ca835a64facd8b0328a6bddeaa9db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="65fedbec948e0fc83c65d93e86ad6afd" level="file">
        <did>
          <unittitle>TML, 42-13 - Sirolimus (Rapamune) for transplant rejection</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="8db471cb887d0805a3f2d2c156195dd6" label="mixed materials (A0000000075889)" type="box">47</container>
          <container id="f9d72f53f93267eaab41ececd318fcca" parent="8db471cb887d0805a3f2d2c156195dd6" type="folder">4-6</container>
        </did>
        <accessrestrict id="7082abcbc2a52e308ef67322853d8731">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="43b3f1afcb8ce7fdcc73ea538a9dcaef" level="file">
        <did>
          <unittitle>TML, 42-56 - Drug interactions with St. John's Wort</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="3d8d7d9860bad2523045bc2ddcbb4682" label="mixed materials (A0000000075889)" type="box">47</container>
          <container id="f14e4fc37eb4f10f342b2fe21d2dc633" parent="3d8d7d9860bad2523045bc2ddcbb4682" type="folder">7-9</container>
        </did>
        <accessrestrict id="fc05579a4affa53f15f6bf7701c8c36c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="13d9761c756a2fe7adb0ccd2bd89e5c3" level="file">
        <did>
          <unittitle>TML, 42-27 - Curosurf</unittitle>
          <unitdate type="inclusive">2000 March 20</unitdate>
          <container id="525fba447e69f364cd7bc5232267e7ef" label="mixed materials (A0000000075889)" type="box">47</container>
          <container id="54d4d0fb1e8541d21e1b9f5e0faa5dc7" parent="525fba447e69f364cd7bc5232267e7ef" type="folder">10-12</container>
        </did>
        <accessrestrict id="a42091b45287859d025abbb92f4814dc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c1fd925b81d971c06ec273ef08f3cb74" level="file">
        <did>
          <unittitle>TML, 42-81 - Photodynamic therapy with veterfporfin (Visudyne) for macular degeneration</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="358c1eebaec6cd7c74fa9b36f4b3f42e" label="mixed materials (A0000000075889)" type="box">47</container>
          <container id="7ea73114461f82369ac60a92cc7ebb9f" parent="358c1eebaec6cd7c74fa9b36f4b3f42e" type="folder">13-15</container>
        </did>
        <accessrestrict id="25831287c40dd007e7ad4f179aa90da2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="259c3ccf591bab51ffdaba3a9994e765" level="file">
        <did>
          <unittitle>TML, 42-57 - Drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2000 July 10</unitdate>
          <container id="e0cd882c3665e3aae64c07184f9aa017" label="mixed materials (A0000000075889)" type="box">47</container>
          <container id="bc68bc81ce6e6c2d3522d7e532602e40" parent="e0cd882c3665e3aae64c07184f9aa017" type="folder">16-20</container>
        </did>
        <accessrestrict id="162cb0e7647f4a98954f5445c257c882">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="62b6871b865b6d75c47266161b21cb21" level="file">
        <did>
          <unittitle>TML, 42-113 - Phenylpropanolamine</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="69b7102306a5a78b1178ea2e91c9dece" label="mixed materials (A0000000075890)" type="box">48</container>
          <container id="c33311f3ec4d962b208121e72d62486f" parent="69b7102306a5a78b1178ea2e91c9dece" type="folder">1</container>
        </did>
        <accessrestrict id="3a8380c96fc7714fa7d33e8fc9eda5f1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="7e8cf0d2095db89bdcf602dcfa388b37" level="file">
        <did>
          <unittitle>TML, 42-94 - Zonisamide (Zonegran) for epilepsy</unittitle>
          <unitdate type="inclusive">2000 August 1</unitdate>
          <container id="8b4866cfdf51bcc47e155affb452866e" label="mixed materials (A0000000075890)" type="box">48</container>
          <container id="92042adb26dec18b42bd4632d07eaa54" parent="8b4866cfdf51bcc47e155affb452866e" type="folder">2-4</container>
        </did>
        <accessrestrict id="af9a344f43755a6c943435e3e709888a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="505b60f40ff960c724ff856e304ce951" level="file">
        <did>
          <unittitle>TML, 42-10 - Emergency Contraception - Plan B</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="e4844e43f1f80f0b13234eef6660fdc3" label="mixed materials (A0000000075890)" type="box">48</container>
          <container id="5688d85cf7c1605dd5baad78ec6f32ee" parent="e4844e43f1f80f0b13234eef6660fdc3" type="folder">5</container>
        </did>
        <accessrestrict id="3cd71612bf2f98b55022fa5ad125e9e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="86b41328d3a3f3bd0b39258221d169af" level="file">
        <did>
          <unittitle>TML, 42-42 - Oral contraceptives</unittitle>
          <unitdate type="inclusive">2000 May 15</unitdate>
          <container id="2a6da60b8e3b58af574c3a56bd71f34e" label="mixed materials (A0000000075890)" type="box">48</container>
          <container id="1c07db3e33979ca59316ae19bda929d9" parent="2a6da60b8e3b58af574c3a56bd71f34e" type="folder">6-11</container>
        </did>
        <accessrestrict id="362a441b3fc8d8a82b31585a57ea0665">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="5af9d8711bf691d44ab3b1e5bb256681" level="file">
        <did>
          <unittitle>TML, 42-17 - Phytoestrogens</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="e7218d6392e32061ca550efdd6aff4a6" label="mixed materials (A0000000075890)" type="box">48</container>
          <container id="5c793ec2594707cfeec2c0c5dbee6859" parent="e7218d6392e32061ca550efdd6aff4a6" type="folder">12-14</container>
        </did>
        <accessrestrict id="b6923da0f1e80e36ed724d7930240ab0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="408be2b8c6034a613b1211f2ecf9b661" level="file">
        <did>
          <unittitle>TML, 42-29 - Calcium citrate vs Calcium carbonate calcium supplements</unittitle>
          <unitdate type="inclusive">2000 April 3</unitdate>
          <container id="e881b441077ac8a2f1e994ef73f46fd3" label="mixed materials (A0000000075890)" type="box">48</container>
          <container id="1d273edd587306f5277d8be78fbe3fb5" parent="e881b441077ac8a2f1e994ef73f46fd3" type="folder">15-16</container>
        </did>
        <accessrestrict id="f012aa712ae69a791944518eafe15ae9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="3335c85c5f584c0623918d305860bba9" level="file">
        <did>
          <unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="df429d4ef8985efdb59faa140cf1e6d7" label="mixed materials (A0000000075890)" type="box">48</container>
          <container id="6a5d20ac42abff90a35694221d686b34" parent="df429d4ef8985efdb59faa140cf1e6d7" type="folder">17-18</container>
        </did>
        <accessrestrict id="55427e8bb48ad2b8315333c1ff339476">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c6d41dc2321b4992a2ce79264290f903" level="file">
        <did>
          <unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="f900b8d222f1e35f7ff7a91ca2cde385" label="mixed materials (A0000000075891)" type="box">49</container>
          <container id="888f903f3c1f9d12d16a943b71f89da5" parent="f900b8d222f1e35f7ff7a91ca2cde385" type="folder">1</container>
        </did>
        <accessrestrict id="a4945089c03fcb0a219bdaccf387431a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="1ff03efd208b21a2efb1beeeca59fbe2" level="file">
        <did>
          <unittitle>TML, 42-41 - Dofetilide for atrial fibrillation</unittitle>
          <unitdate type="inclusive">2000 May 15</unitdate>
          <container id="5a3045164bdf4f072ad40857172b7d8f" label="mixed materials (A0000000075891)" type="box">49</container>
          <container id="0425022303e4d2f48cc9c12510549378" parent="5a3045164bdf4f072ad40857172b7d8f" type="folder">2-4</container>
        </did>
        <accessrestrict id="f05aa84b2f28b6ffb33fe96ec43cd992">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="97e9932d34799dd8520be9e13f8a01ce" level="file">
        <did>
          <unittitle>TML, 40-102 - Colesevelam (Welchol) for hypercholesterolemia</unittitle>
          <unitdate type="inclusive">2000 October 30</unitdate>
          <container id="82885288d0c4f2849373b22b9c79a8f7" label="mixed materials (A0000000075891)" type="box">49</container>
          <container id="0dfca49531b61764bb6a676859b23d2f" parent="82885288d0c4f2849373b22b9c79a8f7" type="folder">5</container>
        </did>
        <accessrestrict id="349dee1a0f2981a7afaffa486ad92400">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b1e989f44b7978ab2b1aaaf201f34aeb" level="file">
        <did>
          <unittitle>TML, 42-108 - Docosanal cream (Abreva) for recurrent herpes labialis</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="c10f35a8246588fc48f4cfeb8e527055" label="mixed materials (A0000000075891)" type="box">49</container>
          <container id="a30b074a5db7a621abd576bc58fd54db" parent="c10f35a8246588fc48f4cfeb8e527055" type="folder">6</container>
        </did>
        <accessrestrict id="086b94bfdd5ebcae1564c66a07d71bf4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="e0e61fb5a1e14299b5769bb3645966af" level="file">
        <did>
          <unittitle>TML, 42-106 - Temecteplase (TNKASE) for thrombolysis</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="6f8c785344d70775be2aca8f02773967" label="mixed materials (A0000000075891)" type="box">49</container>
          <container id="5d0b18d4da40f8ff75004b76ba0bccf3" parent="6f8c785344d70775be2aca8f02773967" type="folder">7-10</container>
        </did>
        <accessrestrict id="6881f1eb6305a22e4485bcca7bf92f20">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="3d342507f2c128f34587c4f458c47ae3" level="file">
        <did>
          <unittitle>TML, 42-113 - Valproate and other anticonvulsants for psychiatric disorders</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="9c2d87d79383451ce8058ee948660929" label="mixed materials (A0000000075891)" type="box">49</container>
          <container id="778832bcbc9790815aa82c8897b797d5" parent="9c2d87d79383451ce8058ee948660929" type="folder">11-14</container>
        </did>
        <accessrestrict id="175706ce1b1be1373cdbf4234daea11e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="89f1be4de95ddec6822bda7f0e83b385" level="file">
        <did>
          <unittitle>TML, 42-8 - Prevention of malaria</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="55d22a06933516e3717a423ff8950df5" label="mixed materials (A0000000075891)" type="box">49</container>
          <container id="1ac86a613963b5aea918edf155373880" parent="55d22a06933516e3717a423ff8950df5" type="folder">15</container>
        </did>
        <accessrestrict id="9af6ac60aa40dc6005ce4edb57dc6970">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="da557a8aeefe93b11b7b65ef3275ee26" level="file">
        <did>
          <unittitle>TML, 42-37 - Lyme disease</unittitle>
          <unitdate type="inclusive">2000 May 1</unitdate>
          <container id="06ab6203959d4a699a850a37ae0e2801" label="mixed materials (A0000000075891)" type="box">49</container>
          <container id="11a04f80c2e18b624ea50361dfc3c892" parent="06ab6203959d4a699a850a37ae0e2801" type="folder">16-18</container>
        </did>
        <accessrestrict id="50f594b6d9dec7b83b3b83386b475dcd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b9d25758af7747ace6aaf80757aac85f" level="file">
        <did>
          <unittitle>TML, 42-18 - Aspirin for primary prevention of cardiovascular disease</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="e7546314dba8f609e2f1b250ae7c4421" label="mixed materials (A0000000075891)" type="box">49</container>
          <container id="4f9190912bf8744d914b64e2cb7ae11d" parent="e7546314dba8f609e2f1b250ae7c4421" type="folder">19-20</container>
        </did>
        <accessrestrict id="bd7e6d6a5d2765181060a6c4e5bc8024">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="8827ef8acb277df2d477589d43015ed3" level="file">
        <did>
          <unittitle>TML, 42-73 - Drugs for pain</unittitle>
          <unitdate type="inclusive">2000 August 21</unitdate>
          <container id="3bbf306b49a8c2bcd018a8d1e3c732e0" label="mixed materials (A0000000075892)" type="box">50</container>
          <container id="f6fe7bf588550582fff8470064d764cc" parent="3bbf306b49a8c2bcd018a8d1e3c732e0" type="folder">1-6</container>
        </did>
        <accessrestrict id="45351d67ab671d76012768894632e65f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="7ca68fc3cc569b193dc410a094f9a61f" level="file">
        <did>
          <unittitle>TML, 42-19 - Drugs for Asthma</unittitle>
          <unitdate type="inclusive">2000 March 6</unitdate>
          <container id="8eaeb7715975bdb5ffd10a637074fe11" label="mixed materials (A0000000075892)" type="box">50</container>
          <container id="f28fdd89d193368b51aaf72e10abdc1b" parent="8eaeb7715975bdb5ffd10a637074fe11" type="folder">7-10</container>
        </did>
        <accessrestrict id="843840cc3a1f4f944dcd68fb679ac778">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="11f2fac87764b93bfe43bd87321c6e78" level="file">
        <did>
          <unittitle>TML, 42-49 - Androgel</unittitle>
          <unitdate type="inclusive">2000 June 1</unitdate>
          <container id="d8060fd2b5e9975d8cce7972fd866885" label="mixed materials (A0000000075892)" type="box">50</container>
          <container id="ad06143f83eeafc71fcb7149131ec0ef" parent="d8060fd2b5e9975d8cce7972fd866885" type="folder">11-13</container>
        </did>
        <accessrestrict id="373b10f2aaf453294914d4fe78b9487f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f519c54c8f624fc16003fa1c04fa88f0" level="file">
        <did>
          <unittitle>TML, 42-97 - Drugs for prevention and treatment of postmenopausal osteoporosis</unittitle>
          <unitdate type="inclusive">2000 October 16</unitdate>
          <container id="abef4c817e0dbd53fd3fd883261ee60d" label="mixed materials (A0000000075892)" type="box">50</container>
          <container id="2c79c3be703c8302cd73db10eb6bc8c3" parent="abef4c817e0dbd53fd3fd883261ee60d" type="folder">14-18</container>
        </did>
        <accessrestrict id="f6c66097c55fc7906c4f0813a2f589d8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="da9eaff7a676c3ce93fb52a83c4df992" level="file">
        <did>
          <unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="6e2aed46a18c25ee576ae38f6b736613" label="mixed materials (A0000000075892)" type="box">50</container>
          <container id="da9eecee0680bd35534a9e5d9c66d058" parent="6e2aed46a18c25ee576ae38f6b736613" type="folder">19-20</container>
        </did>
        <accessrestrict id="0b717ab0083f68384631636b834fec64">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f307fe5a6bafa6083a914965f47c224f" level="file">
        <did>
          <unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="2722cc99e8713c0ae32f3ef0c2727ce1" label="mixed materials (A0000000075893)" type="box">51</container>
          <container id="1a154ea052d8fe70316f70909e84a5ab" parent="2722cc99e8713c0ae32f3ef0c2727ce1" type="folder">1</container>
        </did>
        <accessrestrict id="dc26934d88198182e177b592f4868a43">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0d88056c01b79b6a4d890ffb52ef26d7" level="file">
        <did>
          <unittitle>TML, 42-31 - Bexrotene</unittitle>
          <unitdate type="inclusive">2000 April 3</unitdate>
          <container id="cba55b5edd0cfcc3508d2c4e6fe09d2f" label="mixed materials (A0000000075893)" type="box">51</container>
          <container id="58d7ca4241fc356f25dc551d6151c18a" parent="cba55b5edd0cfcc3508d2c4e6fe09d2f" type="folder">2-4</container>
        </did>
        <accessrestrict id="9a8c86a85c6d5ea077e55d9b7597d55f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="78aad480d71976b1ac63856f8414b2de" level="file">
        <did>
          <unittitle>TML, 42-116 - Portable Defibrillators</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="ddca7a4a979c524aab6a729f380df191" label="mixed materials (A0000000075893)" type="box">51</container>
          <container id="3778f8151c08dcb14d9dbeba5cae2369" parent="ddca7a4a979c524aab6a729f380df191" type="folder">5-6</container>
        </did>
        <accessrestrict id="da50ccc68a37dbb555145dfbcf8f1e7c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="8856ac6d297ba039f5f59b8393406463" level="file">
        <did>
          <unittitle>TML, 42-111 - Drugs that may cause cognitive disorders in the elderly</unittitle>
          <unitdate type="inclusive">2000 November 27</unitdate>
          <container id="e044a1426c26807f33e8686c0023713b" label="mixed materials (A0000000075893)" type="box">51</container>
          <container id="54fdf1f622169ee8114cdd243ca32909" parent="e044a1426c26807f33e8686c0023713b" type="folder">7-10</container>
        </did>
        <accessrestrict id="2247b3013b5d4bd66554d265282ec46f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="d791d0f324ea7d0ebc4dcab430fc3a36" level="file">
        <did>
          <unittitle>TML, 42-36 - Substituting for troglitazone (Rezulin)</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="a8d7f4b842951182be01274dbd5c2c2d" label="mixed materials (A0000000075893)" type="box">51</container>
          <container id="e6b95b5b1c230403c8246d3a9aeda1ec" parent="a8d7f4b842951182be01274dbd5c2c2d" type="folder">11</container>
        </did>
        <accessrestrict id="35757c84324de4837de836a4d664e4bd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="390553fd7a4eea2f5cbee5002f2322bc" level="file">
        <did>
          <unittitle>TML, 42-109 - Atovaquone - Proguanil (Malarone) for malaria</unittitle>
          <unitdate type="inclusive">2000 November 27</unitdate>
          <container id="7960efa0d39fc08af0e02a6ae3881b68" label="mixed materials (A0000000075893)" type="box">51</container>
          <container id="736d64bc7c9296488274491ca6debb1e" parent="7960efa0d39fc08af0e02a6ae3881b68" type="folder">12-15</container>
        </did>
        <accessrestrict id="717bd1e1f90c70ff656382467cc26f89">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="102174d0143d0b7b46d5dbdfb6ee2e6c" level="file">
        <did>
          <unittitle>TML, 42-39 - Ketotifen and Pemirlostat - New drugs for allergic conjunctivitis</unittitle>
          <unitdate type="inclusive">2000 May 1</unitdate>
          <container id="6f58c73b7feb4a0ac07cb022fa9bba8a" label="mixed materials (A0000000075893)" type="box">51</container>
          <container id="be2f581503ecbf1a5845cf0da08cc9c1" parent="6f58c73b7feb4a0ac07cb022fa9bba8a" type="folder">16-17</container>
        </did>
        <accessrestrict id="c0dedfa65ff00b42eaec283e7dbe5ee3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="968dfa06d929ab040463fb621fb94e15" level="file">
        <did>
          <unittitle>TML - HAT - Systemic antifungal</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="c6c88fdb48dd452854d2792354cec1e9" label="mixed materials (A0000000075893)" type="box">51</container>
          <container id="fc76c77be1bede05fede9a6388327946" parent="c6c88fdb48dd452854d2792354cec1e9" type="folder">18-19</container>
        </did>
        <accessrestrict id="a7608b2e6d21017e82cac99f4c300d04">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ffb773729eccb5c024461cb32728a1f5" level="file">
        <did>
          <unittitle>TML - HAT - Systemic antifungal</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="d0f1e6c192f503b5b54337733a8d2269" label="mixed materials (A0000000075894)" type="box">52</container>
          <container id="6977513b0127b851053b3905485bdbf0" parent="d0f1e6c192f503b5b54337733a8d2269" type="folder">1-2</container>
        </did>
        <accessrestrict id="fc274c9d6d48168ac3a11ea6067869e0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b5adf750afaa8fb0be9aa2061a43e3b8" level="file">
        <did>
          <unittitle>TML, 42-96 - Eflornithine cream for facial hair reduction</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="1a6895e79b8cbe19f41e20e8dc139df1" label="mixed materials (A0000000075894)" type="box">52</container>
          <container id="a55d229baf2048a0b1cd59f90e96cc37" parent="1a6895e79b8cbe19f41e20e8dc139df1" type="folder">3</container>
        </did>
        <accessrestrict id="97998d665049bfafbdf7f044ef962ac2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c88b481d9cf92fe516e086aa696f2759" level="file">
        <did>
          <unittitle>TML, 42-67 - Gemtuzumab for relapsed acute myeloid leukemia</unittitle>
          <unitdate type="inclusive">2000 July 24</unitdate>
          <container id="7b7ec531cc924d1e806e4328a329ef9a" label="mixed materials (A0000000075894)" type="box">52</container>
          <container id="e6752e52f82c3cfbbcf80cbed82233d9" parent="7b7ec531cc924d1e806e4328a329ef9a" type="folder">4-5</container>
        </did>
        <accessrestrict id="8158423ad1861ed096a1f762bea5ed19">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="d316d036d1c1c8b5e65cc5a3309c50cf" level="file">
        <did>
          <unittitle>TML, 42-52 - Atkin's diet</unittitle>
          <unitdate type="inclusive">2000 June 12</unitdate>
          <container id="ab619f6db3d04dfddda81ab7d9ab26ba" label="mixed materials (A0000000075894)" type="box">52</container>
          <container id="872878aa0a3e441cf75258e03660e8ef" parent="ab619f6db3d04dfddda81ab7d9ab26ba" type="folder">6-8</container>
        </did>
        <accessrestrict id="0024c5f9b90643b42da0ff940f490484">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f039186b802088d6736b63d8692ff877" level="file">
        <did>
          <unittitle>TML, 42-71 - Hypnotic drugs</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="7c1541aad624eb71f2111819923f9210" label="mixed materials (A0000000075894)" type="box">52</container>
          <container id="606e30f1922e61d998bcc1922f6b8b8c" parent="7c1541aad624eb71f2111819923f9210" type="folder">9-12</container>
        </did>
        <accessrestrict id="66081d4df14137512de48118dd485bfc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ddaac639270ba0e3369ea6c5bef18c02" level="file">
        <did>
          <unittitle>TML, 42-79 - Influenza update 2000-2001</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="6328c936bbffce047442b8ed85bc30a8" label="mixed materials (A0000000075894)" type="box">52</container>
          <container id="3f3d58a92c90016d5b5936c993a254e4" parent="6328c936bbffce047442b8ed85bc30a8" type="folder">13-14</container>
        </did>
        <accessrestrict id="2370a9ec5de5c8b19f6823b89c720366">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="3b89f483901c2a204aeb8a707d5f619e" level="file">
        <did>
          <unittitle>TML, 42-35 - Exemestane for advanced breast cancer</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="aa96d6719a34d8ac9ce8b827f2bd17a0" label="mixed materials (A0000000075894)" type="box">52</container>
          <container id="024ff9bf1d65f280037a8db27071da35" parent="aa96d6719a34d8ac9ce8b827f2bd17a0" type="folder">15-17</container>
        </did>
        <accessrestrict id="908ae2bf04aa596e7e5c1b4a0b435a1a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="5b4d37f27c36f2cf78b12c02f16d9dd0" level="file">
        <did>
          <unittitle>TML, 42-12 - Epirubicin for adjuvant therapy in node-positive breast cancer</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="7646c1fcaba6c2376b0895753267b5c9" label="mixed materials (A0000000075894)" type="box">52</container>
          <container id="fc5221138de8a3ad1c29ac099392918c" parent="7646c1fcaba6c2376b0895753267b5c9" type="folder">18-20</container>
        </did>
        <accessrestrict id="231c8f3761cd29bf8b9da59c1db76773">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ea21c93279b7213ac4ebcf26ac90ac01" level="file">
        <did>
          <unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="8901423ced1018883e6f48ea4ce0be5b" label="mixed materials (A0000000075894)" type="box">52</container>
          <container id="72be4832f7d6292c67644348fa0b8d8d" parent="8901423ced1018883e6f48ea4ce0be5b" type="folder">21</container>
        </did>
        <accessrestrict id="ecde6f626cda50967973b161a20fcc74">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0670855c3da978011ef91e63b94b8614" level="file">
        <did>
          <unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="db2d0a9ea79aaec083309dde2e89586b" label="mixed materials (A0000000075895)" type="box">53</container>
          <container id="a0617b6d92d5f7d1ed414d0fb274a676" parent="db2d0a9ea79aaec083309dde2e89586b" type="folder">1-2</container>
        </did>
        <accessrestrict id="b1545fba52ccf81c38c8688169dab34a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b9f3b0c3756751d471fc83952e9cdb9e" level="file">
        <did>
          <unittitle>TML - HAT - Adverse Effects</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aab98c19c2df2d4230c4abe1aac1a44c" label="mixed materials (A0000000075895)" type="box">53</container>
          <container id="10cedd1e71091d5ed8c7f023adab4b7a" parent="aab98c19c2df2d4230c4abe1aac1a44c" type="folder">3-4</container>
        </did>
        <accessrestrict id="f035a5812a9a5ba9f187b537f909316a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0f64e1cb70a81058fe2a570f1ccb8c4a" level="file">
        <did>
          <unittitle>TML - Perinopril - A new ACE inhibitor for hypertension</unittitle>
          <unitdate type="inclusive">2000 May 26</unitdate>
          <container id="a1581923cb71aa5fcd250acdb14ef584" label="mixed materials (A0000000075895)" type="box">53</container>
          <container id="fb4bafd3609a5079ae140d97b0cf9cfc" parent="a1581923cb71aa5fcd250acdb14ef584" type="folder">5-8</container>
        </did>
        <accessrestrict id="8e19dab12d3196a7486bcf0f13a7475f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="9370ffe6e8855002d778fc797c644238" level="file">
        <did>
          <unittitle>TML, 42-65 - Pantoprazole (Protonix)</unittitle>
          <unitdate type="inclusive">2000 July 24</unitdate>
          <container id="eca253290d1c2639c9b80458c140d99f" label="mixed materials (A0000000075895)" type="box">53</container>
          <container id="68512cba5eae8220ebcb30c7cbca657d" parent="eca253290d1c2639c9b80458c140d99f" type="folder">9-12</container>
        </did>
        <accessrestrict id="a1015b3acc8c847466def1105f15644b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="354614b4cdeb7c25dce7323acfe3837f" level="file">
        <did>
          <unittitle>TML, 42-15 - Gatifloxacin and Moxifloxacin - Two new fluoroquinolones</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="cf8bd62b43285f49e6aafe3927fc93b1" label="mixed materials (A0000000075895)" type="box">53</container>
          <container id="a662b65dbef4d3698d07620f92e89630" parent="cf8bd62b43285f49e6aafe3927fc93b1" type="folder">13-18</container>
        </did>
        <accessrestrict id="5bf74d558644f64e23255ce061463c78">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ee26dc57604d2e8beb15f5282094c199" level="file">
        <did>
          <unittitle>TML, HAT - Antimicrobial Dosage</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="789df322b76de0a260e237b147075c9f" label="mixed materials (A0000000075895)" type="box">53</container>
          <container id="044274a3efcf1126cda695a359e64367" parent="789df322b76de0a260e237b147075c9f" type="folder">19</container>
        </did>
        <accessrestrict id="11c3455a2f2e87c2b16773aa9e6aea7c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="a088080df443869d26625b88cfb8357c" level="file">
        <did>
          <unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="c4fcd21006c5c445a3c3c9ef7231e854" label="mixed materials (A0000000075895)" type="box">53</container>
          <container id="6beea29f56a880562bb78f228dce50f7" parent="c4fcd21006c5c445a3c3c9ef7231e854" type="folder">20</container>
        </did>
        <accessrestrict id="204852f90f3648c6b6e5e6274cb652ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="4786db2a3aa9c724f7f60dcf4fcf9164" level="file">
        <did>
          <unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="d26fa4fb1680ae00752283ac6fdcd6cc" label="mixed materials (A0000000075896)" type="box">54</container>
          <container id="be3cc971c8d2f670661332be1d6fe977" parent="d26fa4fb1680ae00752283ac6fdcd6cc" type="folder">1-2</container>
        </did>
        <accessrestrict id="19470d2540faf3143d53c5e0f0f04553">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ff8898d4bdb05f23855cdb33eaefc878" level="file">
        <did>
          <unittitle>TML, 42-53 - Alosetron (Lotronex) for irritable bowel syndrome</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="3381bee3c19f037583c9973ff360f011" label="mixed materials (A0000000075896)" type="box">54</container>
          <container id="c79a13458fb861dd0e681926eaf7918d" parent="3381bee3c19f037583c9973ff360f011" type="folder">3-4</container>
        </did>
        <accessrestrict id="a92fba8d7b374bd5ed2b6377d7f5dfcf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c83dbfe7a53fd4d335c81b6902eff92d" level="file">
        <did>
          <unittitle>TML, 42-25 - Conjugated pneumococcal vaccine for infants and children</unittitle>
          <unitdate type="inclusive">2000 March 20</unitdate>
          <container id="62b9cc7e7d97f238afa95b5f38b22789" label="mixed materials (A0000000075896)" type="box">54</container>
          <container id="c9314999b6cafeccd3027f76c115608b" parent="62b9cc7e7d97f238afa95b5f38b22789" type="folder">5-7</container>
        </did>
        <accessrestrict id="aee461894cb0482b20c2792522b46e12">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0c6944c64d3e895d17a92cb7a840b2cc" level="file">
        <did>
          <unittitle>TML, 42-69 - Meningococcal vaccine - College students</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="b5bea30d5ac72e1db835562e982124d2" label="mixed materials (A0000000075896)" type="box">54</container>
          <container id="fe4b6fb3a2c2bf6db9100d80bd16ad52" parent="b5bea30d5ac72e1db835562e982124d2" type="folder">8-9</container>
        </did>
        <accessrestrict id="df37cebc2f1268161ba89264e0aa24c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f8521e46162fc0e16135537e8fe60e0e" level="file">
        <did>
          <unittitle>TML, 42-80 - A new long-acting methylphenidate</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="0ddf5bea1bffd7425aaac3dd5bd4fe7c" label="mixed materials (A0000000075896)" type="box">54</container>
          <container id="aae1e238ba3a55f8d379a88ca7797bca" parent="0ddf5bea1bffd7425aaac3dd5bd4fe7c" type="folder">10-11</container>
        </did>
        <accessrestrict id="a4aa4fa7be7331aba5f8a5db5ecf9418">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="77d873ab9fa6653d75e07ecd29388474" level="file">
        <did>
          <unittitle>TML, 42-17 - Entacapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="7584f0d1b67bb0475b19f7f091bbc2d5" label="mixed materials (A0000000075896)" type="box">54</container>
          <container id="d74a808b04cea15c923fd7f40a3b6820" parent="7584f0d1b67bb0475b19f7f091bbc2d5" type="folder">12-14</container>
        </did>
        <accessrestrict id="c4cc72e54e77645b47ebceda334dae90">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="2c3c36361f7d26d6245b10967d53cba6" level="file">
        <did>
          <unittitle>TML, 42-45 - Linezolid (Zyvox)</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="3ebfad21f1103aa8aa7e2ff8c32788a7" label="mixed materials (A0000000075896)" type="box">54</container>
          <container id="81dfbe2d9a0abe9397f0f342ed699636" parent="3ebfad21f1103aa8aa7e2ff8c32788a7" type="folder">15-18</container>
        </did>
        <accessrestrict id="134bd94a116d4a00868b6be7c821b669">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f3db800fbd8c30fd18c0ce7421c0675c" level="file">
        <did>
          <unittitle>TML, 42-1 - Drugs for HIV</unittitle>
          <unitdate type="inclusive">2000 January 10</unitdate>
          <container id="8eb487a13635d1adc5a0f20074a2d50b" label="mixed materials (A0000000075896)" type="box">54</container>
          <container id="fbe46b2a02d7a079d070b2c8a744b59b" parent="8eb487a13635d1adc5a0f20074a2d50b" type="folder">19-21</container>
        </did>
        <accessrestrict id="6357a8604ec2f14301f33a46a3a3ee64">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c29c016865d236b6f578b647c46a6676" level="file">
        <did>
          <unittitle>TML, 42-1 - Drugs for HIV</unittitle>
          <unitdate type="inclusive">2000 January 10</unitdate>
          <container id="fabe10fd618a30a06a6bbb64ba879217" label="mixed materials (A0000000075897)" type="box">55</container>
          <container id="27005d1af1170e892a56bbfe097e9d59" parent="fabe10fd618a30a06a6bbb64ba879217" type="folder">1-2</container>
        </did>
        <accessrestrict id="8e3afc9c0897bcf7957059afb787d613">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0ef84e9be7c32e14ccb4cf39bfd45359" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="260b958ce156148960dd7c47b8f7072e" label="mixed materials (A0000000075897)" type="box">55</container>
          <container id="abb18965d323f2159c285547e0bcabb8" parent="260b958ce156148960dd7c47b8f7072e" type="folder">3-6</container>
        </did>
        <accessrestrict id="9bb37702887fbb2a3b6b04978a2797eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="cc6bb16d28e33a08e3172f055c9bc2b1" level="file">
        <did>
          <unittitle>TML, 42-11 - Aggrenox - A combination of antiplatelet drugs for stroke prevention</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="e4ff4c3fd542210d13321ef38fc10faa" label="mixed materials (A0000000075897)" type="box">55</container>
          <container id="5a5e412d06239b7e2322b5eb98669099" parent="e4ff4c3fd542210d13321ef38fc10faa" type="folder">7-8</container>
        </did>
        <accessrestrict id="b6c3f76765c91d59d07d1942830fb182">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="7fc91d920ef13c04bcd488ff67fb27eb" level="file">
        <did>
          <unittitle>TML - 42-54 - Beta Blockers for heart failure</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="9ca7aef1fa2bceb023addea214198ddd" label="mixed materials (A0000000075897)" type="box">55</container>
          <container id="94baf2bb368228a1e83849835d7649e8" parent="9ca7aef1fa2bceb023addea214198ddd" type="folder">9-13</container>
        </did>
        <accessrestrict id="ddd4e956f4e4703f485c6e09538b3de5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="2659d96c29ea4c72cecf071a3ffe82cf" level="file">
        <did>
          <unittitle>TML, 42-83 - Drugs of Choice - Cancer chemotherapy</unittitle>
          <unitdate type="inclusive">2000 September 18</unitdate>
          <container id="8f1fe2d38c98e0b0e2a558455117abba" label="mixed materials (A0000000075897)" type="box">55</container>
          <container id="f82540c870dd0f643377e98935017c78" parent="8f1fe2d38c98e0b0e2a558455117abba" type="folder">14-18</container>
        </did>
        <accessrestrict id="fdc72de4846ddb965722a850fb816e7f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="85452dc178e1dadec0332fe42563215d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Tuberculosis</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="9bde851f7b5857ed8efd475ff28da9c7" label="mixed materials (A0000000075898)" type="box">56</container>
          <container id="9ed62ec10564a98c77f0a705f70e4832" parent="9bde851f7b5857ed8efd475ff28da9c7" type="folder">1-4</container>
        </did>
        <accessrestrict id="f9bcd6fc9775a8cd44d753ed67359607">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="9c48a5236a35ed8f3ce7136401b6da9e" level="file">
        <did>
          <unittitle>TML, 42-101 - Mifepristone (RU 486)</unittitle>
          <unitdate type="inclusive">2000 October 30</unitdate>
          <container id="37bb2ac6d583e981f7eb6f7287c1bde7" label="mixed materials (A0000000075898)" type="box">56</container>
          <container id="688f851815483d9a7e19b351dfb50a96" parent="37bb2ac6d583e981f7eb6f7287c1bde7" type="folder">5-8</container>
        </did>
        <accessrestrict id="512097af868e6310c2ef7aa3a3ab7af5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="41cb55e32ff2281af228fcf98e48db43" level="file">
        <did>
          <unittitle>TML - Osteoporosis - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="01082904cc59fbadf7c0affd337bce99" label="mixed materials (A0000000075898)" type="box">56</container>
          <container id="450f37838e0458b37ef7d4ffffb6decf" parent="01082904cc59fbadf7c0affd337bce99" type="folder">9-12</container>
        </did>
        <accessrestrict id="a1eb04973eb4447d22f3324b1056f9bf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="669d4a856fe8af2c5b04130d94fa8d3e" level="file">
        <did>
          <unittitle>TML - Asthma - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="be30c5f61822d1829b8e6f851580632d" label="mixed materials (A0000000075898)" type="box">56</container>
          <container id="63dfee7fdc0d154576c06c1c95c5b42f" parent="be30c5f61822d1829b8e6f851580632d" type="folder">13-16</container>
        </did>
        <accessrestrict id="38e2af006895a52bd2de3eb894293ec3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0ec6c4e753e63df5926b6bb8dc0ec41d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="8fe308561adf85c5d83a867ff07a240a" label="mixed materials (A0000000075898)" type="box">56</container>
          <container id="f94f16eda184716db6038d88679de907" parent="8fe308561adf85c5d83a867ff07a240a" type="folder">17-20</container>
        </did>
        <accessrestrict id="d8d94d63528159d44953c7215892b5f2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="1716a9979d5479baf368216eb3017f50" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="f1e19918b9f4f357e4830bd90eb13f65" label="mixed materials (A0000000075899)" type="box">57</container>
          <container id="da5e330c9cb75b34a1ba3a626f5a3567" parent="f1e19918b9f4f357e4830bd90eb13f65" type="folder">1-4</container>
        </did>
        <accessrestrict id="7be18115960dc69ccd463738ce3438d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="296856f8c0a6139989dec83e2967a3f6" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="b0cf9a5e51a107a691380acbebaa1c85" label="mixed materials (A0000000075899)" type="box">57</container>
          <container id="655656f6db832aa18d51fe0a462d7bf6" parent="b0cf9a5e51a107a691380acbebaa1c85" type="folder">5</container>
        </did>
        <accessrestrict id="44a20fdcc0c5ee5bc8f27d1eb7439095">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="41a4f1b5ec21dcacfcb1590a26be0255" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="fdc0cc80d04f154f6e4327e595331810" label="mixed materials (A0000000075900)" type="box">58</container>
          <container id="48b16f095f49ef81aa6b8d1157dc83b3" parent="fdc0cc80d04f154f6e4327e595331810" type="folder">1-3</container>
        </did>
        <accessrestrict id="aae3719b7a851cb67c17470197b044d1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="8d745390980b9c7fe7639600ac855496" level="file">
        <did>
          <unittitle>TML, 43-92 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">2001 October 29</unitdate>
          <container id="dfa0d76899cca6b80f1cb3a808774979" label="mixed materials (A0000000075901)" type="box">59</container>
          <container id="2c793a6db549e2b1110276fa9097a6d7" parent="dfa0d76899cca6b80f1cb3a808774979" type="folder">1-3</container>
        </did>
        <accessrestrict id="08c08b71a5f549bb03c9e539391bf0c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c8e27cfe3b70673df671446dc0f171dd" level="file">
        <did>
          <unittitle>TML, 43-43 - Choice of Lipid-lowering drugs</unittitle>
          <unitdate type="inclusive">2001 May 28</unitdate>
          <container id="0d8f0ac708374ddaf4ba4e000212c826" label="mixed materials (A0000000075901)" type="box">59</container>
          <container id="80d1707dc5170a38d56e1f34d872f4aa" parent="0d8f0ac708374ddaf4ba4e000212c826" type="folder">4-10</container>
        </did>
        <accessrestrict id="12c485e70ce77057b564f5f005de3180">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="b12b140d39cce8b86f62018ce31197dd" level="file">
        <did>
          <unittitle>TML, 43-1 - Lopinavir - Ritonavir - A protease-inhibitor combination</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="cda0ca693ba15bd8d5dffe39fa4a588c" label="mixed materials (A0000000075901)" type="box">59</container>
          <container id="7d3a05f6bc40799929e84548e135473b" parent="cda0ca693ba15bd8d5dffe39fa4a588c" type="folder">11-13</container>
        </did>
        <accessrestrict id="cb4f314cadf4551b7cb834b70eadf1cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="f3e4fd1faa4faa99ba52ed68b8dde6c9" level="file">
        <did>
          <unittitle>TML, 43-87 - Drugs and vaccines against biological warfare</unittitle>
          <unitdate type="inclusive">2001 October 19</unitdate>
          <container id="10798a74a0edbbc0e9e4a6c973cf0c74" label="mixed materials (A0000000075901)" type="box">59</container>
          <container id="007fa155c7ca8a9a7f966bf99054ce0c" parent="10798a74a0edbbc0e9e4a6c973cf0c74" type="folder">14-17</container>
        </did>
        <accessrestrict id="19d192e97e549e2b446276124a3eb6b6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="f8fecc1cfd922fa2df867ba43e2d95e6" level="file">
        <did>
          <unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="104748ed0e0bf9ae0139eb931ea70b67" label="mixed materials (A0000000075901)" type="box">59</container>
          <container id="9a2404b2fa7aef0e3d4834be04be2c35" parent="104748ed0e0bf9ae0139eb931ea70b67" type="folder">18</container>
        </did>
        <accessrestrict id="bf0a0b9053f30a04f40935cc85ba1264">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3283e79cbed2dd24ba8423865f0e23c0" level="file">
        <did>
          <unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="3053bb7e57c585a339dc4b1ef6f7dbd3" label="mixed materials (A0000000075902)" type="box">60</container>
          <container id="ce0873dc79120d63d54cc541976f2bca" parent="3053bb7e57c585a339dc4b1ef6f7dbd3" type="folder">1</container>
        </did>
        <accessrestrict id="f2c531fe46fbd0a55fbf3a371d0cfb12">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="b08aa5d6ed86fd5fceee0126fd84fd06" level="file">
        <did>
          <unittitle>TML, 43-9 - Beta-Blockers</unittitle>
          <unitdate type="inclusive">2001 February 5</unitdate>
          <container id="8d952770b3eaaf26f2cc3af510a18f13" label="mixed materials (A0000000075902)" type="box">60</container>
          <container id="3901e839d1fea23ef4090f8089051d57" parent="8d952770b3eaaf26f2cc3af510a18f13" type="folder">2-6</container>
        </did>
        <accessrestrict id="6048933eb3a55f5f2d6a90721d4dd65f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="efb930d3872ae9d77c1298a07d7d5921" level="file">
        <did>
          <unittitle>TML, 43-62 - Balsalazide (Colazal) for ulcerative colitis</unittitle>
          <unitdate type="inclusive">2001 July</unitdate>
          <container id="8ba296c49ff8b4e0869bf124a38e4e7e" label="mixed materials (A0000000075902)" type="box">60</container>
          <container id="3ead7abeb353903ecbd03198321c3341" parent="8ba296c49ff8b4e0869bf124a38e4e7e" type="folder">7-9</container>
        </did>
        <accessrestrict id="a454b4aa29b54507db7a4b31bd4c8d5f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="b522bd1a5159bd2d2194d2263cc22904" level="file">
        <did>
          <unittitle>TML, 43-11 - Argatroban for treatment of heparin-induced thrombocytopenia</unittitle>
          <unitdate type="inclusive">2001 February 5</unitdate>
          <container id="91e2f609bc743ae043e4a8feb6977aba" label="mixed materials (A0000000075902)" type="box">60</container>
          <container id="3ca82dd328ab434326a1a000e7c273eb" parent="91e2f609bc743ae043e4a8feb6977aba" type="folder">10-12</container>
        </did>
        <accessrestrict id="a20e6edf2b912e65b1924e6cbfaf7256">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="46514d81205269c17a4b19d49a573235" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="556ee0cb306c1880d1649626bb0c705e" label="mixed materials (A0000000075902)" type="box">60</container>
          <container id="d4d08db75881320122aa7072b698b3e1" parent="556ee0cb306c1880d1649626bb0c705e" type="folder">13-15</container>
        </did>
        <accessrestrict id="0ac715d063832982eec2283c964a4110">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="6dc4850ed3f15e6085336df184251532" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Osteoporosis</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="c8d976273488ea30f94d83ce71036a40" label="mixed materials (A0000000075902)" type="box">60</container>
          <container id="4f0e00efc8511c46d189ce5bd9d0a13f" parent="c8d976273488ea30f94d83ce71036a40" type="folder">16</container>
        </did>
        <accessrestrict id="a5d61d385919f6ecefd5058c2bf3e8d5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="02fc378d7f3b4b93e45c3eef89379858" level="file">
        <did>
          <unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle>
          <unitdate type="inclusive">2001 August 20</unitdate>
          <container id="24872675af6fc03999911329432de6d8" label="mixed materials (A0000000075902)" type="box">60</container>
          <container id="7addfcfc1cbd9ccb2424de6e02617419" parent="24872675af6fc03999911329432de6d8" type="folder">17-18</container>
        </did>
        <accessrestrict id="a1e5c73ef6115e61a317948cb85a9927">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2c6bff42d1f14c6a829324e9782c498a" level="file">
        <did>
          <unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle>
          <unitdate type="inclusive">2001 August 20</unitdate>
          <container id="0669ef4fe67a345723d6c139115b68af" label="mixed materials (A0000000075903)" type="box">61</container>
          <container id="7f26837292b6a1a6c923421f3935f2a3" parent="0669ef4fe67a345723d6c139115b68af" type="folder">1-3</container>
        </did>
        <accessrestrict id="5b52a18cd7491854824957b6528aa161">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="6bf6928a0695a21bf35c621f43a5b338" level="file">
        <did>
          <unittitle>TML - Antimicrobial prophylaxis and Endocarditis - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="5765e48fbf505d69e284d7fcf25b410d" label="mixed materials (A0000000075903)" type="box">61</container>
          <container id="6ba5ede6b730713b21826a6a31635504" parent="5765e48fbf505d69e284d7fcf25b410d" type="folder">4-6</container>
        </did>
        <accessrestrict id="7c855f662c00758a77e6169900e656ac">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="e83ae1dbb9d2dcd79b2efc11e8415787" level="file">
        <did>
          <unittitle>TML - AIDS - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="a2664c8222ce5495a21290cde730e787" label="mixed materials (A0000000075903)" type="box">61</container>
          <container id="c46ef7af5e6fe4667a25fe3bff8f5f30" parent="a2664c8222ce5495a21290cde730e787" type="folder">7-11</container>
        </did>
        <accessrestrict id="6f3b8da68a968edcf7612c6c7ab0d96d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c6e64d3eb72280cbc65604fd0d1ef63b" level="file">
        <did>
          <unittitle>TML, 43-91 - Post Exposure Anthrax prophylaxis</unittitle>
          <unitdate type="inclusive">2001 October 29</unitdate>
          <container id="98491500f1a883b3f82c390e7018665e" label="mixed materials (A0000000075903)" type="box">61</container>
          <container id="7f4e75169551c163e50c0098e7080223" parent="98491500f1a883b3f82c390e7018665e" type="folder">12-13</container>
        </did>
        <accessrestrict id="c107fed35cdd31085f732308990ad842">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="41aa0763a7e36f6ce380706ce01181e3" level="file">
        <did>
          <unittitle>TML, 43-54 - PEG-Intron for chronic Hepatitis C</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="7bdca05e3032b4d4da60a1be0c690606" label="mixed materials (A0000000075903)" type="box">61</container>
          <container id="0312140ced778be7ea1d9066133a6ec2" parent="7bdca05e3032b4d4da60a1be0c690606" type="folder">14-16</container>
        </did>
        <accessrestrict id="10b78f31b326647359759629918503ac">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="21f79f7c6b4acd8a596b33dacb48841b" level="file">
        <did>
          <unittitle>TML, 43-110 - Insulin Glargine - a new long-acting insulin</unittitle>
          <unitdate type="inclusive">2001 August 6</unitdate>
          <container id="64bfde336ee88022828bc2f3d6a60d9c" label="mixed materials (A0000000075903)" type="box">61</container>
          <container id="7ecd01e885bedf96d93902e9b2333bdc" parent="64bfde336ee88022828bc2f3d6a60d9c" type="folder">17-19</container>
        </did>
        <accessrestrict id="ce544613fec94a632b764ccaa6155e27">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2eed515acb400c24339036029a7a8f49" level="file">
        <did>
          <unittitle>TML, 43-29 - Nateglinide for Type 2 diabetes</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="2a96fd86a6c06039b72128a756b423bc" label="mixed materials (A0000000075904)" type="box">62</container>
          <container id="6d6fc19ae244d2919ac58a184e57cd1f" parent="2a96fd86a6c06039b72128a756b423bc" type="folder">1-3</container>
        </did>
        <accessrestrict id="7bf007b3c2f616cf82e76b675923a0ae">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ccba2cedcccf56cdefa0e205fc19e877" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cancer</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="b2857fddce735bed3c3d62a1ad4c5b5a" label="mixed materials (A0000000075904)" type="box">62</container>
          <container id="99aba64095e5af95057575c70ce3eff0" parent="b2857fddce735bed3c3d62a1ad4c5b5a" type="folder">4-5</container>
        </did>
        <accessrestrict id="d687a473729a78247a1c380123065159">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8b4de852b3dcabc7ad6e003cb57745bf" level="file">
        <did>
          <unittitle>TML, 43-100 - Nesiritide for decompensated congestive heart failure</unittitle>
          <unitdate type="inclusive">2001 November 12</unitdate>
          <container id="5c60bf519aaf9d01173f5bb5baedd9e9" label="mixed materials (A0000000075904)" type="box">62</container>
          <container id="1a0b8e36094a364b2667a55b98832ae1" parent="5c60bf519aaf9d01173f5bb5baedd9e9" type="folder">6-9</container>
        </did>
        <accessrestrict id="60722a1253dc5c989a1fb84363bf8347">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ae81e26ee03016b7e8a19efe2323b2b6" level="file">
        <did>
          <unittitle>TML, 43-35 - Non-Sedating Antihistamines</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="1132d3a7ec881be0d7ea0869d81aaad7" label="mixed materials (A0000000075904)" type="box">62</container>
          <container id="770b0b08a1bbe71ea38186f9ae80c9f7" parent="1132d3a7ec881be0d7ea0869d81aaad7" type="folder">10-13</container>
        </did>
        <accessrestrict id="e3c9df3f442f047a5b6b393b36042f5b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ebbf6e65860c02f436f6ca0982c14e3e" level="file">
        <did>
          <unittitle>TML, 43-17 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">2001 March 5</unitdate>
          <container id="fba76af282594885cd05ef9fc793574c" label="mixed materials (A0000000075904)" type="box">62</container>
          <container id="71415227ee6ddcd338336e3942b320e8" parent="fba76af282594885cd05ef9fc793574c" type="folder">14-18</container>
        </did>
        <accessrestrict id="3e2fa8d34c5d3f85b91b8b755235d673">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="dc20397e0f8fc97006ecdf0d5f679b73" level="file">
        <did>
          <unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="93c2c21a2357b965d433b43a43ae2b80" label="mixed materials (A0000000075904)" type="box">62</container>
          <container id="7dbacd1ba7ffcf06583ce85e69f2f72c" parent="93c2c21a2357b965d433b43a43ae2b80" type="folder">19</container>
        </did>
        <accessrestrict id="bedf8436e8ecc88cef43b4466703321f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2a3e11c7291578855058677f583ba4cc" level="file">
        <did>
          <unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="fdfd6083a231f0c9ac3d38e5c2e18833" label="mixed materials (A0000000075905)" type="box">63</container>
          <container id="ae54bfe471bfab441b702c835a7c90a1" parent="fdfd6083a231f0c9ac3d38e5c2e18833" type="folder">1-2</container>
        </did>
        <accessrestrict id="1faf2fbe4c747499b17f777c7da8d367">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="7aeba34ec44547fe9581d43a0fc4043e" level="file">
        <did>
          <unittitle>TML, 43-6 - Nebulized Budesonide for Asthma in children</unittitle>
          <unitdate type="inclusive">2001 January 27</unitdate>
          <container id="3a787bf2ec2123a5a4b8be12b38da682" label="mixed materials (A0000000075905)" type="box">63</container>
          <container id="be392dc8acadaa2c8f0fa26c66241b47" parent="3a787bf2ec2123a5a4b8be12b38da682" type="folder">3-7</container>
        </did>
        <accessrestrict id="d1f83bcd9d1dba630ab83fe624589365">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9011b2319d9d385461bdca83ff03a269" level="file">
        <did>
          <unittitle>TML, 42-2 - Cool Click - a needle-free device for growth hormone delivery</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="1b664b7899393493c729a0d343b0067e" label="mixed materials (A0000000075905)" type="box">63</container>
          <container id="b58a49c0fc4af917efdb48ba94e136fb" parent="1b664b7899393493c729a0d343b0067e" type="folder">8-10</container>
        </did>
        <accessrestrict id="d1142cfc576dc71445c5513786f60e47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="43f128e719abd7716a8b552dab41b4ca" level="file">
        <did>
          <unittitle>TML, 43-84 - Cord Blood Banks</unittitle>
          <unitdate type="inclusive">2001 October 1</unitdate>
          <container id="314350ab3f016e2f975375ced459d436" label="mixed materials (A0000000075905)" type="box">63</container>
          <container id="f6a0c258331e14e773c705ecc88bbb65" parent="314350ab3f016e2f975375ced459d436" type="folder">11-14</container>
        </did>
        <accessrestrict id="d355e32a24f6cffb35162f5a565f8aad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2ca4ec46f32a50a21f55760304d5080b" level="file">
        <did>
          <unittitle>TML, 43-59 - Initital treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="852adbd2f4f44d24bc806a1c71835e40" label="mixed materials (A0000000075905)" type="box">63</container>
          <container id="d3e59629cf371a1b0b8a6af669ab3680" parent="852adbd2f4f44d24bc806a1c71835e40" type="folder">15-16</container>
        </did>
        <accessrestrict id="12449f363aa33b967622999d1c656f25">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="f4881e412a79293a02fce06ab7ada62d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="218bae1c24b58cbfc95f53a3983322ed" label="mixed materials (A0000000075905)" type="box">63</container>
          <container id="d98d3674b76e8e02ec846821ea0c9be8" parent="218bae1c24b58cbfc95f53a3983322ed" type="folder">17-20</container>
        </did>
        <accessrestrict id="762520a711ae5cf2f881c37d75c585e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="076a7f8b55c4644de3dc62c6db843a72" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="e7ecf7f3a3b8a86ddd9f54f2ff9400c1" label="mixed materials (A0000000075906)" type="box">64</container>
          <container id="5583f30b5c892961eefdabea569fc3a1" parent="e7ecf7f3a3b8a86ddd9f54f2ff9400c1" type="folder">1-2</container>
        </did>
        <accessrestrict id="0e6e931602cabb1fe060a758f1e09d3e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="98d5e522f0e12ef676f68b6296b375c4" level="file">
        <did>
          <unittitle>TML, 43-61 - Lung Cancer screening</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="e248deb1c50528564617cbb4447854d3" label="mixed materials (A0000000075906)" type="box">64</container>
          <container id="8401b29b314e895e2279b18fde1d2481" parent="e248deb1c50528564617cbb4447854d3" type="folder">3-5</container>
        </did>
        <accessrestrict id="1fa9376a18b8cabf3a1ced8db4bc6995">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="bbfbf04fd92af083cfe5f2803138df54" level="file">
        <did>
          <unittitle>TML, 43-7 - Mirena</unittitle>
          <unitdate type="inclusive">2001 January 22</unitdate>
          <container id="fe7f75e3712ad772b683578dd589ee4c" label="mixed materials (A0000000075906)" type="box">64</container>
          <container id="c8d04fa2cc0fade72e6d7694668fe101" parent="fe7f75e3712ad772b683578dd589ee4c" type="folder">6-8</container>
        </did>
        <accessrestrict id="6eb2c131de0d820a3d57bfd6b90300e6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3b86dfd5896dc8ed385111ad16cbd218" level="file">
        <did>
          <unittitle>TML, 43-109 - Darbopoetin (Aranesp) - a long acting erythropoietin</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="6ca999c227dcef6628e7d621137f2a94" label="mixed materials (A0000000075906)" type="box">64</container>
          <container id="a92df1b5e84778e8a678954777c2d254" parent="6ca999c227dcef6628e7d621137f2a94" type="folder">9-10</container>
        </did>
        <accessrestrict id="f505d3982f99b3e642ccbf40fbd75883">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="0f9927bdf850374dd901cc030c68dc7c" level="file">
        <did>
          <unittitle>TML - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">2001 April 6</unitdate>
          <container id="8023d7b12405e3a6c79b2912f03fff4d" label="mixed materials (A0000000075906)" type="box">64</container>
          <container id="3636be4c738ab3d1b55d4fd71b57e316" parent="8023d7b12405e3a6c79b2912f03fff4d" type="folder">11-14</container>
        </did>
        <accessrestrict id="6be4b2a90096d23f4c7270994aa74f17">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="97fc093a6a8e4909bb2c604168b0b754" level="file">
        <did>
          <unittitle>TML, 43-58 - Caspofungin (Candidas) for aspergillosis</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="34617eb9c2bdb5cbfae819d584751347" label="mixed materials (A0000000075906)" type="box">64</container>
          <container id="af6c9829dfea9ed1d0b30ddb62c8d25e" parent="34617eb9c2bdb5cbfae819d584751347" type="folder">15-18</container>
        </did>
        <accessrestrict id="f836855e02f4d6fe9f63b628886a4c85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="6da20ff4a72dc0604ae511c5634291e7" level="file">
        <did>
          <unittitle>TML, 43-55 - A new snake antivenin</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="4056284115071ceae386ef9b6266e8fb" label="mixed materials (A0000000075906)" type="box">64</container>
          <container id="cccaae5b2b7edeb865969af3de0c7f26" parent="4056284115071ceae386ef9b6266e8fb" type="folder">19-20</container>
        </did>
        <accessrestrict id="f08173f37c2607c4d273372be7fedab1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ede8d569017eb650ffb86947aa817ebe" level="file">
        <did>
          <unittitle>TML, 43-110 - Zometa (Zoledronic Acid) for injection</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="82917324763f39d7b5af8d8d4e4cdec2" label="mixed materials (A0000000075907)" type="box">65</container>
          <container id="15e905c1f1367f76b97fdcaf160aa546" parent="82917324763f39d7b5af8d8d4e4cdec2" type="folder">1-3</container>
        </did>
        <accessrestrict id="3a54c329c0d6d0bc229bdd0616332d9d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a2f1959db87c3ed2aeb2a70eafd0d767" level="file">
        <did>
          <unittitle>TML, 43-51 - Ziprasidone (Geodon) for schizophrenia</unittitle>
          <unitdate type="inclusive">2001 June 11</unitdate>
          <container id="9fd1fe6d276178f8878b010357f14618" label="mixed materials (A0000000075907)" type="box">65</container>
          <container id="7dae0687783163d2457106fe9f62c2cb" parent="9fd1fe6d276178f8878b010357f14618" type="folder">4-7</container>
        </did>
        <accessrestrict id="810ad5d825ba01f69c55af09b52e33af">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8068f52546b65b321ac2f5fa6a731f4c" level="file">
        <did>
          <unittitle>TML, - Drugs for depression and anxiety</unittitle>
          <unitdate type="inclusive">2001 February 14</unitdate>
          <container id="196b233d6e0bd269c22f0c8d5c703e17" label="mixed materials (A0000000075907)" type="box">65</container>
          <container id="4c9e987684362f0dbe17590bc48e42bd" parent="196b233d6e0bd269c22f0c8d5c703e17" type="folder">8-10</container>
        </did>
        <accessrestrict id="67940cb71724cb07bb1c047808a223cf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="55a8ca16b598343eb87537a2d296ecd1" level="file">
        <did>
          <unittitle>TML, 43-15 - PC-Spes</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="ae06244d7f8eba25073caa7d66c68b93" label="mixed materials (A0000000075907)" type="box">65</container>
          <container id="6de09e563a63432f3a815e7f05f90968" parent="ae06244d7f8eba25073caa7d66c68b93" type="folder">11-12</container>
        </did>
        <accessrestrict id="75c2794ebd1f11660bcef03019daccd2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ebe0e5315e3cdfa6495aed9cdada44d6" level="file">
        <did>
          <unittitle>TML, 43-83 - Metadate (Extended-Release Methylphenidate)</unittitle>
          <unitdate type="inclusive">2001 October 1</unitdate>
          <container id="ce7e797dc095a77a3af01b8184ab6a78" label="mixed materials (A0000000075907)" type="box">65</container>
          <container id="387fdef800cfff96ec7452ece5fb0e2b" parent="ce7e797dc095a77a3af01b8184ab6a78" type="folder">13-16</container>
        </did>
        <accessrestrict id="07f8b933648e23ed47138c1bef096df8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="833ebff3fb7c7c45c0c064414304d04f" level="file">
        <did>
          <unittitle>TML, 43-49 - Gleevec (STI-571) for chronic myeloid leukemia</unittitle>
          <unitdate type="inclusive">2001 June 11</unitdate>
          <container id="a6e951ccdea8a2b7268a750f2ff083d9" label="mixed materials (A0000000075907)" type="box">65</container>
          <container id="26f86fbf85c5be270b4c8067ccd5c79e" parent="a6e951ccdea8a2b7268a750f2ff083d9" type="folder">17-18</container>
        </did>
        <accessrestrict id="8a48c9bb323707808cd2699c098b90df">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="e579c81ba72fe1f002ea554c42ec0eb7" level="file">
        <did>
          <unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="5012aad3fc4128e0ddac9eeae8d9808c" label="mixed materials (A0000000075907)" type="box">65</container>
          <container id="6707c5b6f76f1c09057f4cb3b5b754ad" parent="5012aad3fc4128e0ddac9eeae8d9808c" type="folder">19</container>
        </did>
        <accessrestrict id="5b72b0c715fd854e87ba957e71353a88">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2c8e55774a1bb77e5eb47e4cd5592dca" level="file">
        <did>
          <unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="d65a2cbe0f653b74c4a0d38300d40451" label="mixed materials (A0000000075908)" type="box">66</container>
          <container id="3bca9020a49d217a4e272cd633f5b09c" parent="d65a2cbe0f653b74c4a0d38300d40451" type="folder">1</container>
        </did>
        <accessrestrict id="45e2eef135b65b2a4bc8bfac6895eae6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a3e98844edbadfd1126f96dcee9fa072" level="file">
        <did>
          <unittitle>TML, 43-89 - Insulin Aspart - a new rapid-acting insulin</unittitle>
          <unitdate type="inclusive">2001 October 15</unitdate>
          <container id="c76814eadc96187c41794b67239dcb04" label="mixed materials (A0000000075908)" type="box">66</container>
          <container id="c1105c0a5cb8d42957d024cd11bb4bed" parent="c76814eadc96187c41794b67239dcb04" type="folder">2-3</container>
        </did>
        <accessrestrict id="95db9e419544c222951aae12dd139e45">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2330e815d4bdfd9c12c459306864dcca" level="file">
        <did>
          <unittitle>TML, 43-103 - Drugs for HIV infection</unittitle>
          <unitdate type="inclusive">2001 November 26</unitdate>
          <container id="2ab9554d7f943b372b18072576fecc5f" label="mixed materials (A0000000075908)" type="box">66</container>
          <container id="e0198adf93bdec9c11ea6b8aa0b96f4f" parent="2ab9554d7f943b372b18072576fecc5f" type="folder">4-7</container>
        </did>
        <accessrestrict id="ba5d1519c239af0bb83357cd9431cc00">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c9e718e37292bcb43f7c0f24dd8175bb" level="file">
        <did>
          <unittitle>TML, 43-26 - Once-a-Week Alendronate (Fosamaz)</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="c58c67e2ea58432816c325ade6588e73" label="mixed materials (A0000000075908)" type="box">66</container>
          <container id="c119268eaf6bbe817d920474bbefeb7e" parent="c58c67e2ea58432816c325ade6588e73" type="folder">8</container>
        </did>
        <accessrestrict id="3aaad115d37c1f7c6a8b419cea0284e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ce9f44342b0f523de0bfcb639e0134e8" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Migraine - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="acbc4c2e1a6065a4d0629f6d1f802494" label="mixed materials (A0000000075908)" type="box">66</container>
          <container id="2de7d9544b11ca91ef83c19301730d8f" parent="acbc4c2e1a6065a4d0629f6d1f802494" type="folder">9-10</container>
        </did>
        <accessrestrict id="9d4ad8765f4f79883181f256eb7f9879">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8c50daa78ebe0875cf14c75e503ea1c1" level="file">
        <did>
          <unittitle>TML, Drugs of Choice - Pain</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="696881681c78c6d4da95d97af9c21a9f" label="mixed materials (A0000000075908)" type="box">66</container>
          <container id="b10d1833a1faebe743c196e88d4f59e6" parent="696881681c78c6d4da95d97af9c21a9f" type="folder">11</container>
        </did>
        <accessrestrict id="3b2728fff814b6aa47a93b6386e34381">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="468e734f765a9be3853dd86c21c17c5d" level="file">
        <did>
          <unittitle>TML, 43-25 - Direct-to-Consumer advertisements for Glucophage XR</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="edfb2c7a8b09551a69ff0f361df14c2e" label="mixed materials (A0000000075908)" type="box">66</container>
          <container id="9354f1b1636d43fc688f1914a9b8e4fe" parent="edfb2c7a8b09551a69ff0f361df14c2e" type="folder">12</container>
        </did>
        <accessrestrict id="82bce5eadd0f640bbbd014ce96f624b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d63b61dd440fbe48748ed3adaaa153a3" level="file">
        <did>
          <unittitle>TML, 43-13 - Palivizumab update</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="c52bc8398fd1ba142812126e35901997" label="mixed materials (A0000000075908)" type="box">66</container>
          <container id="0bb60fc15c213f8c15a9b812398f5ac7" parent="c52bc8398fd1ba142812126e35901997" type="folder">13-14</container>
        </did>
        <accessrestrict id="a7dd4884d34880dfc26867a2d2428bf1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="07c5a88addbecee925056539789a95ce" level="file">
        <did>
          <unittitle>TML, 43-14 - Tinzaparin for treatment of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="1780fd8c01127ac6a6f7a57843326785" label="mixed materials (A0000000075908)" type="box">66</container>
          <container id="35fa81956a8a27fb02cda598942ec641" parent="1780fd8c01127ac6a6f7a57843326785" type="folder">15-17</container>
        </did>
        <accessrestrict id="e9948bb5cd6966ff6405e6dc4196d47e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3c99102c3cbe6573776800745f8ae469" level="file">
        <did>
          <unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="1c06c0f51397bf49de836b060f113f96" label="mixed materials (A0000000075908)" type="box">66</container>
          <container id="117f5e00e0077867aa999e92344a9397" parent="1c06c0f51397bf49de836b060f113f96" type="folder">18-20</container>
        </did>
        <accessrestrict id="0e83e8dd8e86709df7f972ac81515598">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c6baca4f86fe997597684780a50afb04" level="file">
        <did>
          <unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="7c5b895bf0a281bf4603cd2dbddd24f4" label="mixed materials (A0000000075909)" type="box">67</container>
          <container id="28c3a24d3a828967094dc8490849248e" parent="7c5b895bf0a281bf4603cd2dbddd24f4" type="folder">1</container>
        </did>
        <accessrestrict id="a04d9293e94b60a9e39c9b4189abc925">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="21563c371ed6d15964e3cc6b122e8325" level="file">
        <did>
          <unittitle>TML, 43-31 - Advair "Diskus" - A combination of fluticasone and salmeterol for asthma</unittitle>
          <unitdate type="inclusive">2001 April 6</unitdate>
          <container id="d329d2ce65595e9105379797f0ee5090" label="mixed materials (A0000000075909)" type="box">67</container>
          <container id="e0c9d11df6c0ff5ccb92f9ebf75fe7e9" parent="d329d2ce65595e9105379797f0ee5090" type="folder">2-5</container>
        </did>
        <accessrestrict id="591f5ce0464ac805e58c930e1f206114">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a56fc8ba008f5ec96cb059f94525d216" level="file">
        <did>
          <unittitle>TML, 43-5 - Fluoxetine (Sarafem) for premenstrual dysphoric disorder</unittitle>
          <unitdate type="inclusive">2001 January 22</unitdate>
          <container id="289f85a84da72d7841a58aa375ad909d" label="mixed materials (A0000000075909)" type="box">67</container>
          <container id="d1c608903de104da553de99b7220a1d2" parent="289f85a84da72d7841a58aa375ad909d" type="folder">6-8</container>
        </did>
        <accessrestrict id="516c40c3c42f23a1ef834fac3280423d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="29dd0d00d8ca1ffa9497a61ade7fcac7" level="file">
        <did>
          <unittitle>TML, 43-57 - Levothyroxine</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="0c860999ecdeb550d58b04bb2884e02a" label="mixed materials (A0000000075909)" type="box">67</container>
          <container id="888bcad0c0ba5de52330597e95117474" parent="0c860999ecdeb550d58b04bb2884e02a" type="folder">9-11</container>
        </did>
        <accessrestrict id="5e4d50d8e1cee2179d409a4d58ebfe39">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d2d95b76affb3a4c9b22a381ae08576d" level="file">
        <did>
          <unittitle>TML, 43-28 - Detrol LA and Ditropan XL for overactive bladder</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="bcf36deb9937543028aa5f38ac76f11c" label="mixed materials (A0000000075909)" type="box">67</container>
          <container id="c08c61d56d320d9c19f40285d5d7343c" parent="bcf36deb9937543028aa5f38ac76f11c" type="folder">12-13</container>
        </did>
        <accessrestrict id="c2a600b167a1d8ec49922e49f096e4ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="bf76f78ab4a4977fe44b60003b8f05f2" level="file">
        <did>
          <unittitle>TML, 43-27 - Prozac Weekly</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="66c7a441f8cdb97aeda5ab4b283de27e" label="mixed materials (A0000000075909)" type="box">67</container>
          <container id="a3435d03b8c270545e29270eb9ee104a" parent="66c7a441f8cdb97aeda5ab4b283de27e" type="folder">14</container>
        </did>
        <accessrestrict id="154ff78d3302dfb71a0c20f63e7f510f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d6b0a2f70273ff0516f8b345cdc4f512" level="file">
        <did>
          <unittitle>TML - Drugs for migraine</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="73018f0283df9f13c9e4e9260d51179a" label="mixed materials (A0000000075909)" type="box">67</container>
          <container id="f691fe83a45d721e73ace3a41f74b2fa" parent="73018f0283df9f13c9e4e9260d51179a" type="folder">15-17</container>
        </did>
        <accessrestrict id="81584269571599c2534c39747bee7f6e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ab3c9b20ba673d3a09626a2131dfbd70" level="file">
        <did>
          <unittitle>TML - Drugs for migraine</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="42882bbdeecbc8d939c45bb548d1dcd3" label="mixed materials (A0000000075910)" type="box">68</container>
          <container id="2cdd9b0121b7a31dba681fc4b3311dae" parent="42882bbdeecbc8d939c45bb548d1dcd3" type="folder">1</container>
        </did>
        <accessrestrict id="33ca4d5589e42adbdeba4c14888b39e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ce9d0ae7e21eaea0c4687dae309cfee9" level="file">
        <did>
          <unittitle>TML, 43-67 - Twinrix - A combination Hepatitis A and B vaccine</unittitle>
          <unitdate type="inclusive">2001 August 6</unitdate>
          <container id="4a469e3fd57c9470e209056f8e16146b" label="mixed materials (A0000000075910)" type="box">68</container>
          <container id="08cf3f9722331cf1a59139c2b086c372" parent="4a469e3fd57c9470e209056f8e16146b" type="folder">2-4</container>
        </did>
        <accessrestrict id="c860c07bca67d0f682cba26ca6577767">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="50348bc86f79794dd7d3880f772dc9fb" level="file">
        <did>
          <unittitle>TML, 43-81 - Influenza prevention 2001-2002</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="561b11178a23990b45feccc75b1a8e92" label="mixed materials (A0000000075910)" type="box">68</container>
          <container id="36de231c31a71b0982355d1f407ed253" parent="561b11178a23990b45feccc75b1a8e92" type="folder">5-8</container>
        </did>
        <accessrestrict id="1bbd28b63a91d7783c47a3da12aa5197">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3b16d2ad8da51e66ff96ab39df1d0aac" level="file">
        <did>
          <unittitle>TML, 43-33 - Topical tacrolimus treatment for atopic dermatitis</unittitle>
          <unitdate type="inclusive">2001 April 16</unitdate>
          <container id="d192011bfd0bc13ad891943847267c02" label="mixed materials (A0000000075910)" type="box">68</container>
          <container id="6c60c5104344bb59c028efe7ac765603" parent="d192011bfd0bc13ad891943847267c02" type="folder">9-12</container>
        </did>
        <accessrestrict id="524857adc52fa0f183b069d3ae7050b5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="41122ea5a6e7981f0132dc387c47d526" level="file">
        <did>
          <unittitle>TML, 43-42 - Glucowatch Biographer - A noninvasive glucose monitoring device</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="cf7625b8742e3126cac6021fe3599181" label="mixed materials (A0000000075910)" type="box">68</container>
          <container id="8ebd0bcb42788b331f68b4afa1dba678" parent="cf7625b8742e3126cac6021fe3599181" type="folder">13-14</container>
        </did>
        <accessrestrict id="8a2f04b8e85fd19c93d31127f994912c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="1f33fb25dbc24b2e3a9cc4123daa4b4c" level="file">
        <did>
          <unittitle>TML, 43-99 - Cardiovascular Safety of COX-2 Inhibitors</unittitle>
          <unitdate type="inclusive">2001 November 12</unitdate>
          <container id="62c4d59f1bf926a1df88f94db37bdf06" label="mixed materials (A0000000075910)" type="box">68</container>
          <container id="824c6ace8155815adf5cad3a136e189d" parent="62c4d59f1bf926a1df88f94db37bdf06" type="folder">15-17</container>
        </did>
        <accessrestrict id="ed26092ce8449e46cf63b80b2a291816">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9c5905505fca4831e512fb2648100be7" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Hypertension and Heart Failure</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="87f5712c0e1ae9aa9db6c94cc14f8b50" label="mixed materials (A0000000075910)" type="box">68</container>
          <container id="26437b291cc26896fc9857bc74172f8e" parent="87f5712c0e1ae9aa9db6c94cc14f8b50" type="folder">18</container>
        </did>
        <accessrestrict id="75c6bb282a1bebd46a6a30af50403e35">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d83158c1d6d2339140e8e837daa705b4" level="file">
        <did>
          <unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="fcc70a087ee9bbb38ed8db571a6dd93c" label="mixed materials (A0000000075910)" type="box">68</container>
          <container id="3366b8f8a91ff96db7352c2ac582442f" parent="fcc70a087ee9bbb38ed8db571a6dd93c" type="folder">19-21</container>
        </did>
        <accessrestrict id="a70ce5ed30190ec1d7686f21b89b6372">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="45a1a372dc6189c488cbf6dbf95adb8d" level="file">
        <did>
          <unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="7d5d940d5b442add146be547125cb01b" label="mixed materials (A0000000075911)" type="box">69</container>
          <container id="07e8d38bb8db1ff703700684a99a0912" parent="7d5d940d5b442add146be547125cb01b" type="folder">1</container>
        </did>
        <accessrestrict id="a1903924a041556ee7b26f4c2b26ac5e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="4cdec89511203afd4fe2dc98bb7107a3" level="file">
        <did>
          <unittitle>TML, 43-3 - Drugs for Vulvovaginal Candidiasis</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="94dc6e70720e6e8bdcfe50b605598d06" label="mixed materials (A0000000075911)" type="box">69</container>
          <container id="2bdb7b3d76074e047ceeaf3464ac1f9b" parent="94dc6e70720e6e8bdcfe50b605598d06" type="folder">2-4</container>
        </did>
        <accessrestrict id="721d15062edf16474f8c9615e7343c9b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9c93f14bdbe03244367dc9260f841c8a" level="file">
        <did>
          <unittitle>TML, 43-40 - Epoetin - Erythropoietin (Procrit; Epogen) Revisited</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="b1d119a94186208973d6c77b64f8a5c2" label="mixed materials (A0000000075911)" type="box">69</container>
          <container id="0a310349d5c291911fc4965ee99cc52f" parent="b1d119a94186208973d6c77b64f8a5c2" type="folder">5-8</container>
        </did>
        <accessrestrict id="0834865471315b83cd87445af0b5d964">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8c1db8b64ee78c1dea2315fd90476615" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="335f42f618cbe2b987defbf7e3c136ff" label="mixed materials (A0000000075911)" type="box">69</container>
          <container id="780a91a7f4640063f94ce8a65793cde3" parent="335f42f618cbe2b987defbf7e3c136ff" type="folder">9-12</container>
        </did>
        <accessrestrict id="0b08c7f91d343d75d562eb65c74f54bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="42c85fbc002a3352f01a11a7e4a6f54d" level="file">
        <did>
          <unittitle>TML, 43-36 - Esomeprazole (Nexium)</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="6e5256e24bb3f07d669dc36563d73904" label="mixed materials (A0000000075911)" type="box">69</container>
          <container id="9f2fea53f5bf2bda332c461cb8ed019c" parent="6e5256e24bb3f07d669dc36563d73904" type="folder">13-14</container>
        </did>
        <accessrestrict id="cc2db5a946dc97445662edf403135cfe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="dde7a8f4a1c15dd762a0160728804b73" level="file">
        <did>
          <unittitle>TML, 43-111 - Update on glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="027d66b3e3f84831b0113f8a7c1e8e58" label="mixed materials (A0000000075911)" type="box">69</container>
          <container id="295834c01d19b67c6b8e1452d46ecae6" parent="027d66b3e3f84831b0113f8a7c1e8e58" type="folder">15-17</container>
        </did>
        <accessrestrict id="5b2a4f2cbe109ddd0b02adec46206e8d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9666394f9b7e1594ab6d9d740833bf6d" level="file">
        <did>
          <unittitle>TML, 43-53 - Galantamine (Reminyl) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="a5f50c7530a83541f08a2615ad510b1c" label="mixed materials (A0000000075911)" type="box">69</container>
          <container id="ebbb15ec09bba6cc59cd6064b26cf914" parent="a5f50c7530a83541f08a2615ad510b1c" type="folder">18-20</container>
        </did>
        <accessrestrict id="64351c947d34d22cef39ad4007296824">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9e514faa1eb026a69873e6b610137535" level="file">
        <did>
          <unittitle>TML, 43-80 - Oxycodone and Oxycontin</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="992e4776e70892e1bd98ba89722d6d24" label="mixed materials (A0000000075912)" type="box">70</container>
          <container id="f3ac2b2d786b43cb8227f27046b1a7cf" parent="992e4776e70892e1bd98ba89722d6d24" type="folder">1-4</container>
        </did>
        <accessrestrict id="71c26f172f9a9a3876c7b24d11cc0db1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9bf44e00458f50d0ecc17dc1d13c078a" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Asthma - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="679e24867ebee0adff2998e1231ed8a9" label="mixed materials (A0000000075912)" type="box">70</container>
          <container id="72fb4fb11b64ca9d2ee134c85cd547b1" parent="679e24867ebee0adff2998e1231ed8a9" type="folder">5-7</container>
        </did>
        <accessrestrict id="753a55d97a80d113ee2476718a3d1661">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="0dc13b68cd4edd9b7be7bd34aad97ff0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Hypertension - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="6e66704654a94d49b695de846d565718" label="mixed materials (A0000000075912)" type="box">70</container>
          <container id="6f9bf4f54215851890f2df5c5debe7d9" parent="6e66704654a94d49b695de846d565718" type="folder">8-10</container>
        </did>
        <accessrestrict id="d504ebc62c5421f5e1d907042650019a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="28985057e383ceb12ff871b5d26e61da" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="b8932ed9d8a770ca7c6a38b365a1e95a" label="mixed materials (A0000000075912)" type="box">70</container>
          <container id="9bf7f6e5f09aab94d5bf0dbd72ab1a96" parent="b8932ed9d8a770ca7c6a38b365a1e95a" type="folder">11-13</container>
        </did>
        <accessrestrict id="22fbfc715602ec37fdf0114b7cb13cbe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="e9eaa9b717e217af3529d05e6f9fbd9e" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Arthritis - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="1822979cba9a4d122e8aa28a3ec737f0" label="mixed materials (A0000000075912)" type="box">70</container>
          <container id="df697da4f7a2a0bc8ce379b97d399ee1" parent="1822979cba9a4d122e8aa28a3ec737f0" type="folder">14-15</container>
        </did>
        <accessrestrict id="b5d06faa04330361ca1ca75b21c017fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a8579ee641a8d372e5b92c341780d2f0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Depression and Anxiety</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="cb3d9f0de39e32ba807af6f6b50d55a7" label="mixed materials (A0000000075912)" type="box">70</container>
          <container id="105536a31dc84f23420812846c3fa959" parent="cb3d9f0de39e32ba807af6f6b50d55a7" type="folder">16-17</container>
        </did>
        <accessrestrict id="85e3914a93c77fea32c035bd079cdf38">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d1091da187ca03263e9fbe06a0c8e8b9" level="file">
        <did>
          <unittitle>TML, 44-105 - Adefovir (Hespera) for chronic Hepatitis B infection</unittitle>
          <unitdate type="inclusive">2002 December 9</unitdate>
          <container id="afb01240540eba94072414c584ef7e53" label="mixed materials (A0000000075913)" type="box">71</container>
          <container id="f69fc977406a2de9fc97cfe9213c2b0a" parent="afb01240540eba94072414c584ef7e53" type="folder">1-4</container>
        </did>
        <accessrestrict id="5e9a358af553725b2b7a0e754e583db4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a52ad11ec1e3f4d9273267e959212194" level="file">
        <did>
          <unittitle>TML, 44-67 - Alosetron (Lotronex) revisited</unittitle>
          <unitdate type="inclusive">2002 August 5</unitdate>
          <container id="79ceeaa7b3261630daf87f85f9f22d8a" label="mixed materials (A0000000075913)" type="box">71</container>
          <container id="0418eb5210a5b6ba030082121fc0026f" parent="79ceeaa7b3261630daf87f85f9f22d8a" type="folder">5-8</container>
        </did>
        <accessrestrict id="44f937981b03e47fe5b48832e2bc3c06">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="524bcd1ef0983fc228db57fdceccbd8a" level="file">
        <did>
          <unittitle>TML, 44-1 - Prevention and treatment of injury from chemical biological warfare</unittitle>
          <unitdate type="inclusive">2002 January 7</unitdate>
          <container id="e6aee0ef0b48d5464f6140910b6b9333" label="mixed materials (A0000000075913)" type="box">71</container>
          <container id="c0811e1dfec2348be666a7c165de4f33" parent="e6aee0ef0b48d5464f6140910b6b9333" type="folder">9-11</container>
        </did>
        <accessrestrict id="41a008738c8b0cf8972cf6b24432d838">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="bad1e6f9e4ec0f760e77c31253787c34" level="file">
        <did>
          <unittitle>TML, 44-18 - Anakinra (Kineret) for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="206a6e6a029b759913247321344bb296" label="mixed materials (A0000000075913)" type="box">71</container>
          <container id="1b88e24abf6d13ed3f24d75002e6305c" parent="206a6e6a029b759913247321344bb296" type="folder">12-13</container>
        </did>
        <accessrestrict id="5283c1dbc9ae363bd049db90b8c9f8d8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="ba78803aaafb030f1962308400163490" level="file">
        <did>
          <unittitle>TML, 44-19 - Almotriptan (Axert) and Frovatriptan (Friva) for migraine</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="68d8a1a1311465fa811ac813c070b531" label="mixed materials (A0000000075913)" type="box">71</container>
          <container id="a20edb654e2fdb4a0097fb95335eccea" parent="68d8a1a1311465fa811ac813c070b531" type="folder">14-16</container>
        </did>
        <accessrestrict id="261eac7e701cc4253a133eadd4895b0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="bb6077375b3a6ffeb4bb53556a4f4c3c" level="file">
        <did>
          <unittitle>TML, 44-110 - Hemolysis from Ceftriaxone</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="1ad7992adb188c6d2db59c42bd29cb59" label="mixed materials (A0000000075913)" type="box">71</container>
          <container id="8328fb59aed40256f3bf1dae1e549a4b" parent="1ad7992adb188c6d2db59c42bd29cb59" type="folder">17-19</container>
        </did>
        <accessrestrict id="06663a53b51c9f32469146874e6a53fd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a4e45a144c74f16ab14378047e5576f1" level="file">
        <did>
          <unittitle>TML, 44-6 - Budesonide (Entocort EC) for Crohn's disease</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="1fc6135126659c1bcb0890f50e248cd0" label="mixed materials (A0000000075913)" type="box">71</container>
          <container id="72169c97d2747c69683d0e132c596945" parent="1fc6135126659c1bcb0890f50e248cd0" type="folder">20-21</container>
        </did>
        <accessrestrict id="344623fd522ad204005bd4713a3a7eaa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9f13d0adec34e41920a5e68ddd64292c" level="file">
        <did>
          <unittitle>TML, 44-109 - Dustateride (Avodart) for benign prostatic hyperplasia</unittitle>
          <unitdate type="inclusive">2002 December 23</unitdate>
          <container id="627dba2b3badc8dad7c4dbe0a8aeb0a0" label="mixed materials (A0000000075914)" type="box">72</container>
          <container id="0d6ec0d9197ccd8df71ea9e361977510" parent="627dba2b3badc8dad7c4dbe0a8aeb0a0" type="folder">1</container>
        </did>
        <accessrestrict id="867284bb3e82161ed3ce13cf85bb50cf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9263ee3a396996d1f6c92f91c990e8b4" level="file">
        <did>
          <unittitle>TML, 44-55 - Yasmin - an oral contraceptive with a new progestin</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="2543029dddf7fb9af2e39a27596c1518" label="mixed materials (A0000000075914)" type="box">72</container>
          <container id="af8881aa924a7fb607e8c44ae134dcfa" parent="2543029dddf7fb9af2e39a27596c1518" type="folder">2-7</container>
        </did>
        <accessrestrict id="c400e4bb55cfe7ea165cfb2d2dc99c6b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="fec2a29720e66cc581b066877ffa632d" level="file">
        <did>
          <unittitle>TML, 44-8 - Othro Evra - A contraceptive patch</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="22eac6801bf843de0e5f640490cc445a" label="mixed materials (A0000000075914)" type="box">72</container>
          <container id="b68afd3795993193c2653774b8ff6312" parent="22eac6801bf843de0e5f640490cc445a" type="folder">8-9</container>
        </did>
        <accessrestrict id="f89be5a42a6e7c9142c05161a1bb4330">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="ea19cfea9c41aa789e87a27139849cc9" level="file">
        <did>
          <unittitle>TML, 44-42 - Copyright violations</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="4341d73503860aca5303bbf9cc76c5b3" label="mixed materials (A0000000075914)" type="box">72</container>
          <container id="15f6bf67d8116279d56558b6ce9fb941" parent="4341d73503860aca5303bbf9cc76c5b3" type="folder">10</container>
        </did>
        <accessrestrict id="ec1aa5a5bbffa7071d0ee4e1725ec096">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="573b9aa7949c2b6064549d58f22d1ef4" level="file">
        <did>
          <unittitle>TML, 44-89 - Generic drugs</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="86efb11df1a1a102480a9cb2fb0dc9f9" label="mixed materials (A0000000075914)" type="box">72</container>
          <container id="6b0614032bbaaea56241424b94398dfe" parent="86efb11df1a1a102480a9cb2fb0dc9f9" type="folder">11-13</container>
        </did>
        <accessrestrict id="5b1243a2f3ac837601682945b4ad6a9e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="eca6e6e8880da77ade266c114c4c3ef8" level="file">
        <did>
          <unittitle>TML, 44-77 - Gefitinib (Iressa) for advanced non-small cell lung cancer</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="d6a95ee9598bce9b311432c42b807b28" label="mixed materials (A0000000075914)" type="box">72</container>
          <container id="09df28ef78b7ab4440314c187319c30d" parent="d6a95ee9598bce9b311432c42b807b28" type="folder">14-16</container>
        </did>
        <accessrestrict id="e52979497dde6f1c31a59d9d3764a403">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a5125bf7e9b481c9cf3b474c751ee55e" level="file">
        <did>
          <unittitle>TML, 44-103 - GHB for nacolepsy</unittitle>
          <unitdate type="inclusive">2002 December 9</unitdate>
          <container id="cd13094a15563017f683050f5f7e4197" label="mixed materials (A0000000075914)" type="box">72</container>
          <container id="ef66203a0dd1c5ec7f18461ed77fba72" parent="cd13094a15563017f683050f5f7e4197" type="folder">17-19</container>
        </did>
        <accessrestrict id="0fce222a44f0f4d669d6446bfe4d0948">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="5f1f43a60e3a918e61f1524dd78e1670" level="file">
        <did>
          <unittitle>TML - Fungal Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="bc1406b1a471f52d8f541f7a29da2cbe" label="mixed materials (A0000000075914)" type="box">72</container>
          <container id="9917ae2fb7e283ccad2a3a003b180049" parent="bc1406b1a471f52d8f541f7a29da2cbe" type="folder">20</container>
        </did>
        <accessrestrict id="43b31e9dd0e56b4393c587638541da8a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="d0277fd8830f2d769496c88f15bb859c" level="file">
        <did>
          <unittitle>TML - Fungal Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="95cd80238e7965aa5262158fbe8bc2cf" label="mixed materials (A0000000075915)" type="box">73</container>
          <container id="73185acb51496a22a139bb34d6b79377" parent="95cd80238e7965aa5262158fbe8bc2cf" type="folder">1</container>
        </did>
        <accessrestrict id="0374c695f899676ae2f0f4ab46c32079">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="38f15317a1ab04ccab7ddf87c59865ca" level="file">
        <did>
          <unittitle>TML, 44-65 - Fulvestrant (Faslodex) for advanced breast cancer</unittitle>
          <unitdate type="inclusive">2002 July 22</unitdate>
          <container id="a0783225c3ab0215cf35073a15fa4a3b" label="mixed materials (A0000000075915)" type="box">73</container>
          <container id="8da69fa821e180e471d4d28792848b36" parent="a0783225c3ab0215cf35073a15fa4a3b" type="folder">2-4</container>
        </did>
        <accessrestrict id="ce879f9aa1fe59c4646fb8a958d249d1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="c2dd44962d67176662e4db78dd0a66d1" level="file">
        <did>
          <unittitle>TML, 44-5 - Cefditoren (Spectracef) - A new oral cephalosporin</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="c48e1911ba4c72ef54bdf88aca8610b8" label="mixed materials (A0000000075915)" type="box">73</container>
          <container id="a5f0d98451c0ad610b3f81fd78ca417c" parent="c48e1911ba4c72ef54bdf88aca8610b8" type="folder">5-7</container>
        </did>
        <accessrestrict id="a137a040fd97e7017313ae9a82d2fe86">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="70993f6f906adca6d28b7cec87c5cbab" level="file">
        <did>
          <unittitle>TML, 44-93 - Drugs past their expiration date</unittitle>
          <unitdate type="inclusive">2002 October 28</unitdate>
          <container id="713d005572e092f95903e7e7a84b71be" label="mixed materials (A0000000075915)" type="box">73</container>
          <container id="70946e0b212f89744ae3ff194a153fba" parent="713d005572e092f95903e7e7a84b71be" type="folder">8-10</container>
        </did>
        <accessrestrict id="e06690c5813977cdcc6c8a5a7653718f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f9bc602671296cc3d2de922401f1986e" level="file">
        <did>
          <unittitle>TML, 44-83 - Escitalopram (Lexapro) for depression</unittitle>
          <unitdate type="inclusive">2002 September 30</unitdate>
          <container id="d0ea8164e77a8925a6667da55932c7fe" label="mixed materials (A0000000075915)" type="box">73</container>
          <container id="b83012b8df235e5bfeac4e7229995cf0" parent="d0ea8164e77a8925a6667da55932c7fe" type="folder">11-12</container>
        </did>
        <accessrestrict id="fdb13be24c2193fa8c3289e7d5ad654a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="88bf2c423e244a87d79645badbf2e9f3" level="file">
        <did>
          <unittitle>TML, 44-43 - Fondaparinux (Arixtra) - a new anticoagulant</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="8efd0e7568e0887679f127be61080aa4" label="mixed materials (A0000000075915)" type="box">73</container>
          <container id="795afde7e5881564cfd85f33af7c6b5c" parent="8efd0e7568e0887679f127be61080aa4" type="folder">13-15</container>
        </did>
        <accessrestrict id="bbbdd53df2b8ebd0612902a21d46a748">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="05b64e3022467a23598c9201bc74dfdf" level="file">
        <did>
          <unittitle>TML - Cefepime</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="a2a2f8555cb55449ece8143b9e77d1e0" label="mixed materials (A0000000075915)" type="box">73</container>
          <container id="7f3ca766f8367957867fcd90c480a596" parent="a2a2f8555cb55449ece8143b9e77d1e0" type="folder">16-18</container>
        </did>
        <accessrestrict id="394b3115bcff39760eac5c39dc81bdb6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0b79a2b45ac5a48beb03988b3255f34c" level="file">
        <did>
          <unittitle>TML, 44-126 - Eratapenem - a new parenteral carbapenem</unittitle>
          <unitdate type="inclusive">2002 March 18</unitdate>
          <container id="72adbcb20a3564d49ad2dabf91b3a007" label="mixed materials (A0000000075915)" type="box">73</container>
          <container id="78353643ba9f4e30fdfd7ec6722526ad" parent="72adbcb20a3564d49ad2dabf91b3a007" type="folder">19-21</container>
        </did>
        <accessrestrict id="556a688586b09ef7523a269879e4d606">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2ab8dcb85ae9ce0ddd2d1fdc51a02ee6" level="file">
        <did>
          <unittitle>TML - Echinacea</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="60e06b738fecf7ee3d93e2f95b42530a" label="mixed materials (A0000000075916)" type="box">74</container>
          <container id="632c2f29a336e1d8f55dcb08c976ad4f" parent="60e06b738fecf7ee3d93e2f95b42530a" type="folder">1-3</container>
        </did>
        <accessrestrict id="dc18fb2ef4fb05f2fdaba6355d199ff6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="af85bd11efe07fd729751c8c218f32d2" level="file">
        <did>
          <unittitle>TML, 44-47 - Botulinum Toxin (Botox Cosmetic) for frown lines</unittitle>
          <unitdate type="inclusive">2002 May 27</unitdate>
          <container id="7f4326acc51921c5f046e51c291c6281" label="mixed materials (A0000000075916)" type="box">74</container>
          <container id="f4ae8274e6de99d74b4d6e03762cdde3" parent="7f4326acc51921c5f046e51c291c6281" type="folder">4-6</container>
        </did>
        <accessrestrict id="e67c688500af00baeca0146003fa4b6f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="45aa8fe42fd0ddc4536be77350df4b57" level="file">
        <did>
          <unittitle>TML - Fungal Infections - Reprints</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="11c8fa41ddf235dc0119349bc335a33a" label="mixed materials (A0000000075916)" type="box">74</container>
          <container id="a6417f6397b3176b9d40c5cc9e3f675e" parent="11c8fa41ddf235dc0119349bc335a33a" type="folder">7</container>
        </did>
        <accessrestrict id="1f1099e38699970b363bae0c6975a70b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2e47b4ee1607009a90bcdea23b07a404" level="file">
        <did>
          <unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="f5eb30955f1feceec4174d8465f4f47c" label="mixed materials (A0000000075916)" type="box">74</container>
          <container id="e90b6cd864d9c9bc93f68ff77912f615" parent="f5eb30955f1feceec4174d8465f4f47c" type="folder">8-19</container>
        </did>
        <accessrestrict id="831283e78ef78563e6f6b9e3060a60fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f41b47c09c3e11ca72cf6fe9fcfca8b2" level="file">
        <did>
          <unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="3232faf5899ab637af6b711a27acf667" label="mixed materials (A0000000075917)" type="box">75</container>
          <container id="b33df045d34d0f058ef6c3b1f9727673" parent="3232faf5899ab637af6b711a27acf667" type="folder">1-2</container>
        </did>
        <accessrestrict id="37075cc131616efa32d821ddec70e19a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0785dbde88fe25acb019e68e53796851" level="file">
        <did>
          <unittitle>TML, 44-73 - Neotame - a new artificial sweetner</unittitle>
          <unitdate type="inclusive">2002 August 19</unitdate>
          <container id="9e288a791bcf3a21536a733dacc221de" label="mixed materials (A0000000075917)" type="box">75</container>
          <container id="a95cae7dd5f49af13507bd405117b2d0" parent="9e288a791bcf3a21536a733dacc221de" type="folder">3-4</container>
        </did>
        <accessrestrict id="423a699022dfc41e5a19356b8ede358f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="daec721a5877ed667e3be025c5b3972b" level="file">
        <did>
          <unittitle>TML, 44-95 - Valacyclovir (Valtrex) for herpes labialis</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="c3e18990285b1e18682fc43f183c211e" label="mixed materials (A0000000075917)" type="box">75</container>
          <container id="673d6802fad8f56e67c472d12d2adf40" parent="c3e18990285b1e18682fc43f183c211e" type="folder">5-6</container>
        </did>
        <accessrestrict id="65275a0edfafc2779f6f3b12b167613d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="daaa98dacc14a33f7dd8c3607f43fabe" level="file">
        <did>
          <unittitle>TML - Drugs for prevention and treatment of postmenopausal osteoporosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 November 1</unitdate>
          <container id="6fbbc5a74e609d74af0fdfd173860633" label="mixed materials (A0000000075917)" type="box">75</container>
          <container id="4646f0993f4aa00d3d9831f156f6cf40" parent="6fbbc5a74e609d74af0fdfd173860633" type="folder">7-10</container>
        </did>
        <accessrestrict id="66fca14cfc643877b243d938549ef683">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="6c5c80d095e7afd1c721854326e0f8cc" level="file">
        <did>
          <unittitle>TML, 44-9 - Drugs for Non-HIV viral infections</unittitle>
          <unitdate type="inclusive">2002 February 4</unitdate>
          <container id="f380c664fca641cc4957aac58a2e107b" label="mixed materials (A0000000075917)" type="box">75</container>
          <container id="d97a0be31bfb75a05c50ab811cd9d85c" parent="f380c664fca641cc4957aac58a2e107b" type="folder">11-17</container>
        </did>
        <accessrestrict id="bdf05fc38d86db9b72f37658b33c4730">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="bcfed60146a9353c15a7810e066eb562" level="file">
        <did>
          <unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="82b311fd1633413a7e3af3ddb169a800" label="mixed materials (A0000000075917)" type="box">75</container>
          <container id="cebc458093ad5465bb9072113cf44fa0" parent="82b311fd1633413a7e3af3ddb169a800" type="folder">18-19</container>
        </did>
        <accessrestrict id="3f36d4c0ac7dd42dca225464d90a4a7b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="26f9f680797154013e700d36b1ee02cc" level="file">
        <did>
          <unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="732c08ebc619ae365b158e4ac1cd5fe1" label="mixed materials (A0000000075918)" type="box">76</container>
          <container id="54b78c1b9847f898a5d427654c9660c3" parent="732c08ebc619ae365b158e4ac1cd5fe1" type="folder">1-2</container>
        </did>
        <accessrestrict id="538e6db36155fc336b5cd7453b267830">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="87edb03339d8ce2c8587c9b08fa0c33c" level="file">
        <did>
          <unittitle>TML, 44-52 - Tazarotene (Tazorac) for acne</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="def0df115000e61e9c040fbca7d2ab3b" label="mixed materials (A0000000075918)" type="box">76</container>
          <container id="9fd700f7859ae793c90dba3e297fcc11" parent="def0df115000e61e9c040fbca7d2ab3b" type="folder">3-5</container>
        </did>
        <accessrestrict id="009827e7a43d5b337cbe6459416c7913">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="4e2f11c3afbd278cc01889db51cc3594" level="file">
        <did>
          <unittitle>TML - Safety of antimicrobials in pregnancy</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="4d815e89e691a75915b84f885b793c91" label="mixed materials (A0000000075918)" type="box">76</container>
          <container id="a36a57f33ec983ee203fddccf11ced27" parent="4d815e89e691a75915b84f885b793c91" type="folder">6-9</container>
        </did>
        <accessrestrict id="4077280e1fc84a55fa2f33342e312820">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="d9af5da201c75753edd17152b98006c9" level="file">
        <did>
          <unittitle>TML, 44-63 - Voriconazole</unittitle>
          <unitdate type="inclusive">2002 July 22</unitdate>
          <container id="05182e21079706b418e64424e739e2e1" label="mixed materials (A0000000075918)" type="box">76</container>
          <container id="e0e08475ac357c6cfb6f8367a1cf4a09" parent="05182e21079706b418e64424e739e2e1" type="folder">10-14</container>
        </did>
        <accessrestrict id="7f7313cf1c86daf164b8b5b1d2c47390">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f449d0ea0cb02a16dc4bb161afd0e8e1" level="file">
        <did>
          <unittitle>TML - Cardiovascular drugs in the ICU - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 December</unitdate>
          <container id="592da7cf0b11bbd425f1d270470cd4c7" label="mixed materials (A0000000075918)" type="box">76</container>
          <container id="be750f200a0087129e5a835da7cfadd0" parent="592da7cf0b11bbd425f1d270470cd4c7" type="folder">15-20</container>
        </did>
        <accessrestrict id="d78727a12815fb45316cee4c1bb66369">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="4536f53d88709a34f9764f238002f522" level="file">
        <did>
          <unittitle>TML, 44-51 - Triptorelin Pamoate (Trelstar)</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="7e54006c54b59191509eba654796ac45" label="mixed materials (A0000000075919)" type="box">77</container>
          <container id="6b47f8180252c1059fc3d36cc774347b" parent="7e54006c54b59191509eba654796ac45" type="folder">1-4</container>
        </did>
        <accessrestrict id="3f564956f49faf84f827624973a86572">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="8319ac1e74f3772c55f953d49d1fe802" level="file">
        <did>
          <unittitle>TML - Drugs for Tuberculosis</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="55328529618226f598d5608a4dc03ec2" label="mixed materials (A0000000075919)" type="box">77</container>
          <container id="3e5a508d778de236fb417aac4cf152f8" parent="55328529618226f598d5608a4dc03ec2" type="folder">5-8</container>
        </did>
        <accessrestrict id="6e3e6b2b8bab0f3a6559d5327bba741c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="c61123a9a767eb2a2f0665b7e710f056" level="file">
        <did>
          <unittitle>TML, 44-80 - Tepostinil (Remodulin) for pulmonary arterial hypertension</unittitle>
          <unitdate type="inclusive">2002 September 16</unitdate>
          <container id="4a0c53dd25fc6f2bf29cb5afb8d041e7" label="mixed materials (A0000000075919)" type="box">77</container>
          <container id="50ddf8b8ec759c334c3b8dd49b603f9e" parent="4a0c53dd25fc6f2bf29cb5afb8d041e7" type="folder">9-11</container>
        </did>
        <accessrestrict id="96d0a14409c624606417824206c572f4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9c1edb72ecb57f4a5cf544ab8a33f1ca" level="file">
        <did>
          <unittitle>TML, 44-59 - Drugs that may cause psychiatric symptoms</unittitle>
          <unitdate type="inclusive">2002 July 8</unitdate>
          <container id="47cc35f7ef0e60c55cd85d67e1ba7eb9" label="mixed materials (A0000000075919)" type="box">77</container>
          <container id="42784bcf19b476e6b98a3d71bfc52611" parent="47cc35f7ef0e60c55cd85d67e1ba7eb9" type="folder">12-16</container>
        </did>
        <accessrestrict id="049b266831555277c80bf92411b09f0b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="83c1e0a1fb9e3488cec1e298480b45b9" level="file">
        <did>
          <unittitle>TML, 44-79 - Tegaserod Maleate (Zelnom) for IBS with constipation</unittitle>
          <unitdate type="inclusive">2002 September 16</unitdate>
          <container id="af851b885095872cb1c2dc10dc8d8239" label="mixed materials (A0000000075919)" type="box">77</container>
          <container id="7ff4bc20908f3063d74fb65e1c6634b7" parent="af851b885095872cb1c2dc10dc8d8239" type="folder">17-19</container>
        </did>
        <accessrestrict id="6b6e7ca2998642d620f912e4ae273e58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="702df7b3933e28f25249b7010b1efc23" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="292bb09944456b72f25edcf99dfd3cc2" label="mixed materials (A0000000075919)" type="box">77</container>
          <container id="bcac7d5bc1f69ba3262196e3db0d5338" parent="292bb09944456b72f25edcf99dfd3cc2" type="folder">20</container>
        </did>
        <accessrestrict id="21f8d786633e1a74c8baaec02b6e69c6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="fbd9f3d2b393e963f637e86d90ca6f0c" level="file">
        <did>
          <unittitle>TML - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="9136b8a2d7f8ceb652fef518357611a4" label="mixed materials (A0000000075919)" type="box">77</container>
          <container id="1fa5a26264ea3ac61971515ff3f7956c" parent="9136b8a2d7f8ceb652fef518357611a4" type="folder">21</container>
        </did>
        <accessrestrict id="8c19ab74e7734be86d15ccfc2ffd8632">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="3238875c71befee0c843bfb578b0af6f" level="file">
        <did>
          <unittitle>TML - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="13665b557bf23ab1ee9781e0c972b985" label="mixed materials (A0000000075920)" type="box">78</container>
          <container id="9aa7cd4a702bb68b7f92543a67111274" parent="13665b557bf23ab1ee9781e0c972b985" type="folder">1-3</container>
        </did>
        <accessrestrict id="f07baa851539686de763d2f786c2177e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0f73f901dbd4ead91b01d80ceed67c30" level="file">
        <did>
          <unittitle>TML, 44-75 - Influenza prevention 2002-2003</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="b6cc4ef1a31831454a4a5d451b26b91a" label="mixed materials (A0000000075920)" type="box">78</container>
          <container id="ec723fcb5db6238eaa22cce43cdd1c3a" parent="b6cc4ef1a31831454a4a5d451b26b91a" type="folder">4-6</container>
        </did>
        <accessrestrict id="f979eb1f784b0838d5a64de4d9ac9da1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="23ee674858aa228c8597cb11a5363b5d" level="file">
        <did>
          <unittitle>TML, 44-33 - Advice for travelers</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="72c8a12fa8f1b66fb1d084f5736d6b4d" label="mixed materials (A0000000075920)" type="box">78</container>
          <container id="b27c6bec60b34b60798b9b107e55994b" parent="72c8a12fa8f1b66fb1d084f5736d6b4d" type="folder">7-9</container>
        </did>
        <accessrestrict id="687d9c16855007cc90b89408873e9116">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="c3ff86733b644974c019ea29b403f49f" level="file">
        <did>
          <unittitle>TML, 44-97 - Potassium Iodine for thyroid protection in a nuclear accident or attack</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="5eb19ae1c60c7a561ac7a7fc67a21a8a" label="mixed materials (A0000000075920)" type="box">78</container>
          <container id="d74308d2a4aa6759477f61ba0f31d4dc" parent="5eb19ae1c60c7a561ac7a7fc67a21a8a" type="folder">10-11</container>
        </did>
        <accessrestrict id="ae3d1b9904d63ec7a442b7bf1ecd8dc5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="24af9a9128ef19b87942303f71c93a4b" level="file">
        <did>
          <unittitle>TML, 44-91 - Acetaminophen safety</unittitle>
          <unitdate type="inclusive">2002 October 28</unitdate>
          <container id="d1b74ec1af4f80e38d8e429b2bf27a85" label="mixed materials (A0000000075920)" type="box">78</container>
          <container id="feea75afc7eaf1dc0127f5ad58ecbc54" parent="d1b74ec1af4f80e38d8e429b2bf27a85" type="folder">12-16</container>
        </did>
        <accessrestrict id="7768a5d75ddf57469eb3bbdfec0f20af">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="b3aae1ba9f482e9eeee3c33251fd33f7" level="file">
        <did>
          <unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="e16b947380ca60d19bc61507f4f07825" label="mixed materials (A0000000075920)" type="box">78</container>
          <container id="ebc60a675796066dd683bc6d2aaf2be4" parent="e16b947380ca60d19bc61507f4f07825" type="folder">17-19</container>
        </did>
        <accessrestrict id="afa4af3e07bce4f2fa04d79ed2a8e09b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="8104e8da1a3aff8455ce0008f38fee5a" level="file">
        <did>
          <unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="ff586d9fa0ad00f075afafe22bc0138c" label="mixed materials (A0000000075921)" type="box">79</container>
          <container id="168aaf9cf8cd1ab459babab53ccfd8fd" parent="ff586d9fa0ad00f075afafe22bc0138c" type="folder">1-2</container>
        </did>
        <accessrestrict id="aca0e4a78b7223c626fd6a43994f5d31">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="02479e2c1173076c05f34aa17007ba49" level="file">
        <did>
          <unittitle>TML, 44-21 - Acute reactions of drug abuse</unittitle>
          <unitdate type="inclusive">2002 March 4</unitdate>
          <container id="95f3feb1e0158619fdb60a2b0f48174f" label="mixed materials (A0000000075921)" type="box">79</container>
          <container id="c2481fc33004c8638381e633026439f4" parent="95f3feb1e0158619fdb60a2b0f48174f" type="folder">3-6</container>
        </did>
        <accessrestrict id="c95f7f827b4be73752d104280c14ae0c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="d1098818233489d81f3ee9a35c491fda" level="file">
        <did>
          <unittitle>TML, 44-71 - Tests for drug abuse</unittitle>
          <unitdate type="inclusive">2002 August 19</unitdate>
          <container id="7e085f8008a0afb1e6f1584939446797" label="mixed materials (A0000000075921)" type="box">79</container>
          <container id="8bbbab6d567b494fae0e222c8c686b67" parent="7e085f8008a0afb1e6f1584939446797" type="folder">7-10</container>
        </did>
        <accessrestrict id="6b5deed194656d7a78e4584eaf23da1c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a2d97df9926c22348169dc85fc2da466" level="file">
        <did>
          <unittitle>TML, 44-82 - Accutane</unittitle>
          <unitdate type="inclusive">2002 September</unitdate>
          <container id="b0a138d0cfc8cb74a404cf7df49ace6e" label="mixed materials (A0000000075921)" type="box">79</container>
          <container id="39e9f2ab7c018bff56ab2f31b7aecc1d" parent="b0a138d0cfc8cb74a404cf7df49ace6e" type="folder">11-12</container>
        </did>
        <accessrestrict id="811a73112a0f3db0c61460c6f50c3a83">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="77f6dda8f57e4d024c751d9255cb8084" level="file">
        <did>
          <unittitle>TML, 44-50 - Spinal Manipulation</unittitle>
          <unitdate type="inclusive">2002 May 22</unitdate>
          <container id="88f1dc887426b492bc47d1738422bd1b" label="mixed materials (A0000000075921)" type="box">79</container>
          <container id="07a95f1940ffe96a1e9e23ee939dbfd6" parent="88f1dc887426b492bc47d1738422bd1b" type="folder">13-15</container>
        </did>
        <accessrestrict id="c6a5678b6a97ed4390bd98a720535a47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="09411c4ec2cd0e10526be529fdbb7c1d" level="file">
        <did>
          <unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="dde973df1b1f504297a7d4482d83af90" label="mixed materials (A0000000075921)" type="box">79</container>
          <container id="be7ddf1c7e0839a30e0f466e086e739f" parent="dde973df1b1f504297a7d4482d83af90" type="folder">16-17</container>
        </did>
        <accessrestrict id="1fde5116b8525bf37872775d4c998b9e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2af7784d4333e1386ceb5387b0141573" level="file">
        <did>
          <unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="bc40d8db55fd9770566eb49948016e92" label="mixed materials (A0000000075922)" type="box">80</container>
          <container id="a239e64332e1d0ac226c398b1fe809b9" parent="bc40d8db55fd9770566eb49948016e92" type="folder">1-2</container>
        </did>
        <accessrestrict id="b2d240752dac7c5d6b161365b06fbe2d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="45b86f5c46903225f479639e02061c91" level="file">
        <did>
          <unittitle>TML, 44-17 - Drotecogin - Activated Protein C (Xigris) for Severe Sepsis</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="eb4d474c71baa4a6b506067071787945" label="mixed materials (A0000000075922)" type="box">80</container>
          <container id="57eff3ae70cd25f285471a8817f7a41d" parent="eb4d474c71baa4a6b506067071787945" type="folder">3-7</container>
        </did>
        <accessrestrict id="c6644b7dd17dbfbedd1d1af2963340f4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2df9fa1b1dadedbd80d056c6d1eb7e1b" level="file">
        <did>
          <unittitle>TML, 44-78 - Hormone replacement therapy</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="93c45bad885874b9b4b25329a054022e" label="mixed materials (A0000000075922)" type="box">80</container>
          <container id="fdf47592c1e53b315c20c834c86b3d67" parent="93c45bad885874b9b4b25329a054022e" type="folder">8-9</container>
        </did>
        <accessrestrict id="25fbac45d92806e8263c700a8600b817">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="79ecc959704f5a99033f6383c71d5e2b" level="file">
        <did>
          <unittitle>TML, 44-30 -Bosentan (Tracleer) for pulmonary arterial hypertension</unittitle>
          <unitdate type="inclusive">2002 April 11</unitdate>
          <container id="fafad7cf38f80f912ff58e71d158f478" label="mixed materials (A0000000075922)" type="box">80</container>
          <container id="c9f73db243b91100bb1c3c46f2b9ac0f" parent="fafad7cf38f80f912ff58e71d158f478" type="folder">10-12</container>
        </did>
        <accessrestrict id="c218a513a6535a5ceb72241f53f1083c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="ebeb0b87fb29433a1b670b6a4d5aa5fc" level="file">
        <did>
          <unittitle>TML, 44-45 - Dexmethylphenidate (Focalin) for ADHD</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="110e170a87430ab156f7336db886cfed" label="mixed materials (A0000000075922)" type="box">80</container>
          <container id="a4b93546d7a03442ee247b6fb7e8b4c9" parent="110e170a87430ab156f7336db886cfed" type="folder">13-14</container>
        </did>
        <accessrestrict id="daa9fc43588271721e9668e6387b1ecc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9cf28c7502d38a3253794dc0aff81d12" level="file">
        <did>
          <unittitle>TML, 44-53 - Droperidol Risk - Arrhythmias</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="80a4541bde9e77dda34ac9a8531b3fe8" label="mixed materials (A0000000075922)" type="box">80</container>
          <container id="323c8ad4e4b8876ac04c06f557dc8b92" parent="80a4541bde9e77dda34ac9a8531b3fe8" type="folder">15-16</container>
        </did>
        <accessrestrict id="9343665bbaab14cdc391de9fbda39aab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="037a4523e063f09b403c4b86b056b0b9" level="file">
        <did>
          <unittitle>TML, 44-84 - Herbal Products - Problems with dietary supplements</unittitle>
          <unitdate type="inclusive">2002 September 30</unitdate>
          <container id="ea13326f50a1d3e9a7cb275fe633df6a" label="mixed materials (A0000000075922)" type="box">80</container>
          <container id="352b71741aebac80cfb48ab74bab74e5" parent="ea13326f50a1d3e9a7cb275fe633df6a" type="folder">17-19</container>
        </did>
        <accessrestrict id="2fdc328774c9f82ce8ebb61aee7387a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="606c2c7591fb4c21ba3d38fc6c7462b0" level="file">
        <did>
          <unittitle>TML, 44-96 - Rasburicase</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="4f5f1c1bf13b4dbc2958cae93df2e682" label="mixed materials (A0000000075923)" type="box">81</container>
          <container id="889ff65b3a1e4fd8e2dc287f67cdf91d" parent="4f5f1c1bf13b4dbc2958cae93df2e682" type="folder">1-2</container>
        </did>
        <accessrestrict id="6dd42fdac95221294c398b8dad4d3a7e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="b3d8e525fd2c6ceabdefb1c16c80e100" level="file">
        <did>
          <unittitle>TML, 44-88 - Three beta-interferons for MS</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="6aa9c267f653a4084be6d393e72afe83" label="mixed materials (A0000000075923)" type="box">81</container>
          <container id="10fc42b8b994229c0611c1bc14b5f119" parent="6aa9c267f653a4084be6d393e72afe83" type="folder">3-6</container>
        </did>
        <accessrestrict id="de5073ebce08ff223cdc3bac4b44096d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="cd35b74adb66fbee3caa77d502914319" level="file">
        <did>
          <unittitle>TML, 44-99 - Indications for an implantable cardioverter defibrillator</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="ea475a9a0d8d282ef956bc8c9cc6ed5c" label="mixed materials (A0000000075923)" type="box">81</container>
          <container id="b3da03e72c1727f53ff32e36c84f009e" parent="ea475a9a0d8d282ef956bc8c9cc6ed5c" type="folder">7-9</container>
        </did>
        <accessrestrict id="44a756d7626a6484624c170f3c9fe601">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="caba3d20cbb6ac2bcf0fffb6486cd172" level="file">
        <did>
          <unittitle>TML - Drugs for Diabetes - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 September</unitdate>
          <container id="5d8ca39f22d6176b96830cd6bf37dc00" label="mixed materials (A0000000075923)" type="box">81</container>
          <container id="44ed52f38a7c3594d7c2e2366d7d63fc" parent="5d8ca39f22d6176b96830cd6bf37dc00" type="folder">10-13</container>
        </did>
        <accessrestrict id="27fb92f6dcd523eaebbcb18be6a423a5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0cdc8024ee854934a00a2e6cc658127c" level="file">
        <did>
          <unittitle>TML, 44-87 - Once-a-Week risedronate (Actonel)</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="91b824f763dcede3aa7e8e632cc79b49" label="mixed materials (A0000000075923)" type="box">81</container>
          <container id="492be52f93b5e7e19a95758e23cae4f8" parent="91b824f763dcede3aa7e8e632cc79b49" type="folder">14-15</container>
        </did>
        <accessrestrict id="3c69c2eda4cf5e33f151894a6dae98fa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="6373e1ea574b03380381b604f8f317ea" level="file">
        <did>
          <unittitle>TML, 44-48 - Topical Primecrolimus (Elidel) for treatment of atopic dermatitis</unittitle>
          <unitdate type="inclusive">2002 May 27</unitdate>
          <container id="5602fd7550c90705d970d2baadd41a84" label="mixed materials (A0000000075923)" type="box">81</container>
          <container id="7e749ec6b3d0022948f3ec2c5c4b2fb1" parent="5602fd7550c90705d970d2baadd41a84" type="folder">16-17</container>
        </did>
        <accessrestrict id="c8982cc8907e5273994dc146b1a74168">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0a43de1bea99678d0bd3f43b5c8e3aab" level="file">
        <did>
          <unittitle>TML, 44-107 - Metaglip and Avandamet for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2002 December 23</unitdate>
          <container id="ab024bb3ad0d3426d34b4d24d0e7e927" label="mixed materials (A0000000075924)" type="box">82</container>
          <container id="1f3aa12fb4c0bb02142349d66e2e70b6" parent="ab024bb3ad0d3426d34b4d24d0e7e927" type="folder">1-3</container>
        </did>
        <accessrestrict id="77f5cb2d5690ac4fb8b1401da5ce42c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0ad024dbe91f78abe8bfbef002c6b1ff" level="file">
        <did>
          <unittitle>TML, 44-27 - Desloratadine</unittitle>
          <unitdate type="inclusive">2002 March 18</unitdate>
          <container id="fcb70e1ae141f1f2a00b22fb821315b6" label="mixed materials (A0000000075924)" type="box">82</container>
          <container id="46846c26510e3110cfdd944e8f3dee83" parent="fcb70e1ae141f1f2a00b22fb821315b6" type="folder">4-6</container>
        </did>
        <accessrestrict id="36a5c8671473d8ebde644f9ea2a482bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="b7991b9a56fe105d30e6587c04553698" level="file">
        <did>
          <unittitle>TML, 44-41 - Pantoprazole (Protonix IV)</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="72150e039d4e25fea439537890ae8037" label="mixed materials (A0000000075924)" type="box">82</container>
          <container id="9c715235d5e3a5aa1982e8900f3cd11b" parent="72150e039d4e25fea439537890ae8037" type="folder">7-8</container>
        </did>
        <accessrestrict id="ecf59515bb41f3b93d8d69d9976e28b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="e886d7140f04a51e798f5685595d8a64" level="file">
        <did>
          <unittitle>TML, 44-69 - Olmesartan (Benicar) for hypertension</unittitle>
          <unitdate type="inclusive">2002 August 5</unitdate>
          <container id="bc1b982d43c42c5ded294632541eef5f" label="mixed materials (A0000000075924)" type="box">82</container>
          <container id="7f38f45787b99ccc327ccbcf92ee761c" parent="bc1b982d43c42c5ded294632541eef5f" type="folder">9-12</container>
        </did>
        <accessrestrict id="74dedc4bdd750d18fabe19b677cbe4fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a62ab234ffcd38be2c7ecb1b5105a478" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="289ffbcf3fa8457f9ab3f187aa6da076" label="mixed materials (A0000000075924)" type="box">82</container>
          <container id="bc854a66ab0c2f155dbb93e9494fec20" parent="289ffbcf3fa8457f9ab3f187aa6da076" type="folder">13-16</container>
        </did>
        <accessrestrict id="a1761f494a6aadd735240b5f6234da0c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="334f7d2fdf7bebf0df4dbded68f76c8d" level="file">
        <did>
          <unittitle>TML, 44-44 - Pegfilgrastin (Neulasta) for prevention of febrile neutropenia</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="6011e80c590ad0ec725f1b345c66f7a6" label="mixed materials (A0000000075924)" type="box">82</container>
          <container id="3fd5d18251ac39ab54208b6a76341512" parent="6011e80c590ad0ec725f1b345c66f7a6" type="folder">17-19</container>
        </did>
        <accessrestrict id="a69e5af2889f08c295264781d0dc1080">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f777550cceb72905734014265970ba2d" level="file">
        <did>
          <unittitle>TML, 45-25 - Adalimumab (Humira) for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2003 March 31</unitdate>
          <container id="bd87df105cd4840b8951f5a493c7684c" label="mixed materials (A0000000075925)" type="box">83</container>
          <container id="1e6723877c00550e8e0e85789c99b714" parent="bd87df105cd4840b8951f5a493c7684c" type="folder">1-3</container>
        </did>
        <accessrestrict id="843488d272c7cd2629b6cfaf3ea233ef">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="755a5cb278c5674c278d62217583d0dc" level="file">
        <did>
          <unittitle>TML, 45-31 - Alefacept (Amevive) for treatment of psoriasis</unittitle>
          <unitdate type="inclusive">2003 April 14</unitdate>
          <container id="fa0bb3ff4c5d30e0ea813d932523a644" label="mixed materials (A0000000075925)" type="box">83</container>
          <container id="ef5b5c61537b6b613cf1364c63f65932" parent="fa0bb3ff4c5d30e0ea813d932523a644" type="folder">4-6</container>
        </did>
        <accessrestrict id="a72cbce0a6c64d80126a119167b5dc50">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9a2ad2a43a1bd9b6c3ff840aca327639" level="file">
        <did>
          <unittitle>TML, 45-43 - Alprazolam XR for panic disorder</unittitle>
          <unitdate type="inclusive">2003 May 26</unitdate>
          <container id="a2700a60f5b2bacf22ba94010e5a2f5b" label="mixed materials (A0000000075925)" type="box">83</container>
          <container id="21570d0db576ca084e0e52eb53a888a1" parent="a2700a60f5b2bacf22ba94010e5a2f5b" type="folder">7</container>
        </did>
        <accessrestrict id="7facc30ebfc92bd3e698021dbdeb21fe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="32827b05df08c432fb2cbb3d952c316a" level="file">
        <did>
          <unittitle>TML, 45-15 - Aripiprazole (Abilify) for schizophrenia</unittitle>
          <unitdate type="inclusive">2003 February 17</unitdate>
          <container id="17a2dcfac3d0e039890fb4194eec6f76" label="mixed materials (A0000000075925)" type="box">83</container>
          <container id="388c6339f1f9620ef72eff5c154da676" parent="17a2dcfac3d0e039890fb4194eec6f76" type="folder">8-10</container>
        </did>
        <accessrestrict id="e9db4aba5feb72c13178e46e3f2599e5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="2dcb5260bf184933786c79514811276a" level="file">
        <did>
          <unittitle>TML, 45-5 - Augmentin XR</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="3b7d921f6dce1aab5bbe995d040b142c" label="mixed materials (A0000000075925)" type="box">83</container>
          <container id="6e2b15f536a7c7e550f79f30514e66cf" parent="3b7d921f6dce1aab5bbe995d040b142c" type="folder">11-13</container>
        </did>
        <accessrestrict id="352c7f8bef5faa523d50be8830568d03">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="6719542efa0dd7e6ff2199fb0fc45784" level="file">
        <did>
          <unittitle>TML, 45-50 - Blue Light (Clearlight) for acne vulgaris</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="dac6d1fe142896d23acbb20db0154f7b" label="mixed materials (A0000000075925)" type="box">83</container>
          <container id="ed31c2e04d82ed01606330ae696c35e0" parent="dac6d1fe142896d23acbb20db0154f7b" type="folder">14-15</container>
        </did>
        <accessrestrict id="dd3798d0577bb9e1fc29332ed3c1ed16">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="face99254c656f96b64bf580e5f85bcf" level="file">
        <did>
          <unittitle>TML, 45-57 - Bortezomib for multiple myeloma</unittitle>
          <unitdate type="inclusive">2003 July 21</unitdate>
          <container id="8e2f0f6b8d747f3de6f32852b7921dd3" label="mixed materials (A0000000075925)" type="box">83</container>
          <container id="721cfc58dfaaf3eeca2a40e4f699c006" parent="8e2f0f6b8d747f3de6f32852b7921dd3" type="folder">16-18</container>
        </did>
        <accessrestrict id="5b737b9395121e3828a6f6fa407666da">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9ec231ed3611900061caae3128c95513" level="file">
        <did>
          <unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="b024cc396c1d18a6c6b0010567baac9a" label="mixed materials (A0000000075925)" type="box">83</container>
          <container id="72f43b4208f295d249ad480abcb8189c" parent="b024cc396c1d18a6c6b0010567baac9a" type="folder">19</container>
        </did>
        <accessrestrict id="e0dca88a43ebdabbfbf835cde2da0a4f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c6404194bb02ecf2496bacd146a0cc60" level="file">
        <did>
          <unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="42b9ccd11bc289bf8b4438b02188d0e3" label="mixed materials (A0000000075926)" type="box">84</container>
          <container id="ea856e3e050d4187a86907692902cc27" parent="42b9ccd11bc289bf8b4438b02188d0e3" type="folder">1-3</container>
        </did>
        <accessrestrict id="ff3d2237bfc8f29c4712b54bf885e9be">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="2ddbc741772355d7dce54b4b63ef6749" level="file">
        <did>
          <unittitle>TML, 45-97 - Efalizumabe (Raptiva) for treatment of psoriasis</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="c9f1ebd04efb098a7240d51154dad9e0" label="mixed materials (A0000000075926)" type="box">84</container>
          <container id="0ad03f123084529496a89cab19b68069" parent="c9f1ebd04efb098a7240d51154dad9e0" type="folder">4-5</container>
        </did>
        <accessrestrict id="6eb237f5b70a5174ed44b4dc845e1439">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0f45b082b3a08c7cce74229a00644b02" level="file">
        <did>
          <unittitle>TML, 45-97 (45-333) - Eletriptan (Replax) for migraine</unittitle>
          <unitdate type="inclusive">2003 April 28</unitdate>
          <container id="e77c2ab47321c8da4ed8d0c1052ec932" label="mixed materials (A0000000075926)" type="box">84</container>
          <container id="c8ffaefccc3b2c111d867965a004b080" parent="e77c2ab47321c8da4ed8d0c1052ec932" type="folder">6-8</container>
        </did>
        <accessrestrict id="f517a35e209156fcce5cddbc43b68b14">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="94948e6e42424f89ec840de91511a768" level="file">
        <did>
          <unittitle>TML, 45-49 - Enfuvirtide (Fuzeon) for HIV infection</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="0a753585dfe1ea08ae6ff8ddd617bd24" label="mixed materials (A0000000075926)" type="box">84</container>
          <container id="b901abcf1b083ed08de00ce1f91a7ea2" parent="0a753585dfe1ea08ae6ff8ddd617bd24" type="folder">9-11</container>
        </did>
        <accessrestrict id="a3551a188d335a0b903727fcd2a48fa4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="48f4b3c522fa705a3ae202735e45ac3b" level="file">
        <did>
          <unittitle>TML, 45-89 - Growth hormone for normal short children</unittitle>
          <unitdate type="inclusive">2003 November 10</unitdate>
          <container id="b685ee8ec2689e0f19fe0db957cd09e4" label="mixed materials (A0000000075926)" type="box">84</container>
          <container id="8b2af86d2ff839c5e3f41ea3c3167638" parent="b685ee8ec2689e0f19fe0db957cd09e4" type="folder">12-14</container>
        </did>
        <accessrestrict id="3229644ce53e8795f97a65d5d61f18e8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="780d425bdbd53ceafd83133223d279a7" level="file">
        <did>
          <unittitle>TML, 45-67 - Omalizumab (Xolair) for Asthma</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="dd6296a0d1aa85a2fe76a337ac6219fa" label="mixed materials (A0000000075926)" type="box">84</container>
          <container id="990e8e3c170b65c6b96a73dbff742e44" parent="dd6296a0d1aa85a2fe76a337ac6219fa" type="folder">15-18</container>
        </did>
        <accessrestrict id="12994eea68e1f09108df54e255ae8cff">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3e27a4c127b0269848618ade1805962f" level="file">
        <did>
          <unittitle>TML, 45-7 - Oxalipatin</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="ccc2afa910a50890300889bd9279abd3" label="mixed materials (A0000000075926)" type="box">84</container>
          <container id="6cc42be3d9c32ef8b35c1c15299dde03" parent="ccc2afa910a50890300889bd9279abd3" type="folder">19</container>
        </did>
        <accessrestrict id="319e1cb1c4d5a539efc2e6af94af005a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="732aaf61ce82ace45c4354ea0038b752" level="file">
        <did>
          <unittitle>TML, 45-7 - Oxalipatin</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="1b00389ea0bda37ef74fa9f99750e77a" label="mixed materials (A0000000075927)" type="box">85</container>
          <container id="91ffbbe470651097750bb0a64717b6cb" parent="1b00389ea0bda37ef74fa9f99750e77a" type="folder">1-2</container>
        </did>
        <accessrestrict id="c716c8d0ab4facf419cf7e7c4082202e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c4617feb74a721aa21a7112babed977f" level="file">
        <did>
          <unittitle>TML, 45-38 - Oxbutynin trandermal (Oxytrol) for overactive bladder</unittitle>
          <unitdate type="inclusive">2003 May 12</unitdate>
          <container id="b5b0bf06e4f14251cf0dfa952c97a991" label="mixed materials (A0000000075927)" type="box">85</container>
          <container id="a25fd07e688b3a9492253c8d1cf90fb8" parent="b5b0bf06e4f14251cf0dfa952c97a991" type="folder">3-4</container>
        </did>
        <accessrestrict id="09ded828b852ae6c86297bc23c88adc0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="8486f3e9d9968bc9f1dce0df7483cd4b" level="file">
        <did>
          <unittitle>TML, 45-54 - Rapid tests for HIV infection</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="fe6a2717966707041229dd2a374c348e" label="mixed materials (A0000000075927)" type="box">85</container>
          <container id="aec8c4dd7e77e326a76610fa3a0cf806" parent="fe6a2717966707041229dd2a374c348e" type="folder">5-8</container>
        </did>
        <accessrestrict id="9d74192e21e6502b4dff990dec4cbb50">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="e54b07dbb6cb8e75aad0e568c11cae0a" level="file">
        <did>
          <unittitle>TML, 45-77 - Vardenafil (Levitra) for erectile dysfunction</unittitle>
          <unitdate type="inclusive">2003 September 29</unitdate>
          <container id="6241df1634079a4dfc839b88f79e88e3" label="mixed materials (A0000000075927)" type="box">85</container>
          <container id="c77a0c4c56efc85805cd7d08376b2fee" parent="6241df1634079a4dfc839b88f79e88e3" type="folder">9-12</container>
        </did>
        <accessrestrict id="f6350ccd6ef35a9adb3c39e7c7bf3a3c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="fdd62d893c6f422fd7c183e65efa7835" level="file">
        <did>
          <unittitle>TML, 45-11 - Atomoxetine (Strattera)</unittitle>
          <unitdate type="inclusive">2003 February 3</unitdate>
          <container id="f92ccc835c28647cfd9183a5aa14db26" label="mixed materials (A0000000075927)" type="box">85</container>
          <container id="dc9e6feaa3e91774a900dbeb1aaec1dd" parent="f92ccc835c28647cfd9183a5aa14db26" type="folder">13-15</container>
        </did>
        <accessrestrict id="36610a7149adbc1f92cfdc7751128db1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="35402d0a4356ba61f6f491a96f89217a" level="file">
        <did>
          <unittitle>TML, 45-15 - Buprenorphine - an alternative to methadone</unittitle>
          <unitdate type="inclusive">2013 February 17</unitdate>
          <container id="3d1e391c962fe98b5cdf3476a5c693c5" label="mixed materials (A0000000075927)" type="box">85</container>
          <container id="07a7c0f4cee777b32d02b0834d573518" parent="3d1e391c962fe98b5cdf3476a5c693c5" type="folder">16-20</container>
        </did>
        <accessrestrict id="136a1315a2303fa111e5d01cb0517e7d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3fc7a0238f453d851bcf8a694afaf2ab" level="file">
        <did>
          <unittitle>TML, 45-74 - Agalsidase beta (Fabrazyme) for Fabry disease</unittitle>
          <unitdate type="inclusive">2003 September 15</unitdate>
          <container id="3f4dfbd26294cdb55f50ea4b28633cde" label="mixed materials (A0000000075928)" type="box">86</container>
          <container id="8176f43c2a96abd576fa340e0c60c1a7" parent="3f4dfbd26294cdb55f50ea4b28633cde" type="folder">1-3</container>
        </did>
        <accessrestrict id="aab1089a7327f8fc78a2fc319190599a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="5569c52b23e7d7eeddf53f7c2b84a996" level="file">
        <did>
          <unittitle>TML, 45-39 - Eplerenone (Inspra)</unittitle>
          <unitdate type="inclusive">2003 May 12</unitdate>
          <container id="47b8e0c655c0ac589e32a7b9c86e9c37" label="mixed materials (A0000000075928)" type="box">86</container>
          <container id="d53b69097d00f600e7e0ec9ee1b765dd" parent="47b8e0c655c0ac589e32a7b9c86e9c37" type="folder">4-6</container>
        </did>
        <accessrestrict id="4fc1e68dd96cabb133f171a2e6a52471">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="19fc064c09e3806caaddbb51b70e4090" level="file">
        <did>
          <unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="0eee3f2ddebcdbb50487580e9e717c90" label="mixed materials (A0000000075928)" type="box">86</container>
          <container id="c998f48400890b1c04d76427f8140ce1" parent="0eee3f2ddebcdbb50487580e9e717c90" type="folder">5A-6A</container>
        </did>
        <accessrestrict id="60b6213d43e89633056c4a067f8c54e8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="f0a8b264973dfe8db5fe8da9b49f6e58" level="file">
        <did>
          <unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="344c59a6c86ed7b5be6fb60842f32241" label="mixed materials (A0000000075928)" type="box">86</container>
          <container id="60c02d480ed63ae141f7e0861abb72d1" parent="344c59a6c86ed7b5be6fb60842f32241" type="folder">7-9</container>
        </did>
        <accessrestrict id="7a45da012d9d8375ab9c62d057d20b13">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="d1e93fdc68ebf64e073b0d53c908f073" level="file">
        <did>
          <unittitle>TML, 45-101 - Tadalafil (Cialis) for Erectile dysfunction</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="e7a2d3e6f7fc23d935b495042db8e00c" label="mixed materials (A0000000075928)" type="box">86</container>
          <container id="8d6c2cec15ea96bcaf75ccf5f625be4e" parent="e7a2d3e6f7fc23d935b495042db8e00c" type="folder">10-11</container>
        </did>
        <accessrestrict id="a187e298156d35ecb24bf62acbaa2162">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="bf6ed6095bb9e6efdcac9a21b49e00e9" level="file">
        <did>
          <unittitle>TML, 45-95 - Tattoo Removal</unittitle>
          <unitdate type="inclusive">2003 November 24</unitdate>
          <container id="6f20b311bc60009f1d849af3edfa8c82" label="mixed materials (A0000000075928)" type="box">86</container>
          <container id="8be6ca656f14414df55539a9ddffe36c" parent="6f20b311bc60009f1d849af3edfa8c82" type="folder">12-13</container>
        </did>
        <accessrestrict id="1cb8774dfbec0195c1be0234b77205c6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="a857cbd537b23d5351b0c89499d70d8e" level="file">
        <did>
          <unittitle>TML, 45-51 - Priloscec, Nexium and stereoisomers</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="66411e9e11242c2e1a69c412eaa2657f" label="mixed materials (A0000000075928)" type="box">86</container>
          <container id="6ee08fb14ad93275f2dce4deb2834137" parent="66411e9e11242c2e1a69c412eaa2657f" type="folder">14</container>
        </did>
        <accessrestrict id="4b2308536bb701384ee28edb8995985a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="1ed11b7c73752bdb0689383a30c1baf5" level="file">
        <did>
          <unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="e0777eb65ec21529d6f91c7ecd7cdcf8" label="mixed materials (A0000000075928)" type="box">86</container>
          <container id="ee3df9eef0f2f4864675ec93c0f2dca1" parent="e0777eb65ec21529d6f91c7ecd7cdcf8" type="folder">15-16</container>
        </did>
        <accessrestrict id="4ae7a8a3386cf59e0586622b1db28e61">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c48f05a528d95bdfee4855de30cb54e2" level="file">
        <did>
          <unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="c96e542c6e6bfb8ccb005d2bf72de00b" label="mixed materials (A0000000075929)" type="box">87</container>
          <container id="5903778d9d0eb00ceba6df0ef34857ce" parent="c96e542c6e6bfb8ccb005d2bf72de00b" type="folder">1</container>
        </did>
        <accessrestrict id="d1a19b29c41ed450efa6dd0a35b030ad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3e6aff84359c7cdd06669d9d72f8c12a" level="file">
        <did>
          <unittitle>TML, 45-21 - Montelukast (Singulair) for allergic rhinitis</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="fd3bac9b9329abd82553846d957fdce1" label="mixed materials (A0000000075929)" type="box">87</container>
          <container id="aeac0a1e96f848111f543be11888d3a9" parent="fd3bac9b9329abd82553846d957fdce1" type="folder">2-4</container>
        </did>
        <accessrestrict id="2b573db89b3a7e7ffb7bbe4571d64e85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="7d40fbe976113721e79b64dd1d00e27d" level="file">
        <did>
          <unittitle>TML, 45-3 - OTC Loratadine</unittitle>
          <unitdate type="inclusive">2003 January 6</unitdate>
          <container id="58b67446334f0ddfdbed99d16ebe7d07" label="mixed materials (A0000000075929)" type="box">87</container>
          <container id="b5dcb33d79d38b3d6a198074c22bc9df" parent="58b67446334f0ddfdbed99d16ebe7d07" type="folder">5</container>
        </did>
        <accessrestrict id="68d83db5324a44659c1dd3f51c2e2864">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="1823eedc9d0074c8a4265ac61efdfda5" level="file">
        <did>
          <unittitle>TML, 45-41 - Insect repellents</unittitle>
          <unitdate type="inclusive">2003 May 26</unitdate>
          <container id="3376e0a944dd2b2b99c4d818c006a290" label="mixed materials (A0000000075929)" type="box">87</container>
          <container id="ad3fb8bae1dfa441e38e2a34cbb44e0f" parent="3376e0a944dd2b2b99c4d818c006a290" type="folder">6-8</container>
        </did>
        <accessrestrict id="fd9f974ca565c85df29a51348d8fb4a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="2f3bcea3a484b983f63233e648e58d71" level="file">
        <did>
          <unittitle>TML, 45-81 - Rosuvastatin - a new lipid-lowering drug</unittitle>
          <unitdate type="inclusive">2003 October 13</unitdate>
          <container id="3c3c312ace620e63e1babe605aadb199" label="mixed materials (A0000000075929)" type="box">87</container>
          <container id="8302399e3beb0dbceb5c6cce8676cfaf" parent="3c3c312ace620e63e1babe605aadb199" type="folder">9-12</container>
        </did>
        <accessrestrict id="43bf4f6f81d3fbdf04c68bbc454e9040">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="ba56ad48c3bef0d702fff7fdda72fa22" level="file">
        <did>
          <unittitle>TML, 45-35 - Insulin-sensitizing drugs for polycystic ovary syndrome</unittitle>
          <unitdate type="inclusive">2003 April 28</unitdate>
          <container id="be399449a99434a7dedfe36879bf03fc" label="mixed materials (A0000000075929)" type="box">87</container>
          <container id="2e26d8614f8da907a0f3bfe9c4aaefe4" parent="be399449a99434a7dedfe36879bf03fc" type="folder">13-15</container>
        </did>
        <accessrestrict id="68c074ca5c7b85d99e37109be8f03f26">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3d9fbb15ae7446c6c645d70bd47fbf3b" level="file">
        <did>
          <unittitle>TML, 45-73 - Memantine for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2003 September 15</unitdate>
          <container id="0d0f8b50cd8aa75533ad72de8c697da7" label="mixed materials (A0000000075929)" type="box">87</container>
          <container id="7406c2428813d57b039b046fd0ab38c3" parent="0d0f8b50cd8aa75533ad72de8c697da7" type="folder">16-18</container>
        </did>
        <accessrestrict id="349dea74056b705fe12a6e58b6be4a61">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="11bdec471c430a38763f1ea9a86eab38" level="file">
        <did>
          <unittitle>TML, 45-58 - Treatment of heat injury</unittitle>
          <unitdate type="inclusive">2003 July 21</unitdate>
          <container id="6871cfbda711df9c0925e9b8477ad73e" label="mixed materials (A0000000075930)" type="box">88</container>
          <container id="6e8f9d8f71b12d36b85eb603c3077f9a" parent="6871cfbda711df9c0925e9b8477ad73e" type="folder">1-2</container>
        </did>
        <accessrestrict id="b32e89185eafe8ec72db09448de5ce28">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="806d8942533d66de734e65e88b3304ee" level="file">
        <did>
          <unittitle>TML, 45-90 - Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV infection</unittitle>
          <unitdate type="inclusive">2003 November 10</unitdate>
          <container id="1e59c7e20de6c038b93288a2c31e9b1b" label="mixed materials (A0000000075930)" type="box">88</container>
          <container id="c8e9aedb8cae2b8c7a4602caa6b04821" parent="1e59c7e20de6c038b93288a2c31e9b1b" type="folder">3-6</container>
        </did>
        <accessrestrict id="d90cbf0a7351c28f0b2d1347edc27949">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="04dee614a81cacb32c43ef5b0a88af03" level="file">
        <did>
          <unittitle>TML, 45-88 - Aldurazyme (Laronidase)</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="d5123cf980a6e6aed170b783620ef252" label="mixed materials (A0000000075930)" type="box">88</container>
          <container id="30ab8371e000af1650653a5d818828cd" parent="d5123cf980a6e6aed170b783620ef252" type="folder">7-8</container>
        </did>
        <accessrestrict id="b53a56596e6cd54c520d93ec764edd68">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9233509af152396c7a0be4f4a4690cec" level="file">
        <did>
          <unittitle>TML, 45-46 - Drug Interactions</unittitle>
          <unitdate type="inclusive">2003 June 9</unitdate>
          <container id="6858221de1eea5cd6fbdfa0cd367b543" label="mixed materials (A0000000075930)" type="box">88</container>
          <container id="d3f9bfe2fe06b198eb477d3d1fbfe458" parent="6858221de1eea5cd6fbdfa0cd367b543" type="folder">9-12</container>
        </did>
        <accessrestrict id="7b355cfd23bf5faae7008b6d8dfcd613">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="95a2b9eb73be12648888070a03ead474" level="file">
        <did>
          <unittitle>TML, 45-85 - Lowering Plasma Homocystein</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="74b19a1615ef8be405dc79550b7f20be" label="mixed materials (A0000000075930)" type="box">88</container>
          <container id="fe3d562ef88db4d60b31b2bc2c86b1a3" parent="74b19a1615ef8be405dc79550b7f20be" type="folder">13-17</container>
        </did>
        <accessrestrict id="150bc9e4636bdbb6ef444d31120758f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="dad27947e40b662edd3cc5a90a0be625" level="file">
        <did>
          <unittitle>TML, 45-83 - Lp-Pla2 - A new marker of Vasular Risk</unittitle>
          <unitdate type="inclusive">2003 October 13</unitdate>
          <container id="4a0ee332f68171b0b48e4b09f94f1a13" label="mixed materials (A0000000075930)" type="box">88</container>
          <container id="437fd449a478cb5e9bba1c47d43c0f47" parent="4a0ee332f68171b0b48e4b09f94f1a13" type="folder">18-19</container>
        </did>
        <accessrestrict id="7bacb749d5cace7b77c6d20686088469">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="e617e6eea5f9996628c705dd200e1ffa" level="file">
        <did>
          <unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="37cc1a854f720fdbb27174ed00576289" label="mixed materials (A0000000075930)" type="box">88</container>
          <container id="fae3f0308939b028bf9332dcfebc564a" parent="37cc1a854f720fdbb27174ed00576289" type="folder">20</container>
        </did>
        <accessrestrict id="8c291adc86b1ece8d63fe68ecf028b3e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9fd8a0d9db61f711e261afe6ec4c49ea" level="file">
        <did>
          <unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="7f3aceacb570f3171c376c7c5268e877" label="mixed materials (A0000000075931)" type="box">89</container>
          <container id="6674c54747d4f83b5a51a73c026ad85a" parent="7f3aceacb570f3171c376c7c5268e877" type="folder">1-4</container>
        </did>
        <accessrestrict id="bce92c80f15ffaccbaa401c6170b83ed">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="edaf8bc319227fe95dce9ce1973f3621" level="file">
        <did>
          <unittitle>TML, 45-86 - Iodine-131 - Tositumomab (Bexxar) for treatment of Lymphoma</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="7d0dfe6c567a488f5ea2c0d9e71c7b3d" label="mixed materials (A0000000075931)" type="box">89</container>
          <container id="76112f30ad4688145b4d02acc43e4314" parent="7d0dfe6c567a488f5ea2c0d9e71c7b3d" type="folder">5-9</container>
        </did>
        <accessrestrict id="a9e5f083314a82f3692a841eac51a5ca">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="f8dc69e4bf109c9986cc722051633070" level="file">
        <did>
          <unittitle>TML, 45-27 - Pneumococcal Conjugate Vaccine</unittitle>
          <unitdate type="inclusive">2003 March 31</unitdate>
          <container id="35ac13f261f9b92876d1be0b6891afc4" label="mixed materials (A0000000075931)" type="box">89</container>
          <container id="59841d63f5d8d25b44de67855b5ca6a4" parent="35ac13f261f9b92876d1be0b6891afc4" type="folder">10-11</container>
        </did>
        <accessrestrict id="e59f218612780c21cd1831f3c38ec08e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="cc9f06be346fedef1f6102477bee9cb2" level="file">
        <did>
          <unittitle>TML, 45-78 - Influenza Prevention</unittitle>
          <unitdate type="inclusive">2003 September 29</unitdate>
          <container id="802130c6677a633ac68f649801c30ef2" label="mixed materials (A0000000075931)" type="box">89</container>
          <container id="26a3637b69c83453095372d756b98fae" parent="802130c6677a633ac68f649801c30ef2" type="folder">12-14</container>
        </did>
        <accessrestrict id="cc6daf505d9a0ea7ee4c3ea324aa8478">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="39d9d76dedec7d6057d3eb65d8744ded" level="file">
        <did>
          <unittitle>TML, 45-19 - Peginterferon alfa (Pegasys) for Chronic Hepatitis C</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="c0e0ff9bae51199f73fac48705bbb379" label="mixed materials (A0000000075931)" type="box">89</container>
          <container id="d79e602aebf4a36f8b5c52bb4233a142" parent="c0e0ff9bae51199f73fac48705bbb379" type="folder">15-16</container>
        </did>
        <accessrestrict id="4cfe15ffe7bdd2742771ed54d3c1d07c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="efd0e7eb3789a0bc30a68f63ca9b430c" level="file">
        <did>
          <unittitle>TML, 45-55 - Pegvisomant (Somavert) for Acromegly</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="6f6d440e5b8dcae05fb6c16418c141ce" label="mixed materials (A0000000075931)" type="box">89</container>
          <container id="b2f16840763341e45e0f23fdd15d5037" parent="6f6d440e5b8dcae05fb6c16418c141ce" type="folder">17-20</container>
        </did>
        <accessrestrict id="565dbbbdc9cf527d50ca1536a406a58f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="e809ce901af88811ad1fd0cb5bc5882c" level="file">
        <did>
          <unittitle>TML, 45-9 - Teriparatide for Osteoporosis</unittitle>
          <unitdate type="inclusive">2003 February 3</unitdate>
          <container id="0ae46039422053cb3f95844fd9d09399" label="mixed materials (A0000000075932)" type="box">90</container>
          <container id="8efe6448b78f6498d4bdcfed818778e2" parent="0ae46039422053cb3f95844fd9d09399" type="folder">1-4</container>
        </did>
        <accessrestrict id="662bdc9f7dbb54b08b4950ea34c176c4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="acd944256fa6e191f50b1c636b7b7bf4" level="file">
        <did>
          <unittitle>TML, 45-70 - Testim and Striant - two new testosterone products</unittitle>
          <unitdate type="inclusive">2003 September 1</unitdate>
          <container id="560cc42347441a796ff8c17a566d8b91" label="mixed materials (A0000000075932)" type="box">90</container>
          <container id="06ae0dd6a423c65713c61c026c1bc6e0" parent="560cc42347441a796ff8c17a566d8b91" type="folder">5-8</container>
        </did>
        <accessrestrict id="56655a641344d4055a005097ec27c5cb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="fbdf4b7f30d77eaf33b84599e0a5e6e6" level="file">
        <did>
          <unittitle>TML, 45-1 - Smallpox vaccine</unittitle>
          <unitdate type="inclusive">2003 January 6</unitdate>
          <container id="fef56a46bb3e5f311050486e84d2b785" label="mixed materials (A0000000075932)" type="box">90</container>
          <container id="d57feec86e85fb6e5ac9c197d558ef5d" parent="fef56a46bb3e5f311050486e84d2b785" type="folder">9-12</container>
        </did>
        <accessrestrict id="df814d1bfcebe53223f1d57c2a6776e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="d9642438ec124cd82d8e135b0198ede7" level="file">
        <did>
          <unittitle>TML, 45-69 - Minimal surgery for treatment of GERD</unittitle>
          <unitdate type="inclusive">2003 September 1</unitdate>
          <container id="a223cd10810e7a63ba9a3c1d45fedd0f" label="mixed materials (A0000000075932)" type="box">90</container>
          <container id="85671becb446ffaf067e268ceee98c29" parent="a223cd10810e7a63ba9a3c1d45fedd0f" type="folder">13-16</container>
        </did>
        <accessrestrict id="572b2a0e74e3c89c9169b31576cc0b55">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0e7f3c8cc41ff780e30caa2e1cd3c245" level="file">
        <did>
          <unittitle>TML, 45-23 - Drug-eluting Stents</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="10c57b3cdf3a0865ca4d0a7418e08c5e" label="mixed materials (A0000000075932)" type="box">90</container>
          <container id="050fc33c9a67bcef89f0a8e497a9ebf9" parent="10c57b3cdf3a0865ca4d0a7418e08c5e" type="folder">17-19</container>
        </did>
        <accessrestrict id="91472bcb765db5980f76960bca69f7bb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="4cbcc7808efc65afe1e68d84b33f1bea" level="file">
        <did>
          <unittitle>TML, 45-23 - Drug-eluting Stents</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="55e5d7a6887f6acd783d75436b554e87" label="mixed materials (A0000000075933)" type="box">91</container>
          <container id="9b9875d3745a781afc30a4a76acbbc18" parent="55e5d7a6887f6acd783d75436b554e87" type="folder">1</container>
        </did>
        <accessrestrict id="ad37cdcd99a2044624e749e1cd39779d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="f9a9c4fc1896553a888be142b1758016" level="file">
        <did>
          <unittitle>TML, 45-61 - Omeprazole (Prilosec) (OTC)</unittitle>
          <unitdate type="inclusive">2003 August 4</unitdate>
          <container id="76013e856d7047a60aa7e794c53c6e0d" label="mixed materials (A0000000075933)" type="box">91</container>
          <container id="37bb9a02076364f1ea058e2cd302e7d8" parent="76013e856d7047a60aa7e794c53c6e0d" type="folder">2-3</container>
        </did>
        <accessrestrict id="d9a5d8493c3334bb1cda4ff7afb8a52c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="839fb8691411f959bd1aac5c4ebf7d26" level="file">
        <did>
          <unittitle>TML, 45-29 - Nitazoxanide (Alina) - a new anti-protozoal agent</unittitle>
          <unitdate type="inclusive">2003 April 14</unitdate>
          <container id="51c5b10d1485c910bb9880b2c068c30b" label="mixed materials (A0000000075933)" type="box">91</container>
          <container id="96c5162f1b3b7b518671259720f09614" parent="51c5b10d1485c910bb9880b2c068c30b" type="folder">4-5</container>
        </did>
        <accessrestrict id="ba825ee552c2bf91acd8b458e0a15d2d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="55365ce4b3ea2d58db64e9416965cb4e" level="file">
        <did>
          <unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="e8c47ef729b0f7c18d2f78f1a093f203" label="mixed materials (A0000000075933)" type="box">91</container>
          <container id="98ff529ddcd62523052c486a5d4b72fe" parent="e8c47ef729b0f7c18d2f78f1a093f203" type="folder">6-17</container>
        </did>
        <accessrestrict id="0ed20f41fac45d1a638a3740752cb703">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="668d7e7e07b5750eb2c823e11c095964" level="file">
        <did>
          <unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="87d4629ecd244b5f01d794d6400f30a7" label="mixed materials (A0000000075934)" type="box">92</container>
          <container id="965e0c7aa2bb08854bf74f2419db9a32" parent="87d4629ecd244b5f01d794d6400f30a7" type="folder">1-4</container>
        </did>
        <accessrestrict id="c2b71f78c735a86ad9547e6e3d24546c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c171f13c04b5ef1cf3b3fe5e96a9ef03" level="file">
        <did>
          <unittitle>TML - Weight Loss - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 December</unitdate>
          <container id="05c344af454dea408e539d929f7e4299" label="mixed materials (A0000000075934)" type="box">92</container>
          <container id="a0233ef3fb09d38b8c5933069a94d3d5" parent="05c344af454dea408e539d929f7e4299" type="folder">5-13</container>
        </did>
        <accessrestrict id="6dd9eece4a3c89e40bca2442781a600d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="ee60c4bf66a25475983425024da14c39" level="file">
        <did>
          <unittitle>TML - Heart Failure - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 April</unitdate>
          <container id="ff4473f95c07a68d2ddeef37134c206b" label="mixed materials (A0000000075934)" type="box">92</container>
          <container id="14044d6d9a2931f00860de8e15d220da" parent="ff4473f95c07a68d2ddeef37134c206b" type="folder">14-18</container>
        </did>
        <accessrestrict id="957488be5b6a3b3f5fb3aca8638e23b6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0be1e684fc9e69b20bc9867cc0b7288f" level="file">
        <did>
          <unittitle>TML - Drugs for rheumatoid arthritis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="20b7d27571de75c06cca1f9cb50899c2" label="mixed materials (A0000000075935)" type="box">93</container>
          <container id="8725e06f53df40a00afa5a78ea70163d" parent="20b7d27571de75c06cca1f9cb50899c2" type="folder">1-7</container>
        </did>
        <accessrestrict id="fea0a477360238ce0c79c9e79ad6d39a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c0978c508033828e366f1d55950a308e" level="file">
        <did>
          <unittitle>TML - Drugs for Psychiatric Disorders</unittitle>
          <unitdate type="inclusive">2003 July</unitdate>
          <container id="9dc2c4405bc4a1084adfd17524c5b3a5" label="mixed materials (A0000000075935)" type="box">93</container>
          <container id="c54d2c6a8fe4bf159149c7fa48a71d96" parent="9dc2c4405bc4a1084adfd17524c5b3a5" type="folder">8-18</container>
        </did>
        <accessrestrict id="03781a219ff982acf63e0290b3b87f0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="a9906d72f32382fa1bb39c1ccd388091" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="ddad226c6c8fca65a8ac74a342004d4c" label="mixed materials (A0000000075935)" type="box">93</container>
          <container id="f885e07eba1a644287864a7d77da218c" parent="ddad226c6c8fca65a8ac74a342004d4c" type="folder">19</container>
        </did>
        <accessrestrict id="a19ba7012ef7e238dc26e208ad0c53df">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9d1257d4a4ba512b1aa0bb0a4c07fdcd" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="0f302129a0c546243322f0683b329333" label="mixed materials (A0000000075936)" type="box">94</container>
          <container id="a35c3f1280ba2e96f68c2554965e36f5" parent="0f302129a0c546243322f0683b329333" type="folder">1-4</container>
        </did>
        <accessrestrict id="2097ee7f9bd39cd5ea6f974d3df6ff1f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="380c664090534851fbc806e0558fde2f" level="file">
        <did>
          <unittitle>TML - Assisted Reproduction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 October</unitdate>
          <container id="be576079a587991f6bec0941e2780eb0" label="mixed materials (A0000000075936)" type="box">94</container>
          <container id="c17795fe6c9c38df7580a51053bba510" parent="be576079a587991f6bec0941e2780eb0" type="folder">5-13</container>
        </did>
        <accessrestrict id="69fb416fcc934ed0c8b1f96140cd08e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="dfe820ca0d9eb165533f652cbc41ee32" level="file">
        <did>
          <unittitle>TML - Drugs for Hypertension - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 February</unitdate>
          <container id="697228f78f6fbb0a3235cf8522b47257" label="mixed materials (A0000000075936)" type="box">94</container>
          <container id="2bd7c32b19635462100da33c30e81296" parent="697228f78f6fbb0a3235cf8522b47257" type="folder">14-17</container>
        </did>
        <accessrestrict id="5a63fa0917343ef8eb141521fcb9e24e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3ce9ce08c457fba44042e2deea5066f7" level="file">
        <did>
          <unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="81da6a7b8196742d1b50403f3e21282a" label="mixed materials (A0000000075936)" type="box">94</container>
          <container id="ada80b8694d8e4bbb1cf9ea1e4fcaacb" parent="81da6a7b8196742d1b50403f3e21282a" type="folder">18</container>
        </did>
        <accessrestrict id="43bc17de19e0d00f4e7031362b3b3efc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="d475b54c5095880adce7b8263966fe2d" level="file">
        <did>
          <unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="876415e6781d2e298b382df936f5e517" label="mixed materials (A0000000075937)" type="box">95</container>
          <container id="fd9d6b5b22f68d39074a3157b19bb053" parent="876415e6781d2e298b382df936f5e517" type="folder">1-8</container>
        </did>
        <accessrestrict id="d727ecc0d3636f553591f418559bc721">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="a6efb00d5c63c6a2ccedf6563ae43110" level="file">
        <did>
          <unittitle>TML - Drugs for Epilepsy - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 May</unitdate>
          <container id="b4b58f67b98dac2303e754fa9859e915" label="mixed materials (A0000000075937)" type="box">95</container>
          <container id="94e03cb67c2675a1dd46b53c49c41280" parent="b4b58f67b98dac2303e754fa9859e915" type="folder">9-14</container>
        </did>
        <accessrestrict id="ae7bd45c44b6a19a25f101af3b5a211a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="5a5ba60bec4d0b97fddcd00799fd7626" level="file">
        <did>
          <unittitle>TML - Drugs for Lipid Disorders - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 August</unitdate>
          <container id="5e1c08b4b5b33d493a6a0c673a786557" label="mixed materials (A0000000075937)" type="box">95</container>
          <container id="1f9eb6934f003103fd0422db56234319" parent="5e1c08b4b5b33d493a6a0c673a786557" type="folder">15-18</container>
        </did>
        <accessrestrict id="334e64660b4fc298f4d1c26e9a76a343">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3c1aea5febbafdf8b5e437a8e97b9218" level="file">
        <did>
          <unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="9d9da8ae21dfe02fc3290de8e214e54b" label="mixed materials (A0000000075937)" type="box">95</container>
          <container id="48b4f1fd94c29d66be96ce553fb229ba" parent="9d9da8ae21dfe02fc3290de8e214e54b" type="folder">19</container>
        </did>
        <accessrestrict id="7cdf942787e0cbed8326189a2020f299">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="ddf6b73987ce0637989f66584610c6ea" level="file">
        <did>
          <unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="b71ba4b62f4c428d86f7022496652a93" label="mixed materials (A0000000075938)" type="box">96</container>
          <container id="80cfc1bb5b1781e65f19ee32b26f3efc" parent="b71ba4b62f4c428d86f7022496652a93" type="folder">1</container>
        </did>
        <accessrestrict id="2b960cecbba771988110df8a9cd33742">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0ca468433bcdc6006e7fb9b0ef21814e" level="file">
        <did>
          <unittitle>TML, 45-93 - Which SSRI</unittitle>
          <unitdate type="inclusive">2003 November 24</unitdate>
          <container id="5dae38513e5b0860ec2a289a9dcdce2f" label="mixed materials (A0000000075938)" type="box">96</container>
          <container id="738b589bed2dd1b3c9d94075841c12d2" parent="5dae38513e5b0860ec2a289a9dcdce2f" type="folder">2-5</container>
        </did>
        <accessrestrict id="72e10bfbf01df945876de61f8480a08b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="1e5a72f232d4e116685aff32e9ed9f87" level="file">
        <did>
          <unittitle>TML - Drugs for Allergic Disorders - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 November</unitdate>
          <container id="431f4d46c9beb1cabdeea18855812dfd" label="mixed materials (A0000000075938)" type="box">96</container>
          <container id="2f54081fa682102f137a912aec053bce" parent="431f4d46c9beb1cabdeea18855812dfd" type="folder">6-9</container>
        </did>
        <accessrestrict id="ce922dcf8bde445758a34a54106e0ec6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="7621ca9e85272fb03e367f6102650bf9" level="file">
        <did>
          <unittitle>TML - Drugs for Pneumonia - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 September</unitdate>
          <container id="dd6a44af204ab9fd3a18bfe713a9026b" label="mixed materials (A0000000075938)" type="box">96</container>
          <container id="eb9abfbbd9ca121c3d9b32a4db5d8ba6" parent="dd6a44af204ab9fd3a18bfe713a9026b" type="folder">10-17</container>
        </did>
        <accessrestrict id="429d1928e15342d8a9639e6b6a92e6d4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="68e729c691bb49c8be35f332fbb1e32b" level="file">
        <did>
          <unittitle>TML - Antimicrobial Prophylaxis for Surgery - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="d3a6494bb2704e93ad8723a461cc046d" label="mixed materials (A0000000075939)" type="box">97</container>
          <container id="7c79eb3da8f1087dc9137a3670b89da5" parent="d3a6494bb2704e93ad8723a461cc046d" type="folder">1-10</container>
        </did>
        <accessrestrict id="084a4278da0f4581918db07f8eb825b4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="07f19737b5f6d3009e9e85a8b0528533" level="file">
        <did>
          <unittitle>TML - Drugs for Cardiac Arrhythmias - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="2d0d999c6dec28dfbada1a342ea508a3" label="mixed materials (A0000000075939)" type="box">97</container>
          <container id="6db733498e151d62a8b33284f905f573" parent="2d0d999c6dec28dfbada1a342ea508a3" type="folder">11-18</container>
        </did>
        <accessrestrict id="8f26a61c71898392ee05f246c39c61b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="c099bb967206188345dcdbf9c2975e6d" level="file">
        <did>
          <unittitle>TML - Advice for Travelers - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="bbd7162cf12a0a57fdafaef4d21bc464" label="mixed materials (A0000000075940)" type="box">98</container>
          <container id="33c1d501e6ae276f85b50d40d6f9e1d9" parent="bbd7162cf12a0a57fdafaef4d21bc464" type="folder">1-9</container>
        </did>
        <accessrestrict id="e0b7814bc924716eb27275e9522cf9ae">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="237497500e700200226282634e319af9" level="file">
        <did>
          <unittitle>TML - Drugs for Migraine - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="6d426b8bab26a5d2728664f8546eb0e6" label="mixed materials (A0000000075940)" type="box">98</container>
          <container id="7473e99fb35c4b0f604b7343062fea4e" parent="6d426b8bab26a5d2728664f8546eb0e6" type="folder">10-15</container>
        </did>
        <accessrestrict id="00d75b64dab2398628516bc88ce53406">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="423b8c383be805c9a485a8fecfe9ddb1" level="file">
        <did>
          <unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 December</unitdate>
          <container id="ca0ed295c6f8ec2714db9242eaf3bcff" label="mixed materials (A0000000075940)" type="box">98</container>
          <container id="40ae5d158231e20376920799b11c36e1" parent="ca0ed295c6f8ec2714db9242eaf3bcff" type="folder">16</container>
        </did>
        <accessrestrict id="98f8b37e529ccb193a51c645e7d19af9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="26700edc7d4dff9bb83e29c005e8dedd" level="file">
        <did>
          <unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 December</unitdate>
          <container id="5c21d59e7ae1b8a6fa7794ccc86234e6" label="mixed materials (A0000000075941)" type="box">99</container>
          <container id="b6d991957d238afc28d92efea1550fe5" parent="5c21d59e7ae1b8a6fa7794ccc86234e6" type="folder">1-5</container>
        </did>
        <accessrestrict id="ff906c4305f7b289ec47141f34c41d10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="bef1ef630d26c3d4f70cc63b2da9dbfa" level="file">
        <did>
          <unittitle>TML - Drugs for Sexually transmitted infections - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 October</unitdate>
          <container id="a9525d9d93631f503d02523a9a21fa34" label="mixed materials (A0000000075941)" type="box">99</container>
          <container id="4d0ee3a36a5e54127dccc61a648e1270" parent="a9525d9d93631f503d02523a9a21fa34" type="folder">6-12</container>
        </did>
        <accessrestrict id="6db6900a0738aa418a1db1239ba995f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="ef8b77a4a9168df66dbaa1d35328f051" level="file">
        <did>
          <unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 June</unitdate>
          <container id="b26edb7c42fe3ade698577ca7d0580ae" label="mixed materials (A0000000075941)" type="box">99</container>
          <container id="0599f0993d2d22ab2a3f88fb254a7e75" parent="b26edb7c42fe3ade698577ca7d0580ae" type="folder">13-18</container>
        </did>
        <accessrestrict id="d4257f7e3e2891eb7db697e7bd0a7fc7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="4122c98e47eb1d53ed958233e91ca5d6" level="file">
        <did>
          <unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 June</unitdate>
          <container id="63e31a83623cc932768ecf697929132c" label="mixed materials (A0000000075942)" type="box">100</container>
          <container id="e2fcc2fa6d87f7f9995ddcfa2491846d" parent="63e31a83623cc932768ecf697929132c" type="folder">1-3</container>
        </did>
        <accessrestrict id="4ac25a41ad51ce40a2b44624b0c6f458">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="1db0c21858cc9e616d5906c203e6860d" level="file">
        <did>
          <unittitle>TML, 46-22 - Abarelix (Plenaxis) for advanced prostrate cancer</unittitle>
          <unitdate type="inclusive">2004 March 15</unitdate>
          <container id="0631fbdfd1d52f7bcfc7d170867e0727" label="mixed materials (A0000000075942)" type="box">100</container>
          <container id="5a6fdb0a3fa1dac10b1a271b2bc89cdb" parent="0631fbdfd1d52f7bcfc7d170867e0727" type="folder">4-5</container>
        </did>
        <accessrestrict id="d7dfc37db7d6c404c6134b6250ab6400">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="7f8aea6a2a9125acc397a2b721ccebdb" level="file">
        <did>
          <unittitle>TML, 46-9 - Daptomycin (Cubicin) for skin and soft tissue infections</unittitle>
          <unitdate type="inclusive">2004 February 2</unitdate>
          <container id="e7c4c78f59791dfef9cf934c016feb80" label="mixed materials (A0000000075942)" type="box">100</container>
          <container id="195857a2e09a8dfd26333f48e9899c86" parent="e7c4c78f59791dfef9cf934c016feb80" type="folder">6-8</container>
        </did>
        <accessrestrict id="8b64bb10092754b7b8a4c90c8deb7337">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="08fbdaa8a0871e1576f4bafb794f57f9" level="file">
        <did>
          <unittitle>TML, 46-10 - Emergency Contraception OTC</unittitle>
          <unitdate type="inclusive">2004 February 2</unitdate>
          <container id="a020b8e42144beab144422c98bc49231" label="mixed materials (A0000000075942)" type="box">100</container>
          <container id="1f3ab22a13e45d46a939beb01696a0c3" parent="a020b8e42144beab144422c98bc49231" type="folder">9-10</container>
        </did>
        <accessrestrict id="00f05ef1f3a72bb3da4ce317cb793c27">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="9ea3892837eec8429d01fe1dc14e6b41" level="file">
        <did>
          <unittitle>TML, 46-5 - Lasik and its alternatives - an update</unittitle>
          <unitdate type="inclusive">2004 January 19</unitdate>
          <container id="70f707d73682185c4d9586048f0d04f7" label="mixed materials (A0000000075942)" type="box">100</container>
          <container id="358a94d47698f64bd57e88c589ada579" parent="70f707d73682185c4d9586048f0d04f7" type="folder">11-14</container>
        </did>
        <accessrestrict id="7815c3c9e1b402b4a02ed5022e168609">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="f1703fc66140060139d86d70ac0c3846" level="file">
        <did>
          <unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle>
          <unitdate type="inclusive">2004 February 16</unitdate>
          <container id="11d5fff7c7046f8ec66becc05fca6346" label="mixed materials (A0000000075942)" type="box">100</container>
          <container id="3bccbb23a02ac6fd1ac14a3c190d8cc2" parent="11d5fff7c7046f8ec66becc05fca6346" type="folder">15-18</container>
        </did>
        <accessrestrict id="dc0cf1e8ca62aefc4f65bdca678ea19e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="e8f33c13c32daa15598a2e144e9f900f" level="file">
        <did>
          <unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle>
          <unitdate type="inclusive">2004 February 16</unitdate>
          <container id="229a22afd6cee6426b20c08e0a27a4de" label="mixed materials (A0000000075943)" type="box">101</container>
          <container id="37ad47267aac6f5b1de216c303bae3cf" parent="229a22afd6cee6426b20c08e0a27a4de" type="folder">1</container>
        </did>
        <accessrestrict id="81a1621d7a2a2452c30a530869fc9bea">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="f1258ee39d7e2cce0fa124be57ed0634" level="file">
        <did>
          <unittitle>TML - Choice of Antibacterial Drugs - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 March</unitdate>
          <container id="e1a140047a77f4c32eec1c9de4f1c7f0" label="mixed materials (A0000000075943)" type="box">101</container>
          <container id="cea8eaa85a78148a84f72fb1bd07c48a" parent="e1a140047a77f4c32eec1c9de4f1c7f0" type="folder">2-8</container>
        </did>
        <accessrestrict id="d14f31516858f5ff1d6ab38316a1acdf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="dcf6c003359f1d37afb6b89504a47763" level="file">
        <did>
          <unittitle>TML - Drugs for Peptic Ulcers - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 February</unitdate>
          <container id="2dbfeb583c8696790c5d53dda2d99a36" label="mixed materials (A0000000075943)" type="box">101</container>
          <container id="a0061b0bd9e3e0875893f990da9b0ef8" parent="2dbfeb583c8696790c5d53dda2d99a36" type="folder">9-17</container>
        </did>
        <accessrestrict id="ee022307e7bb1d19942f259293477255">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="0ba4f3a6cf74e6af72c13dc1e491dbd6" level="file">
        <did>
          <unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 January</unitdate>
          <container id="54a2dba20febae38bab9f63ca61089f0" label="mixed materials (A0000000075943)" type="box">101</container>
          <container id="8944adadc4c0cdcc26dd5f8bc22d41fb" parent="54a2dba20febae38bab9f63ca61089f0" type="folder">18-19</container>
        </did>
        <accessrestrict id="cae76792326d54b966f74999980f0522">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="499346d5020cece037a74d774986c858" level="file">
        <did>
          <unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 January</unitdate>
          <container id="ecec7030f56ad5b9254188d172f582d8" label="mixed materials (A0000000075944)" type="box">102</container>
          <container id="d628ff1870e08bcb368bc4481e1c01cf" parent="ecec7030f56ad5b9254188d172f582d8" type="folder">1-4</container>
        </did>
        <accessrestrict id="78b76f282a6087796d952eea7ca3851b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="e2ff3268992aa759f09a842e60822ffb" level="file">
        <did>
          <unittitle>TML - Drugs for Pain - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 July</unitdate>
          <container id="1351d8ac3d9bbb75be87f4dc12d4340b" label="mixed materials (A0000000075944)" type="box">102</container>
          <container id="50943a14fe6c509c778889c0905e793f" parent="1351d8ac3d9bbb75be87f4dc12d4340b" type="folder">5-14</container>
        </did>
        <accessrestrict id="04e11af6b467a1e7c10d7574675c44fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
    </dsc>
  </archdesc>
</ead>
